index,sex,IBD_type,med_class,antibody_level,seroconversion,age_group,DX_days,vaccine_status,serology_date,vac_date,days_from_vac,vac_type,age_at_collection,decade
1,female,CD,Anti-TNF Only,135,negative,adult,164,primary,16-Jun-21,06-Apr-21,71,vector,51,50 to 59
2,female,CD,Anti-TNF Only,,,adult,,booster2,27-Nov-21,09-Apr-21,232,vector,51,50 to 59
3,female,CD,Anti-TNF Only,447,positive,pediatric,105,booster2,12-Mar-22,06-Apr-21,340,vector,1,00 to 09
4,female,UC,Combination Therapy,114,negative,pediatric,,primary,28-May-21,28-Mar-21,61,mRNA,11,10 to 17
5,female,UC,Combination Therapy,3404,positive,pediatric,,booster1,09-Jul-21,30-Mar-21,101,mRNA,17,10 to 17
6,female,UC,Combination Therapy,2373,positive,pediatric,,booster2,11-Nov-21,01-Apr-21,224,mRNA,1,00 to 09
7,female,UC,Combination Therapy,544,positive,adult,,booster2,30-Jan-22,31-Oct-21,91,mRNA,42,40 to 49
8,female,UC,Combination Therapy,2249,positive,adult,,booster2,03-Jun-22,01-Apr-21,428,mRNA,42,40 to 49
9,male,UC,Ustekinumab Only,2044,positive,adult,,primary,15-May-21,02-Apr-21,43,mRNA,37,30 to 39
10,male,UC,Ustekinumab Only,16939,positive,adult,233,booster1,20-Jul-21,06-Apr-21,105,mRNA,37,30 to 39
11,male,UC,Ustekinumab Only,5153,positive,adult,146,booster1,15-Oct-21,06-Apr-21,192,mRNA,37,30 to 39
12,male,UC,Ustekinumab Only,,,adult,120,booster2,10-Nov-21,08-Apr-21,216,mRNA,37,30 to 39
13,male,UC,Ustekinumab Only,15214,positive,adult,27,booster2,11-Feb-22,06-Apr-21,311,mRNA,38,30 to 39
14,female,CD,No Immunosuppressives,715,positive,elderly,341,booster1,04-Jun-21,12-Mar-21,84,mRNA,82,70+
15,female,CD,No Immunosuppressives,200,positive,elderly,194,booster1,29-Oct-21,12-Mar-21,231,mRNA,82,70+
16,female,CD,No Immunosuppressives,1880,positive,elderly,138,booster2,24-Dec-21,11-Mar-21,288,mRNA,83,70+
17,female,CD,Corticosteroids,782,positive,elderly,61,booster2,11-Mar-22,12-Mar-21,364,mRNA,83,70+
18,female,CD,Corticosteroids,,,elderly,30,booster2,10-Jun-22,13-Mar-21,454,mRNA,83,70+
19,female,CD,Corticosteroids,1728,positive,adult,164,primary,03-Jun-21,12-Apr-21,52,vector,55,50 to 59
20,female,CD,Corticosteroids,15013,positive,adult,320,booster1,12-Aug-21,09-Apr-21,125,vector,55,50 to 59
21,female,CD,No Immunosuppressives,3772,positive,adult,216,booster1,24-Nov-21,08-Apr-21,230,vector,56,50 to 59
22,female,CD,No Immunosuppressives,56235,positive,adult,140,booster2,08-Feb-22,09-Apr-21,305,vector,56,50 to 59
23,female,CD,No Immunosuppressives,26456,positive,adult,68,booster2,21-Apr-22,11-Apr-21,375,vector,56,50 to 59
24,male,UC,No Immunosuppressives,1009,positive,elderly,205,primary,15-May-21,27-Mar-21,49,mRNA,63,60 to 69
25,male,UC,No Immunosuppressives,2418,positive,elderly,268,booster1,17-Jul-21,28-Mar-21,111,mRNA,63,60 to 69
26,male,UC,No Immunosuppressives,12618,positive,elderly,457,booster2,22-Jan-22,28-Mar-21,300,mRNA,63,60 to 69
27,male,UC,No Immunosuppressives,40014,positive,elderly,586,booster2,31-May-22,27-Mar-21,430,mRNA,64,60 to 69
28,female,CD,Ustekinumab Only,478,positive,adult,,primary,12-Jun-21,08-Apr-21,65,mRNA,17,10 to 17
29,female,UC,Anti-TNF Only,86,negative,adult,,primary,21-May-21,30-Mar-21,52,mRNA,49,40 to 49
30,female,UC,No Immunosuppressives,1757,positive,adult,,booster1,20-Jul-21,05-Apr-21,106,mRNA,49,40 to 49
31,female,UC,Anti-TNF Only,280,positive,adult,,booster1,16-Oct-21,02-Apr-21,197,mRNA,50,50 to 59
32,female,UC,Anti-TNF Only,5843,positive,adult,,booster2,20-Nov-21,01-Apr-21,233,mRNA,50,50 to 59
33,male,UC,Combination Therapy,147,negative,adult,,primary,10-Jun-21,08-Apr-21,63,mRNA,42,40 to 49
34,male,UC,Combination Therapy,435,positive,adult,,booster1,26-Aug-21,09-Apr-21,139,mRNA,42,40 to 49
35,male,UC,Combination Therapy,315,positive,adult,,booster1,18-Nov-21,04-Apr-21,228,mRNA,42,40 to 49
36,male,UC,Corticosteroids,5084,positive,adult,,booster2,30-Dec-21,04-Apr-21,270,mRNA,42,40 to 49
37,male,UC,Combination Therapy,813,positive,pediatric,,booster2,28-Apr-22,06-Apr-21,387,mRNA,10,10 to 17
38,male,CD,Anti-TNF Only,1176,positive,pediatric,,booster1,09-May-21,14-Jan-21,115,mRNA,10,10 to 17
39,female,CD,No Immunosuppressives,392,positive,pediatric,105,primary,25-May-21,17-Mar-21,69,vector,11,10 to 17
40,female,CD,No Immunosuppressives,2474,positive,pediatric,187,booster1,17-Jul-21,18-Mar-21,121,vector,17,10 to 17
41,female,CD,No Immunosuppressives,16877,positive,adult,96,booster2,16-Oct-21,14-Mar-21,216,vector,59,50 to 59
42,female,CD,No Immunosuppressives,21662,positive,adult,9,booster2,29-Jan-22,15-Mar-21,320,vector,59,50 to 59
43,female,CD,Combination Therapy,351,positive,adult,90,booster1,15-Jun-21,03-Apr-21,73,mRNA,59,50 to 59
44,female,CD,Combination Therapy,84,negative,pediatric,5,booster1,08-Sep-21,02-Apr-21,159,mRNA,1,00 to 09
45,female,CD,Combination Therapy,39689,positive,pediatric,38,booster2,21-Oct-21,03-Apr-21,201,mRNA,2,00 to 09
46,female,CD,Combination Therapy,8786,positive,pediatric,169,booster2,01-Mar-22,31-Mar-21,335,mRNA,12,10 to 17
47,female,CD,Combination Therapy,18525,positive,pediatric,291,booster2,01-Jul-22,04-Apr-21,453,mRNA,12,10 to 17
48,male,UC,No Immunosuppressives,1007,positive,adult,,primary,20-May-21,03-Apr-21,47,mRNA,36,30 to 39
49,male,UC,No Immunosuppressives,11262,positive,adult,,booster1,29-Jun-21,03-Apr-21,87,mRNA,36,30 to 39
50,male,UC,No Immunosuppressives,2579,positive,adult,,booster1,02-Nov-21,04-Apr-21,212,mRNA,36,30 to 39
51,male,UC,No Immunosuppressives,8737,positive,adult,,booster2,18-Feb-22,08-Apr-21,316,mRNA,36,30 to 39
52,male,UC,No Immunosuppressives,6703,positive,adult,,booster2,11-May-22,03-Apr-21,403,mRNA,37,30 to 39
53,male,UC,Anti-TNF Only,84,negative,elderly,,primary,14-May-21,11-Mar-21,64,mRNA,70,70+
54,male,UC,Anti-TNF Only,5,negative,elderly,,booster1,03-Aug-21,13-Mar-21,143,mRNA,70,70+
55,male,UC,Anti-TNF Only,4146,positive,elderly,,booster2,08-Dec-21,11-Mar-21,272,mRNA,71,70+
56,male,UC,Anti-TNF Only,277,positive,elderly,,booster2,16-Apr-22,11-Mar-21,401,mRNA,71,70+
57,male,UC,Anti-TNF Only,24161,positive,elderly,,booster2,31-May-22,14-Mar-21,443,mRNA,71,70+
58,female,UC,No Immunosuppressives,2847,positive,adult,,primary,26-May-21,21-Apr-21,35,vector,59,50 to 59
59,female,UC,No Immunosuppressives,51835,positive,adult,,booster1,24-Jun-21,22-Apr-21,63,vector,59,50 to 59
60,female,UC,No Immunosuppressives,3136,positive,adult,,booster1,07-Oct-21,25-Apr-21,165,vector,60,60 to 69
61,female,UC,No Immunosuppressives,21249,positive,adult,,booster2,17-Feb-22,23-Apr-21,300,vector,60,60 to 69
62,female,UC,No Immunosuppressives,12137,positive,adult,,booster2,04-May-22,24-Apr-21,375,vector,60,60 to 69
63,female,UC,No Immunosuppressives,377,positive,adult,,primary,05-Jun-21,18-Apr-21,48,mRNA,33,30 to 39
64,female,UC,No Immunosuppressives,5429,positive,adult,,booster1,14-Aug-21,14-Apr-21,122,mRNA,33,30 to 39
65,female,UC,No Immunosuppressives,477,positive,adult,262,primary,01-Jun-21,14-Apr-21,48,mRNA,36,30 to 39
66,female,UC,No Immunosuppressives,17812,positive,adult,218,booster1,15-Jul-21,18-Apr-21,88,mRNA,37,30 to 39
67,female,UC,No Immunosuppressives,1263,positive,adult,77,booster1,03-Dec-21,19-Apr-21,228,mRNA,37,30 to 39
68,female,UC,No Immunosuppressives,24723,positive,adult,23,booster2,26-Jan-22,16-Apr-21,285,mRNA,37,30 to 39
69,female,UC,No Immunosuppressives,27717,positive,adult,,booster2,14-May-22,14-Apr-21,395,mRNA,37,30 to 39
70,male,UC,Vedolizumab Only,1569,positive,adult,401,primary,03-Jun-21,22-Apr-21,42,mRNA,28,18 to 29
71,male,UC,Vedolizumab Only,31029,positive,adult,350,booster1,24-Jul-21,21-Apr-21,94,mRNA,28,18 to 29
72,male,UC,Vedolizumab Only,9811,positive,adult,210,booster1,11-Dec-21,19-Apr-21,236,mRNA,28,18 to 29
73,male,UC,Vedolizumab Only,16069,positive,adult,39,booster2,31-May-22,21-Apr-21,405,mRNA,29,18 to 29
74,female,CD,Ustekinumab Only,1626,positive,adult,,primary,14-Jun-21,17-Apr-21,58,mRNA,46,40 to 49
75,female,CD,Ustekinumab Only,19827,positive,adult,,booster1,23-Jul-21,14-Apr-21,100,mRNA,46,40 to 49
76,female,CD,Ustekinumab Only,698,positive,adult,,booster1,18-Jan-22,14-Apr-21,279,mRNA,47,40 to 49
77,female,CD,Ustekinumab Only,55016,positive,adult,,booster2,19-Feb-22,16-Apr-21,309,mRNA,47,40 to 49
78,female,CD,Ustekinumab Only,21397,positive,adult,,booster2,06-Jun-22,18-Apr-21,414,mRNA,47,40 to 49
79,male,CD,Combination Therapy,54,negative,adult,,primary,21-May-21,06-Apr-21,45,mRNA,28,18 to 29
80,male,CD,Combination Therapy,9,negative,adult,,booster1,05-Aug-21,04-Apr-21,123,mRNA,28,18 to 29
81,male,CD,Combination Therapy,19653,positive,adult,,booster2,29-Oct-21,02-Apr-21,210,mRNA,28,18 to 29
82,male,CD,Combination Therapy,1578,positive,adult,,booster2,10-Mar-22,06-Apr-21,338,mRNA,28,18 to 29
83,female,CD,Combination Therapy,69,negative,adult,,primary,26-May-21,10-Apr-21,46,mRNA,52,50 to 59
84,female,CD,Combination Therapy,1468,positive,adult,,booster1,24-Jul-21,10-Apr-21,105,mRNA,52,50 to 59
85,female,CD,Combination Therapy,296,positive,adult,,booster1,18-Oct-21,11-Apr-21,190,mRNA,52,50 to 59
86,female,CD,Combination Therapy,16732,positive,adult,,booster2,21-Jan-22,12-Apr-21,284,mRNA,53,50 to 59
87,female,CD,Combination Therapy,74218,positive,adult,,booster2,12-May-22,16-Apr-21,391,mRNA,53,50 to 59
88,male,CD,Corticosteroids,22,negative,elderly,,primary,15-Jun-21,09-Apr-21,67,vector,70,70+
89,male,CD,Corticosteroids,19,negative,elderly,,booster1,09-Sep-21,06-Apr-21,156,vector,70,70+
90,male,CD,Corticosteroids,217,positive,elderly,,booster2,17-Dec-21,03-Apr-21,258,vector,71,70+
91,male,CD,Corticosteroids,10,negative,elderly,,booster2,17-Mar-22,04-Apr-21,347,vector,71,70+
92,male,CD,Corticosteroids,57,negative,elderly,,booster2,21-Jun-22,03-Apr-21,444,vector,71,70+
93,female,CD,Anti-TNF Only,76,negative,elderly,112,primary,12-May-21,19-Mar-21,54,mRNA,67,60 to 69
94,female,CD,Anti-TNF Only,634,positive,elderly,26,booster1,06-Aug-21,19-Mar-21,140,mRNA,67,60 to 69
95,female,CD,Anti-TNF Only,209,positive,elderly,48,booster1,19-Oct-21,15-Mar-21,218,mRNA,67,60 to 69
96,female,CD,Anti-TNF Only,5248,positive,elderly,162,booster2,10-Feb-22,16-Mar-21,331,mRNA,68,60 to 69
97,female,CD,Anti-TNF Only,794,positive,elderly,245,booster2,04-May-22,19-Mar-21,411,mRNA,68,60 to 69
98,female,UC,Anti-TNF Only,407,positive,adult,275,primary,25-May-21,03-Apr-21,52,mRNA,28,18 to 29
99,male,UC,No Immunosuppressives,9407,positive,elderly,,booster1,01-Jun-21,10-Apr-21,52,mRNA,72,70+
100,male,UC,No Immunosuppressives,1919,positive,elderly,233,booster1,24-Sep-21,04-Apr-21,173,mRNA,72,70+
101,male,UC,No Immunosuppressives,3816,positive,elderly,146,booster2,23-Mar-22,07-Apr-21,350,mRNA,73,70+
102,male,UC,No Immunosuppressives,28207,positive,elderly,120,booster2,20-May-22,10-Apr-21,405,mRNA,73,70+
103,female,CD,No Immunosuppressives,643,positive,elderly,27,primary,02-Jun-21,26-Mar-21,68,mRNA,68,60 to 69
104,female,CD,No Immunosuppressives,3751,positive,elderly,341,booster1,17-Jul-21,24-Mar-21,115,mRNA,68,60 to 69
105,female,CD,No Immunosuppressives,1343,positive,elderly,194,booster1,02-Dec-21,25-Mar-21,252,mRNA,68,60 to 69
106,female,CD,No Immunosuppressives,14360,positive,elderly,138,booster2,02-Feb-22,25-Mar-21,314,mRNA,69,60 to 69
107,female,CD,No Immunosuppressives,5262,positive,elderly,61,booster2,19-May-22,23-Mar-21,422,mRNA,69,60 to 69
108,female,CD,No Immunosuppressives,19592,positive,elderly,30,booster2,07-Jul-22,23-Mar-21,471,mRNA,69,60 to 69
109,female,UC,Anti-TNF Only,42,negative,adult,233,primary,27-May-21,11-Apr-21,46,mRNA,33,30 to 39
110,female,UC,Anti-TNF Only,5763,positive,adult,209,booster1,22-Jul-21,08-Apr-21,105,mRNA,34,30 to 39
111,female,UC,Anti-TNF Only,21089,positive,adult,125,booster2,14-Oct-21,11-Apr-21,186,mRNA,34,30 to 39
112,female,UC,Anti-TNF Only,987,positive,adult,13,booster2,03-Feb-22,11-Apr-21,298,mRNA,34,30 to 39
113,female,CD,Anti-TNF Only,18924,positive,adult,,booster1,20-Jul-21,26-Apr-21,85,vector,24,18 to 29
114,female,CD,Anti-TNF Only,16653,positive,adult,,booster2,12-Nov-21,21-Apr-21,205,vector,24,18 to 29
115,female,CD,Anti-TNF Only,1258,positive,adult,,booster2,05-Mar-22,27-Apr-21,312,vector,25,18 to 29
116,female,CD,Anti-TNF Only,4924,positive,adult,,booster2,29-Apr-22,24-Apr-21,370,vector,25,18 to 29
117,female,CD,Ustekinumab Only,294,positive,pediatric,,primary,05-Jun-21,11-Apr-21,55,mRNA,12,10 to 17
118,female,CD,Ustekinumab Only,207,positive,pediatric,,primary,29-Jul-21,12-Apr-21,108,mRNA,7,00 to 09
119,female,CD,Ustekinumab Only,111,negative,pediatric,146,primary,29-Jul-21,10-Apr-21,110,mRNA,12,10 to 17
120,female,CD,Ustekinumab Only,6552,positive,pediatric,,booster1,28-Aug-21,14-Apr-21,136,mRNA,4,00 to 09
121,male,CD,Anti-TNF Only,1079,positive,adult,,primary,22-May-21,14-Apr-21,38,mRNA,31,30 to 39
122,male,CD,Anti-TNF Only,3789,positive,adult,,booster1,11-Sep-21,12-Apr-21,152,mRNA,32,30 to 39
123,male,CD,Anti-TNF Only,19078,positive,adult,,booster2,06-Nov-21,12-Apr-21,208,mRNA,32,30 to 39
124,male,CD,Corticosteroids,54,negative,adult,,primary,19-May-21,12-Apr-21,37,mRNA,52,50 to 59
125,male,CD,Corticosteroids,20152,positive,adult,,booster1,24-Aug-21,12-Apr-21,134,mRNA,52,50 to 59
126,male,CD,Corticosteroids,8473,positive,adult,,booster2,29-Oct-21,13-Apr-21,199,mRNA,52,50 to 59
127,male,CD,Corticosteroids,1189,positive,adult,,booster2,02-Mar-22,13-Apr-21,323,mRNA,53,50 to 59
128,male,CD,No Immunosuppressives,1585,positive,adult,,primary,09-Jun-21,22-Apr-21,48,vector,50,50 to 59
129,male,CD,No Immunosuppressives,29216,positive,adult,120,booster1,31-Jul-21,21-Apr-21,101,vector,50,50 to 59
130,male,CD,No Immunosuppressives,72731,positive,adult,,booster2,12-Feb-22,20-Apr-21,298,vector,50,50 to 59
131,male,CD,No Immunosuppressives,79909,positive,adult,,booster2,28-Jun-22,21-Apr-21,433,vector,51,50 to 59
132,female,CD,No Immunosuppressives,464,positive,adult,,primary,21-May-21,14-Mar-21,68,vector,62,60 to 69
133,female,CD,No Immunosuppressives,4176,positive,elderly,,booster1,10-Aug-21,12-Mar-21,151,vector,62,60 to 69
134,female,CD,No Immunosuppressives,493,positive,elderly,,booster1,25-Nov-21,13-Mar-21,257,vector,62,60 to 69
135,male,UC,Ustekinumab Only,436,positive,adult,390,primary,09-May-21,30-Mar-21,40,mRNA,39,30 to 39
136,male,UC,Ustekinumab Only,4891,positive,adult,300,booster1,07-Aug-21,28-Mar-21,132,mRNA,39,30 to 39
137,male,UC,Ustekinumab Only,19644,positive,adult,185,booster2,30-Nov-21,28-Mar-21,247,mRNA,39,30 to 39
138,male,UC,Ustekinumab Only,2670,positive,adult,73,booster2,22-Mar-22,02-Apr-21,354,mRNA,39,30 to 39
139,female,CD,Vedolizumab Only,110,negative,elderly,27,primary,14-May-21,13-Mar-21,62,mRNA,72,70+
140,female,CD,Vedolizumab Only,5009,positive,elderly,,booster1,27-Nov-21,13-Mar-21,259,mRNA,72,70+
141,female,CD,Vedolizumab Only,62498,positive,elderly,,booster2,18-Feb-22,12-Mar-21,343,mRNA,73,70+
142,female,UC,Combination Therapy,1319,positive,adult,237,primary,22-May-21,08-Apr-21,44,mRNA,35,30 to 39
143,female,UC,Combination Therapy,2521,positive,adult,162,booster1,05-Aug-21,06-Apr-21,121,mRNA,35,30 to 39
144,female,UC,Combination Therapy,7001,positive,adult,50,booster2,25-Nov-21,12-Apr-21,227,mRNA,35,30 to 39
145,female,UC,Combination Therapy,11069,positive,adult,56,booster2,11-Mar-22,10-Apr-21,335,mRNA,36,30 to 39
146,female,UC,Combination Therapy,48,negative,elderly,,primary,23-Jun-21,08-Apr-21,76,mRNA,71,70+
147,female,UC,Combination Therapy,36,negative,elderly,,booster1,10-Aug-21,07-Apr-21,125,mRNA,71,70+
148,female,UC,Combination Therapy,118,negative,elderly,,booster1,23-Dec-21,07-Apr-21,260,mRNA,71,70+
149,female,UC,Combination Therapy,3252,positive,elderly,341,booster2,22-Jun-22,08-Apr-21,440,mRNA,72,70+
150,female,UC,Anti-TNF Only,29,negative,adult,225,primary,01-Jul-21,04-Apr-21,88,mRNA,54,50 to 59
151,female,UC,Anti-TNF Only,2182,positive,adult,169,booster1,26-Aug-21,05-Apr-21,143,mRNA,54,50 to 59
152,female,UC,Anti-TNF Only,499,positive,adult,8,booster1,03-Feb-22,05-Apr-21,304,mRNA,55,50 to 59
153,male,CD,Anti-TNF Only,331,positive,adult,345,primary,14-May-21,05-Apr-21,39,mRNA,48,40 to 49
154,male,CD,Anti-TNF Only,7454,positive,adult,302,booster1,26-Jun-21,04-Apr-21,83,mRNA,48,40 to 49
155,male,CD,Anti-TNF Only,12438,positive,adult,187,booster2,19-Oct-21,04-Apr-21,198,mRNA,48,40 to 49
156,male,CD,Anti-TNF Only,1405,positive,adult,36,booster2,19-Mar-22,05-Apr-21,348,mRNA,49,40 to 49
157,female,CD,Vedolizumab Only,149,negative,adult,,primary,26-May-21,26-Apr-21,30,mRNA,46,40 to 49
158,female,CD,Vedolizumab Only,4288,positive,adult,,booster2,17-May-22,25-Apr-21,387,mRNA,47,40 to 49
159,male,UC,No Immunosuppressives,48,negative,adult,194,primary,13-May-21,19-Mar-21,55,vector,61,60 to 69
160,male,UC,No Immunosuppressives,4597,positive,adult,,booster1,25-Aug-21,19-Mar-21,159,vector,61,60 to 69
161,male,UC,No Immunosuppressives,,,adult,,booster2,05-Mar-22,14-Mar-21,356,vector,62,60 to 69
162,female,CD,Anti-TNF Only,3229,positive,elderly,,booster1,25-May-21,27-Feb-21,87,mRNA,64,60 to 69
163,female,CD,Anti-TNF Only,1112,positive,elderly,,booster1,16-Sep-21,01-Mar-21,199,mRNA,65,60 to 69
164,female,CD,Anti-TNF Only,4298,positive,elderly,,booster2,02-Feb-22,05-Mar-21,334,mRNA,65,60 to 69
165,female,CD,Anti-TNF Only,589,positive,elderly,,booster2,31-Mar-22,03-Mar-21,393,mRNA,65,60 to 69
166,female,CD,Anti-TNF Only,23935,positive,elderly,,booster2,18-May-22,04-Mar-21,440,mRNA,65,60 to 69
167,male,UC,Corticosteroids,4818,positive,elderly,23,primary,25-May-21,27-Mar-21,59,mRNA,64,60 to 69
168,male,UC,Corticosteroids,3697,positive,elderly,108,booster1,18-Aug-21,27-Mar-21,144,mRNA,65,60 to 69
169,male,UC,Corticosteroids,52571,positive,elderly,138,booster2,31-Dec-21,27-Mar-21,279,mRNA,65,60 to 69
170,male,UC,Corticosteroids,10625,positive,elderly,355,booster2,22-Apr-22,28-Mar-21,390,mRNA,65,60 to 69
171,female,UC,Anti-TNF Only,530,positive,elderly,232,primary,21-May-21,12-Apr-21,39,mRNA,70,70+
172,female,UC,Anti-TNF Only,492,positive,elderly,137,booster1,24-Aug-21,17-Apr-21,129,mRNA,70,70+
173,female,UC,Anti-TNF Only,990,positive,elderly,64,booster2,05-Nov-21,11-Apr-21,208,mRNA,70,70+
174,female,UC,Anti-TNF Only,38245,positive,elderly,25,booster2,02-Feb-22,17-Apr-21,291,mRNA,70,70+
175,female,UC,Anti-TNF Only,11056,positive,elderly,117,booster2,05-May-22,15-Apr-21,385,mRNA,71,70+
176,female,CD,Immunomodulator Only,153,positive,adult,,primary,14-May-21,31-Mar-21,44,mRNA,51,50 to 59
177,female,CD,Immunomodulator Only,318,positive,adult,,booster1,07-Jul-21,31-Mar-21,98,mRNA,52,50 to 59
178,female,CD,Immunomodulator Only,853,positive,adult,,booster2,13-Nov-21,31-Mar-21,227,mRNA,52,50 to 59
179,female,CD,Immunomodulator Only,606,positive,adult,61,booster2,12-Feb-22,04-Apr-21,314,mRNA,52,50 to 59
180,female,CD,Immunomodulator Only,3669,positive,adult,,booster2,13-May-22,03-Apr-21,405,mRNA,52,50 to 59
181,male,CD,Anti-TNF Only,7464,positive,adult,,booster1,22-Jul-21,21-Apr-21,92,mRNA,53,50 to 59
182,female,CD,Vedolizumab Only,174,positive,adult,,primary,16-Jun-21,06-Apr-21,71,mRNA,57,50 to 59
183,female,CD,Vedolizumab Only,4207,positive,adult,,booster2,26-Mar-22,06-Apr-21,354,mRNA,57,50 to 59
184,male,CD,No Immunosuppressives,484,positive,elderly,,primary,08-May-21,28-Mar-21,41,mRNA,66,60 to 69
185,male,CD,No Immunosuppressives,5714,positive,elderly,,booster1,27-Jul-21,28-Mar-21,121,mRNA,66,60 to 69
186,male,CD,No Immunosuppressives,2669,positive,elderly,,booster1,20-Nov-21,23-Mar-21,242,mRNA,67,60 to 69
187,male,CD,No Immunosuppressives,14567,positive,elderly,,booster2,19-Jan-22,29-Mar-21,296,mRNA,67,60 to 69
188,male,CD,No Immunosuppressives,5975,positive,elderly,,booster2,06-May-22,27-Mar-21,405,mRNA,67,60 to 69
189,female,CD,Vedolizumab Only,9136,positive,adult,30,booster1,06-Aug-21,08-Apr-21,120,mRNA,56,50 to 59
190,female,CD,Vedolizumab Only,10415,positive,adult,,booster2,27-Nov-21,04-Apr-21,237,mRNA,56,50 to 59
191,female,CD,Vedolizumab Only,1551,positive,adult,,booster2,28-Jan-22,08-Apr-21,295,mRNA,56,50 to 59
192,female,CD,Anti-TNF Only,37,negative,adult,359,primary,19-May-21,29-Mar-21,51,mRNA,47,40 to 49
193,female,CD,Anti-TNF Only,160,positive,adult,304,booster1,13-Jul-21,30-Mar-21,105,mRNA,47,40 to 49
194,female,CD,Anti-TNF Only,129,negative,adult,239,booster1,16-Sep-21,02-Apr-21,167,mRNA,47,40 to 49
195,female,CD,Anti-TNF Only,4919,positive,adult,220,booster2,05-Oct-21,03-Apr-21,185,mRNA,47,40 to 49
196,female,CD,Anti-TNF Only,1267,positive,adult,112,booster2,21-Jan-22,02-Apr-21,294,mRNA,48,40 to 49
197,female,CD,Anti-TNF Only,27138,positive,adult,50,booster2,24-Mar-22,02-Apr-21,356,mRNA,48,40 to 49
198,female,CD,Anti-TNF Only,48669,positive,adult,40,booster2,22-Jun-22,01-Apr-21,447,mRNA,48,40 to 49
199,female,CD,Combination Therapy,625,positive,adult,164,primary,22-Jun-21,03-May-21,50,vector,37,30 to 39
200,female,CD,Combination Therapy,15618,positive,pediatric,320,booster2,18-Nov-21,07-May-21,195,vector,1,00 to 09
201,female,CD,Combination Therapy,,,adult,216,booster2,10-Feb-22,05-May-21,281,vector,38,30 to 39
202,male,CD,Anti-TNF Only,340,positive,adult,140,primary,30-May-21,12-Apr-21,48,mRNA,27,18 to 29
203,male,CD,Anti-TNF Only,5019,positive,adult,68,booster1,21-Jul-21,08-Apr-21,104,mRNA,27,18 to 29
204,male,CD,Anti-TNF Only,1782,positive,adult,205,booster2,07-Jan-22,08-Apr-21,274,mRNA,28,18 to 29
205,female,CD,Ustekinumab Only,18253,positive,pediatric,268,booster1,31-Jul-21,25-Apr-21,97,mRNA,17,10 to 17
206,female,CD,Ustekinumab Only,30918,positive,adult,457,booster2,25-Feb-22,25-Apr-21,306,mRNA,54,50 to 59
207,female,CD,Ustekinumab Only,3773,positive,adult,586,booster2,14-Jun-22,24-Apr-21,416,mRNA,54,50 to 59
208,male,CD,Immunomodulator Only,318,positive,adult,,primary,30-Jun-21,15-Apr-21,76,mRNA,43,40 to 49
209,male,CD,Immunomodulator Only,43,negative,adult,320,booster1,07-Aug-21,12-Apr-21,117,mRNA,43,40 to 49
210,male,CD,Immunomodulator Only,61394,positive,adult,,booster2,15-Jan-22,11-Apr-21,279,mRNA,44,40 to 49
211,female,UC,Vedolizumab Only,476,positive,adult,217,primary,09-Jun-21,16-Apr-21,54,mRNA,34,30 to 39
212,female,UC,Vedolizumab Only,17117,positive,adult,57,booster1,10-Mar-22,15-Apr-21,329,mRNA,35,30 to 39
213,male,UC,Combination Therapy,2731,positive,elderly,,primary,23-Jun-21,26-Mar-21,89,mRNA,64,60 to 69
214,male,UC,Combination Therapy,10676,positive,elderly,,booster2,12-Nov-21,27-Mar-21,230,mRNA,65,60 to 69
215,male,UC,Combination Therapy,1384,positive,elderly,,booster2,18-Feb-22,26-Mar-21,329,mRNA,65,60 to 69
216,male,UC,Combination Therapy,4084,positive,elderly,,booster2,10-Jun-22,28-Mar-21,439,mRNA,65,60 to 69
217,male,CD,Anti-TNF Only,7694,positive,adult,354,booster1,02-Jul-21,15-Apr-21,78,vector,18,18 to 29
218,male,CD,Anti-TNF Only,13379,positive,adult,230,booster2,03-Nov-21,10-Apr-21,207,vector,19,18 to 29
219,male,CD,Anti-TNF Only,3685,positive,adult,216,booster2,19-Mar-22,13-Apr-21,340,vector,19,18 to 29
220,female,UC,Tofacitinib Only,124,negative,adult,,primary,03-Jul-21,10-Apr-21,84,mRNA,42,40 to 49
221,female,UC,Tofacitinib Only,1078,positive,adult,,booster1,31-Jul-21,15-Apr-21,107,mRNA,42,40 to 49
222,other,UC,Tofacitinib Only,1505,positive,pediatric,,booster2,22-Feb-22,12-Apr-21,316,mRNA,2,00 to 09
223,other,UC,Tofacitinib Only,208,positive,adult,,primary,27-May-21,10-Apr-21,47,mRNA,50,50 to 59
224,other,UC,Tofacitinib Only,1043,positive,adult,,booster1,21-Aug-21,11-Apr-21,132,mRNA,50,50 to 59
225,female,UC,Tofacitinib Only,536,positive,adult,,booster1,09-Dec-21,15-Apr-21,238,mRNA,50,50 to 59
226,female,UC,Tofacitinib Only,16191,positive,adult,,booster2,18-Feb-22,13-Apr-21,311,mRNA,51,50 to 59
227,female,UC,Tofacitinib Only,25336,positive,adult,,booster2,09-Jun-22,12-Apr-21,423,mRNA,51,50 to 59
228,female,UC,Anti-TNF Only,3726,positive,adult,304,booster1,22-Jul-21,02-May-21,81,mRNA,37,30 to 39
229,female,UC,Anti-TNF Only,7356,positive,adult,140,booster2,07-Jan-22,06-May-21,246,mRNA,38,30 to 39
230,female,CD,Anti-TNF Only,4087,positive,elderly,181,booster1,09-Jul-21,28-Mar-21,103,mRNA,63,60 to 69
231,female,CD,Anti-TNF Only,43709,positive,elderly,,booster2,06-Jan-22,29-Mar-21,283,mRNA,64,60 to 69
232,female,CD,Anti-TNF Only,24454,positive,elderly,91,booster2,07-Apr-22,31-Mar-21,372,mRNA,64,60 to 69
233,male,CD,Immunomodulator Only,6630,positive,adult,,booster1,24-Jul-21,12-Apr-21,103,mRNA,32,30 to 39
234,male,CD,Immunomodulator Only,9869,positive,adult,,booster2,20-Nov-21,07-Apr-21,227,mRNA,32,30 to 39
235,male,CD,Immunomodulator Only,22642,positive,adult,,booster2,21-May-22,09-Apr-21,407,mRNA,33,30 to 39
236,female,UC,Corticosteroids,388,positive,adult,189,booster1,07-Jul-21,25-Feb-21,132,mRNA,50,50 to 59
237,female,UC,Corticosteroids,283,positive,adult,132,booster1,02-Sep-21,26-Feb-21,188,mRNA,50,50 to 59
238,female,UC,Corticosteroids,67937,positive,adult,98,booster2,20-Apr-22,22-Feb-21,422,mRNA,51,50 to 59
239,female,CD,No Immunosuppressives,654,positive,adult,68,primary,03-Jun-21,09-Apr-21,55,vector,58,50 to 59
240,female,CD,No Immunosuppressives,9916,positive,adult,,booster1,22-Aug-21,05-Apr-21,139,vector,58,50 to 59
241,female,CD,No Immunosuppressives,56215,positive,adult,,booster2,01-Apr-22,06-Apr-21,360,vector,59,50 to 59
242,female,CD,No Immunosuppressives,25829,positive,adult,,booster2,15-Jun-22,06-Apr-21,435,vector,59,50 to 59
243,female,CD,Ustekinumab Only,540,positive,adult,,primary,02-Jun-21,10-Apr-21,53,mRNA,45,40 to 49
244,female,CD,Ustekinumab Only,5481,positive,adult,,booster1,19-Aug-21,06-Apr-21,135,mRNA,45,40 to 49
245,female,CD,Ustekinumab Only,20331,positive,adult,,booster2,14-Oct-21,11-Apr-21,186,mRNA,45,40 to 49
246,female,CD,Ustekinumab Only,2722,positive,adult,,booster2,13-Feb-22,05-Apr-21,314,mRNA,45,40 to 49
247,female,CD,Ustekinumab Only,86,negative,elderly,231,primary,02-Jul-21,10-Apr-21,83,mRNA,64,60 to 69
248,female,CD,Ustekinumab Only,31304,positive,elderly,199,booster1,03-Aug-21,08-Apr-21,117,mRNA,64,60 to 69
249,female,CD,Ustekinumab Only,12036,positive,elderly,205,booster2,17-Dec-21,06-Apr-21,255,mRNA,64,60 to 69
250,female,CD,Ustekinumab Only,36765,positive,elderly,49,booster2,08-Apr-22,08-Apr-21,365,mRNA,65,60 to 69
251,female,CD,Ustekinumab Only,40038,positive,elderly,105,booster2,03-Jun-22,09-Apr-21,420,mRNA,65,60 to 69
252,male,CD,No Immunosuppressives,6,negative,adult,,primary,18-May-21,01-Apr-21,47,mRNA,53,50 to 59
253,male,CD,No Immunosuppressives,153,positive,adult,,booster1,05-Jun-21,05-Apr-21,61,mRNA,53,50 to 59
254,male,CD,No Immunosuppressives,5599,positive,adult,,booster2,05-Oct-21,06-Apr-21,182,mRNA,53,50 to 59
255,male,CD,No Immunosuppressives,7227,positive,adult,,booster2,26-Jan-22,04-Apr-21,297,mRNA,53,50 to 59
256,male,CD,No Immunosuppressives,30882,positive,adult,,booster2,11-Mar-22,03-Apr-21,342,mRNA,53,50 to 59
257,male,CD,No Immunosuppressives,48960,positive,adult,,booster2,08-Jul-22,03-Apr-21,461,mRNA,54,50 to 59
258,male,UC,Anti-TNF Only,68,negative,elderly,,primary,04-Jun-21,09-Apr-21,56,mRNA,67,60 to 69
259,male,UC,Anti-TNF Only,2362,positive,elderly,268,booster1,10-Aug-21,04-Apr-21,128,mRNA,67,60 to 69
260,male,UC,Anti-TNF Only,1280,positive,elderly,,booster2,23-Nov-21,07-Apr-21,230,mRNA,67,60 to 69
261,male,CD,Vedolizumab Only,120,negative,elderly,,primary,27-Jun-21,29-Apr-21,59,vector,68,60 to 69
262,male,CD,Vedolizumab Only,770,positive,elderly,,booster1,24-Feb-22,23-Apr-21,307,vector,69,60 to 69
263,female,UC,No Immunosuppressives,31564,positive,adult,,booster1,29-Aug-21,14-Apr-21,137,vector,23,18 to 29
264,female,UC,No Immunosuppressives,,,adult,,booster2,27-Apr-22,17-Apr-21,375,vector,24,18 to 29
265,male,CD,Anti-TNF Only,18,negative,adult,,primary,09-Jun-21,06-Apr-21,64,mRNA,20,18 to 29
266,male,CD,Anti-TNF Only,2044,positive,adult,,booster1,14-Sep-21,31-Mar-21,167,mRNA,20,18 to 29
267,female,CD,Anti-TNF Only,71,negative,adult,205,primary,25-Jun-21,27-Apr-21,59,mRNA,37,30 to 39
268,female,CD,Anti-TNF Only,6085,positive,adult,157,booster1,12-Aug-21,29-Apr-21,105,mRNA,37,30 to 39
269,female,CD,Anti-TNF Only,222,positive,adult,457,booster1,21-Dec-21,27-Apr-21,238,mRNA,37,30 to 39
270,male,CD,Anti-TNF Only,168,positive,elderly,,primary,09-Jun-21,07-May-21,33,mRNA,64,60 to 69
271,male,CD,Anti-TNF Only,4195,positive,elderly,,booster2,26-Mar-22,05-May-21,325,mRNA,65,60 to 69
272,male,UC,Anti-TNF Only,1977,positive,adult,,booster1,10-Jun-21,28-Mar-21,74,mRNA,40,40 to 49
273,male,UC,Anti-TNF Only,5168,positive,adult,,booster2,23-Jun-22,28-Mar-21,452,mRNA,41,40 to 49
274,male,CD,Anti-TNF Only,98,negative,adult,,primary,04-Jun-21,16-Apr-21,49,mRNA,22,18 to 29
275,male,CD,Anti-TNF Only,7335,positive,adult,,booster1,24-Aug-21,17-Apr-21,129,mRNA,22,18 to 29
276,female,CD,Anti-TNF Only,8105,positive,adult,268,booster1,11-Jun-21,08-Apr-21,64,mRNA,49,40 to 49
277,female,CD,Anti-TNF Only,360,positive,adult,157,booster1,30-Sep-21,08-Apr-21,175,mRNA,49,40 to 49
278,female,CD,Anti-TNF Only,15645,positive,adult,124,booster2,02-Nov-21,09-Apr-21,207,mRNA,49,40 to 49
279,female,CD,Anti-TNF Only,1732,positive,adult,586,booster2,16-Feb-22,08-Apr-21,314,mRNA,49,40 to 49
280,male,UC,No Immunosuppressives,521,positive,adult,,primary,23-Jun-21,21-Apr-21,63,mRNA,48,40 to 49
281,male,UC,No Immunosuppressives,7741,positive,adult,,booster1,03-Aug-21,25-Apr-21,100,mRNA,48,40 to 49
282,male,UC,No Immunosuppressives,12505,positive,adult,,booster2,31-May-22,26-Apr-21,400,mRNA,49,40 to 49
283,male,UC,Ustekinumab Only,222,positive,adult,,primary,02-Jul-21,10-May-21,53,mRNA,54,50 to 59
284,male,UC,Ustekinumab Only,16361,positive,adult,,booster1,01-Aug-21,16-May-21,77,mRNA,54,50 to 59
285,male,UC,Ustekinumab Only,858,positive,adult,,booster1,15-Dec-21,10-May-21,219,mRNA,55,50 to 59
286,male,UC,Ustekinumab Only,15564,positive,adult,,booster2,16-Feb-22,16-May-21,276,mRNA,55,50 to 59
287,male,UC,Ustekinumab Only,6444,positive,adult,,booster2,28-May-22,12-May-21,381,mRNA,55,50 to 59
288,male,CD,Anti-TNF Only,284,positive,adult,,primary,10-Jun-21,11-Apr-21,60,mRNA,47,40 to 49
289,male,CD,Anti-TNF Only,564,positive,adult,,booster1,24-Sep-21,12-Apr-21,165,mRNA,47,40 to 49
290,male,CD,Anti-TNF Only,1686,positive,adult,,booster2,30-Dec-21,10-Apr-21,264,mRNA,47,40 to 49
291,male,CD,Anti-TNF Only,1191,positive,adult,,booster2,29-Jan-22,11-Apr-21,293,mRNA,48,40 to 49
292,male,CD,Anti-TNF Only,14721,positive,adult,,booster2,15-Mar-22,10-Apr-21,339,mRNA,48,40 to 49
293,male,CD,Anti-TNF Only,1933,positive,adult,,booster2,05-Jul-22,15-Apr-21,446,mRNA,48,40 to 49
294,female,CD,Immunomodulator Only,204,positive,adult,,primary,25-Jun-21,09-May-21,47,mRNA,34,30 to 39
295,female,CD,Immunomodulator Only,2011,positive,adult,,booster1,24-Jul-21,07-May-21,78,mRNA,34,30 to 39
296,female,CD,Immunomodulator Only,15854,positive,adult,,booster2,06-Feb-22,08-May-21,274,mRNA,34,30 to 39
297,male,CD,Anti-TNF Only,120,negative,adult,,primary,23-Jun-21,10-Apr-21,74,mRNA,43,40 to 49
298,male,CD,Anti-TNF Only,6065,positive,adult,,booster1,20-Aug-21,07-Apr-21,135,mRNA,44,40 to 49
299,male,CD,Ustekinumab Only,1098,positive,adult,,primary,30-Jun-21,03-May-21,58,mRNA,21,18 to 29
300,female,CD,Anti-TNF Only,23601,positive,adult,,booster1,02-Jun-21,01-Apr-21,62,mRNA,62,60 to 69
301,female,CD,Anti-TNF Only,4573,positive,elderly,,booster1,31-Aug-21,05-Apr-21,148,mRNA,62,60 to 69
302,female,CD,Anti-TNF Only,80000,positive,elderly,,booster2,16-Oct-21,31-Mar-21,199,mRNA,62,60 to 69
303,female,CD,Anti-TNF Only,13034,positive,elderly,,booster2,02-Feb-22,05-Apr-21,303,mRNA,63,60 to 69
304,female,CD,Anti-TNF Only,42265,positive,elderly,,booster2,23-Mar-22,05-Apr-21,352,mRNA,63,60 to 69
305,female,CD,Anti-TNF Only,7879,positive,elderly,,booster2,07-Jul-22,01-Apr-21,462,mRNA,63,60 to 69
306,female,CD,Ustekinumab Only,1012,positive,adult,,primary,17-Jun-21,20-Apr-21,58,vector,41,40 to 49
307,female,CD,Ustekinumab Only,7109,positive,adult,,booster1,27-Jul-21,21-Apr-21,97,vector,41,40 to 49
308,female,CD,Ustekinumab Only,869,positive,adult,,booster1,29-Dec-21,26-Apr-21,247,vector,42,40 to 49
309,male,CD,Anti-TNF Only,1652,positive,elderly,,booster1,07-Jul-21,01-Mar-21,128,mRNA,76,70+
310,male,CD,Vedolizumab Only,12824,positive,adult,39,pre_dose,10-Jun-21,04-Jun-21,6,vector,33,30 to 39
311,female,CD,Combination Therapy,2373,positive,adult,310,primary,24-Jun-21,29-Apr-21,56,mRNA,37,30 to 39
312,male,CD,Immunomodulator Only,43,negative,adult,308,primary,05-Jun-21,19-Apr-21,47,mRNA,52,50 to 59
313,male,CD,Immunomodulator Only,1971,positive,pediatric,249,booster1,03-Aug-21,15-Apr-21,110,mRNA,13,10 to 17
314,male,CD,Immunomodulator Only,12099,positive,adult,57,booster2,11-Feb-22,14-Apr-21,303,mRNA,52,50 to 59
315,male,CD,Immunomodulator Only,45635,positive,adult,63,booster2,11-Jun-22,18-Apr-21,419,mRNA,53,50 to 59
316,male,UC,No Immunosuppressives,989,positive,adult,208,primary,15-Jun-21,26-Apr-21,50,vector,33,30 to 39
317,male,UC,No Immunosuppressives,10173,positive,adult,156,booster1,06-Aug-21,28-Apr-21,100,vector,34,30 to 39
318,other,UC,No Immunosuppressives,2366,positive,adult,2,booster1,07-Jan-22,28-Apr-21,254,vector,34,30 to 39
319,male,UC,No Immunosuppressives,40034,positive,adult,,booster2,14-Jun-22,22-Apr-21,418,vector,34,30 to 39
320,male,CD,Combination Therapy,58,negative,adult,,primary,13-Jun-21,19-Apr-21,55,mRNA,49,40 to 49
321,other,CD,Combination Therapy,7813,positive,adult,,booster1,10-Jul-21,16-Apr-21,85,mRNA,49,40 to 49
322,male,CD,Combination Therapy,1560,positive,adult,,booster2,12-Nov-21,14-Apr-21,212,mRNA,49,40 to 49
323,male,CD,Combination Therapy,769,positive,adult,,booster2,19-Jul-22,16-Apr-21,459,mRNA,50,50 to 59
324,male,CD,No Immunosuppressives,1695,positive,adult,,booster1,25-Aug-21,22-Apr-21,125,mRNA,31,30 to 39
325,male,CD,No Immunosuppressives,3185,positive,adult,,booster2,18-Mar-22,18-Apr-21,334,mRNA,32,30 to 39
326,male,CD,Ustekinumab Only,1023,positive,adult,,primary,09-Jun-21,15-Apr-21,55,mRNA,49,40 to 49
327,male,CD,Ustekinumab Only,11056,positive,adult,,booster1,22-Aug-21,15-Apr-21,129,mRNA,49,40 to 49
328,male,CD,Ustekinumab Only,2381,positive,adult,,booster1,06-Jan-22,12-Apr-21,269,mRNA,50,50 to 59
329,female,UC,Anti-TNF Only,4120,positive,adult,,booster1,29-Jun-21,19-Mar-21,102,mRNA,28,18 to 29
330,female,UC,Anti-TNF Only,579,positive,adult,130,booster1,09-Sep-21,21-Mar-21,172,mRNA,28,18 to 29
331,female,UC,Anti-TNF Only,,,adult,24,booster1,10-Feb-22,23-Mar-21,324,mRNA,29,18 to 29
332,male,UC,No Immunosuppressives,171,positive,adult,,primary,17-Jun-21,20-Apr-21,58,mRNA,32,30 to 39
333,male,UC,No Immunosuppressives,2705,positive,adult,,booster1,12-Aug-21,19-Apr-21,115,mRNA,32,30 to 39
334,male,UC,No Immunosuppressives,21084,positive,adult,,booster2,26-Mar-22,22-Apr-21,338,mRNA,33,30 to 39
335,female,UC,No Immunosuppressives,152,positive,adult,,primary,01-Jul-21,09-May-21,53,mRNA,58,50 to 59
336,female,UC,No Immunosuppressives,3894,positive,adult,,booster1,07-Oct-21,09-May-21,151,mRNA,59,50 to 59
337,female,UC,No Immunosuppressives,35461,positive,adult,,booster2,05-Feb-22,09-May-21,272,mRNA,59,50 to 59
338,female,UC,No Immunosuppressives,8277,positive,adult,,booster2,14-Jul-22,08-May-21,432,mRNA,60,60 to 69
339,female,CD,Ustekinumab Only,2191,positive,adult,,booster1,15-Sep-21,14-Apr-21,154,mRNA,41,40 to 49
340,female,UC,Corticosteroids,86,negative,adult,,primary,17-Jun-21,28-Apr-21,50,mRNA,56,50 to 59
341,female,UC,Corticosteroids,1906,positive,adult,,booster1,20-Jul-21,28-Apr-21,83,mRNA,56,50 to 59
342,female,UC,Corticosteroids,990,positive,adult,,booster1,24-Aug-21,25-Apr-21,121,mRNA,56,50 to 59
343,female,UC,Corticosteroids,53554,positive,adult,,booster2,01-Feb-22,29-Apr-21,278,mRNA,57,50 to 59
344,female,UC,Corticosteroids,10590,positive,adult,,booster2,24-May-22,25-Apr-21,394,mRNA,57,50 to 59
345,female,CD,Ustekinumab Only,2625,positive,adult,,booster1,24-Jun-21,02-May-21,53,vector,56,50 to 59
346,female,CD,Ustekinumab Only,2848,positive,adult,,booster1,17-Sep-21,28-Apr-21,142,vector,57,50 to 59
347,female,CD,Ustekinumab Only,8790,positive,adult,,booster2,09-Dec-21,29-Apr-21,224,vector,57,50 to 59
348,female,CD,Ustekinumab Only,3958,positive,adult,,booster2,23-Feb-22,30-Apr-21,299,vector,57,50 to 59
349,male,CD,Anti-TNF Only,125,negative,adult,,primary,15-Jun-21,16-Apr-21,60,mRNA,62,60 to 69
350,male,CD,Anti-TNF Only,649,positive,elderly,,booster1,13-Aug-21,16-Apr-21,119,mRNA,62,60 to 69
351,male,CD,Anti-TNF Only,2127,positive,elderly,,booster2,27-Nov-21,18-Apr-21,223,mRNA,62,60 to 69
352,male,CD,Anti-TNF Only,805,positive,elderly,,booster2,22-Feb-22,13-Apr-21,315,mRNA,63,60 to 69
353,male,CD,Anti-TNF Only,4272,positive,elderly,,booster2,19-Apr-22,16-Apr-21,368,mRNA,63,60 to 69
354,female,UC,No Immunosuppressives,6511,positive,adult,28,pre_dose,11-Jun-21,28-May-21,14,mRNA,56,50 to 59
355,female,UC,No Immunosuppressives,25923,positive,adult,69,primary,22-Jul-21,30-May-21,53,mRNA,56,50 to 59
356,female,UC,No Immunosuppressives,51171,positive,adult,84,booster1,06-Aug-21,27-May-21,71,mRNA,56,50 to 59
357,female,UC,No Immunosuppressives,14724,positive,adult,252,booster1,21-Jan-22,26-May-21,240,mRNA,56,50 to 59
358,female,UC,No Immunosuppressives,24038,positive,adult,272,booster2,10-Feb-22,31-May-21,255,mRNA,56,50 to 59
359,female,UC,No Immunosuppressives,16488,positive,adult,,booster2,01-Jun-22,30-May-21,367,mRNA,57,50 to 59
360,male,UC,Combination Therapy,496,positive,adult,,primary,18-Jun-21,26-Apr-21,53,mRNA,18,18 to 29
361,male,UC,Anti-TNF Only,7570,positive,adult,74,booster1,02-Jul-21,30-Mar-21,94,mRNA,43,40 to 49
362,male,UC,Anti-TNF Only,76777,positive,adult,25,booster1,09-Oct-21,31-Mar-21,192,mRNA,43,40 to 49
363,male,UC,Anti-TNF Only,31052,positive,adult,176,booster2,09-Mar-22,30-Mar-21,344,mRNA,44,40 to 49
364,male,UC,Anti-TNF Only,3907,positive,adult,,booster1,24-Jul-21,14-Apr-21,101,vector,31,30 to 39
365,male,UC,Anti-TNF Only,768,positive,adult,,booster1,06-Jan-22,14-Apr-21,267,vector,32,30 to 39
366,male,UC,Anti-TNF Only,24711,positive,adult,,booster2,05-Mar-22,16-Apr-21,323,vector,32,30 to 39
367,male,UC,Anti-TNF Only,35520,positive,adult,,booster2,25-Jun-22,16-Apr-21,435,vector,32,30 to 39
368,male,CD,Anti-TNF Only,389,positive,adult,,primary,23-Jun-21,19-May-21,35,vector,36,30 to 39
369,male,CD,Anti-TNF Only,4437,positive,adult,,booster1,13-Jul-21,21-May-21,53,vector,36,30 to 39
370,male,CD,Anti-TNF Only,20118,positive,adult,,booster2,07-Apr-22,20-May-21,322,vector,37,30 to 39
371,male,CD,Anti-TNF Only,7220,positive,adult,,booster2,30-Jun-22,18-May-21,408,vector,37,30 to 39
372,female,CD,Combination Therapy,70,negative,adult,,primary,30-Jun-21,28-Apr-21,63,mRNA,24,18 to 29
373,female,CD,Combination Therapy,5604,positive,adult,,booster1,13-Aug-21,03-May-21,102,mRNA,24,18 to 29
374,female,CD,Combination Therapy,9173,positive,adult,,booster2,02-Dec-21,28-Apr-21,218,mRNA,24,18 to 29
375,female,CD,Combination Therapy,1007,positive,adult,,booster2,24-Mar-22,03-May-21,325,mRNA,24,18 to 29
376,male,CD,Vedolizumab Only,2691,positive,adult,,booster1,13-Jul-21,09-Apr-21,95,mRNA,37,30 to 39
377,male,CD,Vedolizumab Only,485,positive,adult,,booster2,03-Dec-21,10-Apr-21,237,mRNA,38,30 to 39
378,male,CD,Combination Therapy,31025,positive,adult,36,primary,25-Jun-21,08-Apr-21,78,mRNA,42,40 to 49
379,male,CD,Combination Therapy,47,negative,adult,,booster1,18-Aug-21,11-Apr-21,129,mRNA,42,40 to 49
380,male,CD,Combination Therapy,60010,positive,adult,184,booster2,20-Nov-21,06-Apr-21,228,mRNA,42,40 to 49
381,male,CD,Combination Therapy,18723,positive,adult,302,booster2,18-Mar-22,09-Apr-21,343,mRNA,43,40 to 49
382,male,CD,Anti-TNF Only,437,positive,adult,,primary,18-Jun-21,25-Apr-21,54,mRNA,40,40 to 49
383,male,CD,Anti-TNF Only,13187,positive,adult,,booster1,10-Jul-21,25-Apr-21,76,mRNA,40,40 to 49
384,male,CD,Anti-TNF Only,25052,positive,adult,,booster2,13-Nov-21,24-Apr-21,203,mRNA,40,40 to 49
385,male,CD,Anti-TNF Only,1216,positive,adult,,booster2,04-Mar-22,19-Apr-21,319,mRNA,40,40 to 49
386,male,CD,Anti-TNF Only,3030,positive,adult,,booster2,15-Apr-22,19-Apr-21,361,mRNA,40,40 to 49
387,female,UC,No Immunosuppressives,628,positive,adult,238,primary,30-Jun-21,08-May-21,53,mRNA,40,40 to 49
388,female,UC,No Immunosuppressives,13874,positive,adult,193,booster1,14-Aug-21,09-May-21,97,mRNA,40,40 to 49
389,female,UC,No Immunosuppressives,7764,positive,pediatric,,booster2,13-Nov-21,08-May-21,189,mRNA,5,00 to 09
390,female,UC,No Immunosuppressives,2393,positive,pediatric,4,booster2,19-Feb-22,05-May-21,290,mRNA,10,10 to 17
391,male,UC,Ustekinumab Only,10412,positive,pediatric,,booster1,17-Jun-21,12-Apr-21,66,mRNA,5,00 to 09
392,male,UC,Ustekinumab Only,919,positive,pediatric,,booster1,14-Oct-21,10-Apr-21,187,mRNA,11,10 to 17
393,male,UC,Ustekinumab Only,23730,positive,pediatric,,booster2,18-Dec-21,14-Apr-21,248,mRNA,7,00 to 09
394,male,UC,Ustekinumab Only,3435,positive,pediatric,,booster2,01-Apr-22,12-Apr-21,354,mRNA,5,00 to 09
395,male,UC,Ustekinumab Only,20421,positive,pediatric,,booster2,29-Jun-22,11-Apr-21,444,mRNA,1,00 to 09
396,female,CD,Combination Therapy,4943,positive,pediatric,31,primary,23-Jun-21,23-May-21,31,mRNA,3,00 to 09
397,female,CD,Ustekinumab Only,568,positive,pediatric,,primary,22-Jul-21,18-May-21,65,mRNA,2,00 to 09
398,female,CD,Ustekinumab Only,6663,positive,pediatric,,booster1,17-Sep-21,18-May-21,122,mRNA,6,00 to 09
399,female,CD,Ustekinumab Only,291,positive,pediatric,105,booster1,07-Jan-22,19-May-21,233,mRNA,1,00 to 09
400,male,CD,Ustekinumab Only,131,negative,pediatric,187,primary,15-Jun-21,20-Apr-21,56,mRNA,17,10 to 17
401,male,CD,Ustekinumab Only,10877,positive,adult,96,booster1,07-Aug-21,21-Apr-21,108,mRNA,45,40 to 49
402,male,CD,Ustekinumab Only,12997,positive,adult,9,booster2,15-Oct-21,24-Apr-21,174,mRNA,45,40 to 49
403,male,CD,Ustekinumab Only,4360,positive,adult,90,booster2,22-Jan-22,23-Apr-21,274,mRNA,45,40 to 49
404,male,CD,Ustekinumab Only,12871,positive,adult,5,booster2,14-May-22,22-Apr-21,387,mRNA,46,40 to 49
405,female,UC,Anti-TNF Only,538,positive,adult,38,booster1,04-Jun-21,03-Apr-21,62,mRNA,62,60 to 69
406,female,UC,Anti-TNF Only,56,negative,elderly,169,booster1,22-Sep-21,29-Mar-21,177,mRNA,62,60 to 69
407,female,UC,Anti-TNF Only,6974,positive,elderly,291,booster2,16-Dec-21,30-Mar-21,261,mRNA,62,60 to 69
408,female,UC,Anti-TNF Only,990,positive,elderly,,booster2,21-Apr-22,28-Mar-21,389,mRNA,63,60 to 69
409,male,CD,Anti-TNF Only,44,negative,adult,187,primary,13-Jul-21,15-May-21,59,vector,45,40 to 49
410,male,CD,No Immunosuppressives,16997,positive,elderly,,booster1,01-Jul-21,26-Mar-21,97,mRNA,66,60 to 69
411,male,CD,No Immunosuppressives,76852,positive,elderly,,booster2,21-Jan-22,29-Mar-21,298,mRNA,67,60 to 69
412,male,CD,Vedolizumab Only,37,negative,adult,,primary,01-Jun-21,21-Apr-21,41,vector,53,50 to 59
413,male,CD,Vedolizumab Only,2645,positive,adult,,booster1,06-Aug-21,25-Apr-21,103,vector,53,50 to 59
414,male,CD,Vedolizumab Only,3115,positive,adult,,booster2,14-Jan-22,20-Apr-21,269,vector,54,50 to 59
415,male,CD,Vedolizumab Only,,,adult,,booster2,05-Jul-22,24-Apr-21,437,vector,54,50 to 59
416,male,CD,Ustekinumab Only,14683,positive,elderly,,booster1,13-Aug-21,26-Mar-21,140,mRNA,70,70+
417,male,CD,Ustekinumab Only,7613,positive,elderly,,booster2,10-Mar-22,27-Mar-21,348,mRNA,70,70+
418,male,CD,Ustekinumab Only,39680,positive,elderly,,booster2,28-Jun-22,26-Mar-21,459,mRNA,71,70+
419,male,CD,Anti-TNF Only,11488,positive,adult,96,booster1,05-Aug-21,12-Apr-21,115,mRNA,40,40 to 49
420,male,CD,Anti-TNF Only,545,positive,adult,243,booster1,29-Jan-22,11-Apr-21,293,mRNA,41,40 to 49
421,male,CD,Anti-TNF Only,39039,positive,adult,267,booster2,22-Feb-22,10-Apr-21,318,mRNA,41,40 to 49
422,male,CD,Anti-TNF Only,6045,positive,adult,386,booster2,21-Jun-22,08-Apr-21,439,mRNA,41,40 to 49
423,female,CD,Anti-TNF Only,431,positive,adult,,booster1,09-Jun-21,15-Mar-21,86,mRNA,56,50 to 59
424,female,CD,Anti-TNF Only,129,negative,adult,,booster1,31-Jul-21,18-Mar-21,135,mRNA,56,50 to 59
425,female,CD,Anti-TNF Only,5962,positive,adult,,booster2,05-Oct-21,17-Mar-21,202,mRNA,56,50 to 59
426,female,CD,Anti-TNF Only,5986,positive,adult,,booster2,29-Jan-22,18-Mar-21,317,mRNA,57,50 to 59
427,male,CD,Anti-TNF Only,1368,positive,adult,191,primary,28-Jul-21,03-Jun-21,55,mRNA,43,40 to 49
428,male,CD,Anti-TNF Only,5361,positive,adult,86,booster1,10-Nov-21,06-Jun-21,157,mRNA,43,40 to 49
429,male,CD,Anti-TNF Only,23638,positive,adult,9,booster1,12-Feb-22,03-Jun-21,254,mRNA,43,40 to 49
430,male,UC,Anti-TNF Only,557,positive,adult,,primary,02-Jul-21,22-Apr-21,71,vector,42,40 to 49
431,male,UC,Anti-TNF Only,3570,positive,adult,,booster1,10-Sep-21,21-Apr-21,142,vector,42,40 to 49
432,male,UC,Anti-TNF Only,920,positive,adult,,booster1,04-Dec-21,24-Apr-21,224,vector,42,40 to 49
433,male,CD,Anti-TNF Only,139,negative,elderly,,booster1,22-Jun-21,28-Feb-21,114,mRNA,78,70+
434,male,CD,Anti-TNF Only,3121,positive,elderly,,booster2,13-Oct-21,27-Feb-21,228,mRNA,78,70+
435,male,CD,Anti-TNF Only,379,positive,elderly,,booster2,02-Feb-22,28-Feb-21,339,mRNA,78,70+
436,male,CD,Anti-TNF Only,7494,positive,elderly,,booster2,29-Mar-22,28-Feb-21,394,mRNA,78,70+
437,male,CD,Anti-TNF Only,1018,positive,elderly,,booster2,19-Jul-22,04-Mar-22,137,mRNA,79,70+
438,female,CD,Combination Therapy,196,positive,adult,,booster1,26-Sep-21,16-May-21,133,mRNA,44,40 to 49
439,male,UC,No Immunosuppressives,115,negative,adult,90,primary,02-Jul-21,20-Mar-21,104,vector,60,60 to 69
440,male,UC,No Immunosuppressives,258,positive,adult,,booster1,20-Aug-21,20-Mar-21,153,vector,60,60 to 69
441,male,UC,No Immunosuppressives,34269,positive,adult,,booster2,13-Jan-22,23-Mar-21,296,vector,61,60 to 69
442,male,UC,No Immunosuppressives,37299,positive,adult,,booster2,17-May-22,19-Mar-21,424,vector,61,60 to 69
443,male,UC,Anti-TNF Only,4239,positive,adult,,booster1,26-Aug-21,27-May-21,91,mRNA,38,30 to 39
444,male,UC,Anti-TNF Only,2397,positive,adult,52,booster1,02-Jul-21,10-Apr-21,83,mRNA,38,30 to 39
445,male,UC,Anti-TNF Only,271,positive,adult,217,booster1,14-Dec-21,09-Apr-21,249,mRNA,38,30 to 39
446,male,UC,Anti-TNF Only,3769,positive,adult,393,booster2,08-Jun-22,05-Apr-21,429,mRNA,39,30 to 39
447,female,UC,No Immunosuppressives,99,negative,adult,38,pre_dose,30-Jun-21,13-Jun-21,17,mRNA,19,18 to 29
448,female,UC,No Immunosuppressives,6736,positive,adult,117,primary,17-Sep-21,15-Jun-21,94,mRNA,19,18 to 29
449,female,UC,No Immunosuppressives,3932,positive,adult,5,booster1,12-Feb-22,18-Jun-21,239,mRNA,20,18 to 29
450,female,CD,Ustekinumab Only,443,positive,adult,,primary,30-Jun-21,23-Apr-21,68,mRNA,39,30 to 39
451,female,CD,Ustekinumab Only,,,adult,,booster1,23-Jul-21,21-Apr-21,93,mRNA,39,30 to 39
452,female,CD,Ustekinumab Only,3561,positive,adult,,booster1,16-Nov-21,24-Apr-21,206,mRNA,40,40 to 49
453,female,CD,Ustekinumab Only,29259,positive,adult,,booster2,21-Jan-22,22-Apr-21,274,mRNA,40,40 to 49
454,female,CD,Ustekinumab Only,8275,positive,adult,,booster2,13-May-22,23-Apr-21,385,mRNA,40,40 to 49
455,male,CD,No Immunosuppressives,280,positive,adult,,primary,15-Jul-21,01-Jun-21,44,mRNA,51,50 to 59
456,male,CD,No Immunosuppressives,10858,positive,adult,,booster1,20-Aug-21,27-May-21,85,mRNA,51,50 to 59
457,male,CD,No Immunosuppressives,1192,positive,adult,,booster1,02-Dec-21,28-May-21,188,mRNA,51,50 to 59
458,male,CD,No Immunosuppressives,17231,positive,adult,,booster2,25-Feb-22,28-May-21,273,mRNA,52,50 to 59
459,other,CD,No Immunosuppressives,8966,positive,adult,38,booster2,21-May-22,31-May-21,355,mRNA,52,50 to 59
460,male,UC,Anti-TNF Only,7814,positive,adult,,booster1,21-Jul-21,13-Apr-21,99,mRNA,25,18 to 29
461,female,CD,Anti-TNF Only,6619,positive,adult,294,booster1,01-Jul-21,20-Apr-21,72,vector,47,40 to 49
462,other,CD,Anti-TNF Only,173,positive,adult,197,booster1,06-Oct-21,23-Apr-21,166,vector,48,40 to 49
463,female,CD,Anti-TNF Only,1943,positive,adult,111,booster2,31-Dec-21,23-Apr-21,252,vector,48,40 to 49
464,female,CD,Anti-TNF Only,341,positive,adult,34,booster2,18-Mar-22,18-Apr-21,334,vector,48,40 to 49
465,male,UC,No Immunosuppressives,11632,positive,adult,,booster1,09-Jul-21,07-Apr-21,93,mRNA,54,50 to 59
466,male,UC,No Immunosuppressives,3897,positive,adult,,booster2,22-Apr-22,13-Apr-21,374,mRNA,55,50 to 59
467,male,CD,Combination Therapy,249,positive,adult,,booster1,25-Aug-21,31-Mar-21,147,mRNA,55,50 to 59
468,male,CD,Combination Therapy,912,positive,adult,,booster2,18-Jun-22,27-Mar-21,448,mRNA,56,50 to 59
469,female,CD,Anti-TNF Only,7592,positive,adult,169,booster1,15-Jul-21,07-Apr-21,99,mRNA,57,50 to 59
470,female,CD,Anti-TNF Only,58075,positive,adult,,booster2,09-Oct-21,10-Apr-21,182,mRNA,57,50 to 59
471,female,CD,Anti-TNF Only,45773,positive,adult,,booster2,18-Mar-22,04-Apr-21,348,mRNA,58,50 to 59
472,female,CD,Anti-TNF Only,8620,positive,adult,,booster2,01-Jul-22,08-Apr-21,449,mRNA,58,50 to 59
473,male,CD,Anti-TNF Only,2716,positive,adult,,booster1,31-Aug-21,20-Apr-21,133,mRNA,58,50 to 59
474,female,CD,Anti-TNF Only,843,positive,adult,199,booster1,07-Aug-21,31-Mar-21,129,mRNA,61,60 to 69
475,female,CD,Anti-TNF Only,367,positive,adult,157,booster1,18-Sep-21,03-Apr-21,168,mRNA,61,60 to 69
476,female,CD,Anti-TNF Only,7240,positive,adult,69,booster2,15-Dec-21,03-Apr-21,256,mRNA,61,60 to 69
477,female,CD,Anti-TNF Only,1256,positive,adult,11,booster2,05-Mar-22,03-Apr-21,336,mRNA,62,60 to 69
478,male,UC,Tofacitinib Only,33902,positive,elderly,,booster1,04-Aug-21,01-May-21,95,vector,62,60 to 69
479,male,UC,Tofacitinib Only,31459,positive,elderly,291,booster2,26-May-22,30-Apr-21,391,vector,63,60 to 69
480,female,CD,Ustekinumab Only,8481,positive,adult,,booster1,24-Jul-21,24-Apr-21,91,mRNA,45,40 to 49
481,male,UC,Vedolizumab Only,15183,positive,adult,,booster1,19-Jun-21,30-Mar-21,81,mRNA,43,40 to 49
482,male,UC,Vedolizumab Only,12357,positive,adult,,booster2,10-Dec-21,30-Mar-21,255,mRNA,44,40 to 49
483,male,UC,Vedolizumab Only,8805,positive,adult,,booster2,04-Feb-22,31-Mar-21,310,mRNA,44,40 to 49
484,female,CD,No Immunosuppressives,3932,positive,adult,226,booster1,03-Jul-21,22-Apr-21,72,mRNA,38,30 to 39
485,female,CD,No Immunosuppressives,626,positive,adult,82,booster1,24-Nov-21,18-Apr-21,220,mRNA,38,30 to 39
486,female,CD,No Immunosuppressives,18566,positive,adult,41,booster2,04-Jan-22,17-Apr-21,262,mRNA,38,30 to 39
487,female,CD,No Immunosuppressives,,,adult,79,booster2,04-May-22,16-Apr-21,383,mRNA,39,30 to 39
488,male,CD,No Immunosuppressives,764,positive,elderly,,booster1,04-Aug-21,28-Mar-21,129,mRNA,71,70+
489,male,CD,No Immunosuppressives,370,positive,elderly,,booster1,15-Oct-21,02-Apr-21,196,mRNA,71,70+
490,male,CD,No Immunosuppressives,6863,positive,elderly,,booster2,28-Dec-21,01-Apr-21,271,mRNA,71,70+
491,male,CD,No Immunosuppressives,2795,positive,elderly,,booster2,19-Apr-22,02-Apr-21,382,mRNA,71,70+
492,female,UC,No Immunosuppressives,22196,positive,adult,,booster1,18-Jul-21,10-Apr-21,99,vector,54,50 to 59
493,female,UC,No Immunosuppressives,54915,positive,adult,,booster2,06-Feb-22,15-Apr-21,297,vector,55,50 to 59
494,female,UC,Vedolizumab Only,21025,positive,adult,,booster1,29-Jul-21,21-Apr-21,99,vector,59,50 to 59
495,female,UC,Vedolizumab Only,2990,positive,adult,,booster1,07-Jan-22,23-Apr-21,259,vector,60,60 to 69
496,female,UC,Vedolizumab Only,,,adult,,booster2,15-Mar-22,22-Apr-21,327,vector,60,60 to 69
497,female,UC,Vedolizumab Only,32068,positive,adult,,booster2,22-Jul-22,19-Apr-21,459,vector,60,60 to 69
498,male,CD,Anti-TNF Only,3,negative,elderly,,booster1,07-Jul-21,30-Mar-21,99,mRNA,71,70+
499,male,CD,Anti-TNF Only,0,negative,elderly,,booster2,02-Oct-21,03-Apr-21,182,mRNA,71,70+
500,male,CD,Anti-TNF Only,5,negative,elderly,,booster2,10-Mar-22,30-Mar-21,345,mRNA,72,70+
501,male,CD,Anti-TNF Only,16,negative,elderly,,booster2,15-Jun-22,05-Apr-21,436,mRNA,72,70+
502,male,CD,Anti-TNF Only,34,negative,elderly,,booster2,26-Jul-22,31-Mar-22,117,mRNA,72,70+
503,male,CD,Anti-TNF Only,741,positive,adult,,booster1,05-Aug-21,27-Mar-21,131,mRNA,56,50 to 59
504,male,CD,Anti-TNF Only,127,negative,adult,,booster1,17-Dec-21,01-Apr-21,260,mRNA,56,50 to 59
505,male,CD,Anti-TNF Only,2401,positive,adult,,booster2,11-Mar-22,29-Mar-21,347,mRNA,56,50 to 59
506,male,CD,Anti-TNF Only,1902,positive,adult,,booster2,31-May-22,30-Mar-21,427,mRNA,57,50 to 59
507,male,UC,No Immunosuppressives,7656,positive,adult,,booster1,14-Jul-21,24-Mar-21,112,vector,59,50 to 59
508,male,UC,No Immunosuppressives,1289,positive,adult,,booster1,22-Dec-21,19-Mar-21,278,vector,60,60 to 69
509,male,CD,Anti-TNF Only,27,negative,elderly,,primary,30-Jun-21,16-May-21,45,mRNA,69,60 to 69
510,male,CD,Anti-TNF Only,28,negative,elderly,,booster1,25-Aug-21,18-May-21,99,mRNA,69,60 to 69
511,male,CD,Anti-TNF Only,63,negative,elderly,,booster1,15-Dec-21,14-May-21,215,mRNA,69,60 to 69
512,male,CD,Anti-TNF Only,14,negative,elderly,,booster1,29-Jul-22,16-May-21,439,mRNA,70,70+
513,female,UC,No Immunosuppressives,5580,positive,adult,,booster1,20-Jul-21,09-Apr-21,102,mRNA,50,50 to 59
514,male,UC,Tofacitinib Only,4686,positive,adult,,booster1,10-Jul-21,22-Apr-21,79,vector,34,30 to 39
515,male,UC,Tofacitinib Only,25390,positive,adult,,booster2,09-Apr-22,22-Apr-21,352,vector,35,30 to 39
516,female,CD,Anti-TNF Only,137,negative,adult,,booster1,15-Jul-21,03-Apr-21,103,mRNA,41,40 to 49
517,female,CD,Anti-TNF Only,1280,positive,adult,,booster2,07-Oct-21,30-Mar-21,191,mRNA,41,40 to 49
518,female,CD,Anti-TNF Only,257,positive,adult,,booster2,08-Feb-22,04-Apr-21,310,mRNA,42,40 to 49
519,female,CD,Anti-TNF Only,402,positive,adult,,booster2,03-Apr-22,03-Apr-21,365,mRNA,42,40 to 49
520,male,CD,Ustekinumab Only,27454,positive,adult,,booster1,10-Aug-21,05-May-21,97,mRNA,53,50 to 59
521,male,CD,Ustekinumab Only,2170,positive,adult,,booster1,25-Jan-22,05-May-21,265,mRNA,53,50 to 59
522,female,CD,Ustekinumab Only,2280,positive,adult,,booster1,30-Jul-21,08-Apr-21,113,mRNA,43,40 to 49
523,female,CD,Ustekinumab Only,12214,positive,adult,,booster2,30-Sep-21,07-Apr-21,176,mRNA,43,40 to 49
524,female,CD,Ustekinumab Only,2123,positive,adult,,booster2,27-Jan-22,09-Apr-21,293,mRNA,43,40 to 49
525,female,CD,Ustekinumab Only,1931,positive,adult,,booster2,29-Jan-22,08-Apr-21,296,mRNA,43,40 to 49
526,male,UC,Corticosteroids,6808,positive,adult,,primary,07-Aug-21,24-Apr-21,105,mRNA,21,18 to 29
527,male,UC,Corticosteroids,7787,positive,adult,,booster1,24-Sep-21,21-Apr-21,156,mRNA,21,18 to 29
528,male,UC,Corticosteroids,12233,positive,adult,,booster2,20-Nov-21,19-Apr-21,215,mRNA,21,18 to 29
529,male,UC,Corticosteroids,3252,positive,adult,,booster2,10-Mar-22,25-Apr-21,319,mRNA,21,18 to 29
530,male,UC,Corticosteroids,14395,positive,adult,,booster2,30-Jun-22,21-Apr-21,435,mRNA,21,18 to 29
531,female,CD,Immunomodulator Only,2465,positive,adult,,booster1,06-Aug-21,21-Apr-21,107,vector,38,30 to 39
532,female,CD,Immunomodulator Only,9760,positive,adult,,booster2,13-Nov-21,19-Apr-21,208,vector,39,30 to 39
533,female,CD,Immunomodulator Only,1549,positive,adult,,booster2,23-Feb-22,17-Apr-21,312,vector,39,30 to 39
534,female,CD,Anti-TNF Only,6,negative,adult,98,primary,09-Oct-21,16-Jan-21,266,vector,39,30 to 39
535,male,CD,Combination Therapy,1097,positive,adult,,primary,03-Sep-21,27-Jul-21,38,mRNA,60,60 to 69
536,male,CD,Combination Therapy,48602,positive,adult,,booster1,01-Oct-21,28-Jul-21,65,mRNA,60,60 to 69
537,male,CD,Combination Therapy,4267,positive,adult,,booster1,11-Feb-22,29-Jul-21,197,mRNA,61,60 to 69
538,female,CD,Anti-TNF Only,886,positive,adult,135,booster1,29-Sep-21,19-Mar-21,194,vector,59,50 to 59
539,female,CD,Anti-TNF Only,6282,positive,adult,,booster2,19-Nov-21,14-Mar-21,250,vector,59,50 to 59
540,female,CD,Anti-TNF Only,,,adult,40,booster2,23-Mar-22,18-Mar-21,370,vector,60,60 to 69
541,male,CD,Anti-TNF Only,2388,positive,adult,,booster1,18-Sep-21,08-May-21,133,mRNA,55,50 to 59
542,male,CD,Anti-TNF Only,21205,positive,adult,,booster2,15-Mar-22,07-May-21,312,mRNA,56,50 to 59
543,female,CD,Combination Therapy,4466,positive,adult,,booster1,13-Oct-21,11-May-21,155,mRNA,28,18 to 29
544,female,CD,Combination Therapy,6341,positive,adult,,booster2,27-Nov-21,13-May-21,198,mRNA,28,18 to 29
545,female,CD,Combination Therapy,753,positive,adult,,booster2,22-Apr-22,10-May-21,347,mRNA,28,18 to 29
546,female,CD,Combination Therapy,5971,positive,adult,,booster2,27-May-22,15-May-21,377,mRNA,29,18 to 29
547,female,CD,Vedolizumab Only,7063,positive,adult,,booster1,17-Sep-21,19-Apr-21,151,mRNA,54,50 to 59
548,female,CD,Vedolizumab Only,56362,positive,adult,,booster2,03-Nov-21,19-Apr-21,198,mRNA,54,50 to 59
549,female,CD,Vedolizumab Only,40167,positive,adult,,booster2,12-May-22,20-Apr-21,387,mRNA,55,50 to 59
550,female,CD,Combination Therapy,36177,positive,adult,21,booster1,06-Oct-21,28-Apr-21,161,mRNA,21,18 to 29
551,female,CD,Combination Therapy,40153,positive,adult,62,booster2,16-Nov-21,25-Apr-21,205,mRNA,21,18 to 29
552,female,CD,Combination Therapy,38861,positive,adult,181,booster2,15-Mar-22,26-Apr-21,323,mRNA,21,18 to 29
553,female,CD,Anti-TNF Only,1891,positive,elderly,,booster1,30-Sep-21,23-Apr-21,160,vector,72,70+
554,male,UC,Immunomodulator Only,,,adult,36,booster1,01-Dec-21,08-Apr-21,237,mRNA,26,18 to 29
555,female,CD,Anti-TNF Only,40868,positive,adult,,booster2,11-Feb-22,29-Apr-21,288,mRNA,50,50 to 59
556,male,UC,Vedolizumab Only,388,positive,elderly,,primary,26-May-21,03-Apr-21,53,mRNA,66,60 to 69
557,male,UC,Vedolizumab Only,23945,positive,elderly,,booster1,26-Jun-21,06-Apr-21,81,mRNA,66,60 to 69
558,male,UC,Vedolizumab Only,37672,positive,elderly,,booster2,14-Oct-21,03-Apr-21,194,mRNA,66,60 to 69
559,male,UC,Vedolizumab Only,4212,positive,elderly,,booster2,28-Jan-22,05-Apr-21,298,mRNA,67,60 to 69
560,female,UC,Combination Therapy,128,negative,adult,357,primary,19-May-21,05-Apr-21,44,vector,46,40 to 49
561,female,UC,Combination Therapy,702,positive,adult,306,booster1,09-Jul-21,08-Apr-21,92,vector,46,40 to 49
562,female,UC,Combination Therapy,73,negative,adult,94,booster2,06-Feb-22,07-Apr-21,305,vector,47,40 to 49
563,female,UC,Combination Therapy,4770,positive,adult,56,booster2,16-Mar-22,07-Apr-21,343,vector,47,40 to 49
564,other,UC,Combination Therapy,4075,positive,adult,55,booster2,05-Jul-22,02-Apr-21,459,vector,47,40 to 49
565,female,CD,Anti-TNF Only,24264,positive,adult,395,booster2,21-Apr-22,25-Apr-21,361,mRNA,33,30 to 39
566,male,CD,Ustekinumab Only,973,positive,adult,,primary,25-Sep-21,19-Jun-21,98,vector,60,60 to 69
567,male,CD,Ustekinumab Only,30157,positive,adult,,booster1,23-Oct-21,18-Jun-21,127,vector,60,60 to 69
568,female,CD,Vedolizumab Only,11686,positive,adult,,booster1,03-Aug-21,20-Apr-21,105,mRNA,29,18 to 29
569,female,CD,Vedolizumab Only,713,positive,adult,259,primary,22-May-21,04-Apr-21,48,mRNA,39,30 to 39
570,female,CD,Vedolizumab Only,4282,positive,adult,212,booster1,08-Jul-21,06-Apr-21,93,mRNA,39,30 to 39
571,female,CD,Vedolizumab Only,3570,positive,adult,135,booster1,23-Sep-21,05-Apr-21,171,mRNA,39,30 to 39
572,female,CD,Vedolizumab Only,7123,positive,adult,4,booster2,01-Feb-22,31-Mar-21,307,mRNA,39,30 to 39
573,female,CD,Vedolizumab Only,39043,positive,adult,18,booster2,23-Feb-22,01-Apr-21,328,mRNA,40,40 to 49
574,male,UC,Anti-TNF Only,32,negative,adult,271,pre_dose,24-Apr-21,24-Apr-21,0,mRNA,27,18 to 29
575,female,CD,Vedolizumab Only,640,positive,adult,,primary,22-Jun-21,12-Apr-21,71,vector,36,30 to 39
576,female,CD,Vedolizumab Only,21139,positive,adult,,booster1,04-Sep-21,16-Apr-21,141,vector,36,30 to 39
577,female,CD,Vedolizumab Only,4677,positive,adult,,booster1,16-Dec-21,10-Apr-21,250,vector,37,30 to 39
578,female,CD,Vedolizumab Only,9886,positive,adult,,booster2,30-Mar-22,12-Apr-21,352,vector,37,30 to 39
579,female,CD,Vedolizumab Only,11122,positive,adult,,booster2,23-Jun-22,15-Apr-21,434,vector,37,30 to 39
580,male,UC,Anti-TNF Only,6071,positive,adult,,booster1,22-Jul-21,16-Apr-21,97,mRNA,51,50 to 59
581,male,UC,Anti-TNF Only,468,positive,adult,,booster1,06-Jan-22,19-Apr-21,262,mRNA,51,50 to 59
582,female,CD,Vedolizumab Only,627,positive,adult,,primary,14-Apr-21,25-Feb-21,48,mRNA,35,30 to 39
583,female,CD,Vedolizumab Only,4319,positive,adult,,booster1,10-Jun-21,23-Feb-21,107,mRNA,35,30 to 39
584,female,CD,Vedolizumab Only,787,positive,adult,,booster1,30-Sep-21,22-Feb-21,220,mRNA,35,30 to 39
585,female,CD,Vedolizumab Only,2017,positive,adult,,booster2,29-Mar-22,26-Feb-21,396,mRNA,36,30 to 39
586,female,CD,Anti-TNF Only,375,positive,adult,,booster1,19-Sep-21,21-Jun-21,90,mRNA,57,50 to 59
587,female,CD,Anti-TNF Only,639,positive,adult,,booster2,30-Jan-22,21-Jun-21,223,mRNA,57,50 to 59
588,female,CD,Anti-TNF Only,4559,positive,adult,,booster2,24-Apr-22,15-Jun-21,313,mRNA,57,50 to 59
589,female,CD,Anti-TNF Only,1094,positive,adult,,booster1,20-Jul-21,21-Apr-21,90,mRNA,58,50 to 59
590,female,CD,Anti-TNF Only,4318,positive,adult,,booster2,18-Nov-21,23-Apr-21,209,mRNA,58,50 to 59
591,female,CD,Anti-TNF Only,441,positive,adult,,booster2,01-Mar-22,21-Apr-21,314,mRNA,58,50 to 59
592,female,CD,Vedolizumab Only,706,positive,adult,,booster1,14-Dec-21,19-Feb-21,298,mRNA,32,30 to 39
593,female,CD,Vedolizumab Only,12666,positive,adult,,booster2,25-Mar-22,18-Feb-21,400,mRNA,33,30 to 39
594,male,CD,Anti-TNF Only,752,positive,adult,,booster1,07-Jul-21,11-Apr-21,87,mRNA,42,40 to 49
595,male,CD,Anti-TNF Only,518,positive,adult,,booster1,01-Sep-21,07-Apr-21,147,mRNA,42,40 to 49
596,male,CD,Anti-TNF Only,3904,positive,adult,,booster2,22-Dec-21,06-Apr-21,260,mRNA,42,40 to 49
597,male,CD,Anti-TNF Only,6478,positive,adult,,booster2,08-Jun-22,10-Apr-21,424,mRNA,43,40 to 49
598,female,CD,Vedolizumab Only,260,positive,elderly,,primary,18-May-21,28-Mar-21,51,mRNA,67,60 to 69
599,female,CD,Vedolizumab Only,9173,positive,elderly,,booster1,13-Jul-21,28-Mar-21,107,mRNA,67,60 to 69
600,female,CD,Vedolizumab Only,1088,positive,elderly,,booster1,06-Jan-22,30-Mar-21,282,mRNA,67,60 to 69
601,female,CD,Vedolizumab Only,28573,positive,elderly,,booster2,03-Feb-22,25-Mar-21,315,mRNA,67,60 to 69
602,male,UC,Anti-TNF Only,5508,positive,adult,,booster1,15-Jul-21,06-Apr-21,100,mRNA,28,18 to 29
603,female,CD,Ustekinumab Only,9177,positive,adult,,booster1,27-May-21,09-Apr-21,48,mRNA,35,30 to 39
604,female,CD,Ustekinumab Only,2350,positive,adult,262,booster1,21-Aug-21,06-Apr-21,137,mRNA,36,30 to 39
605,female,CD,Ustekinumab Only,41329,positive,adult,218,booster2,12-Mar-22,05-Apr-21,341,mRNA,36,30 to 39
606,female,CD,Ustekinumab Only,673,positive,adult,77,primary,02-Jun-21,20-Apr-21,43,mRNA,48,40 to 49
607,female,CD,Ustekinumab Only,28511,positive,adult,23,booster1,04-Aug-21,22-Apr-21,104,mRNA,48,40 to 49
608,female,CD,Ustekinumab Only,1748,positive,adult,,booster1,19-Jan-22,22-Apr-21,272,mRNA,49,40 to 49
609,female,CD,Ustekinumab Only,19830,positive,adult,,booster2,17-Jun-22,24-Apr-21,419,mRNA,49,40 to 49
610,female,CD,Vedolizumab Only,17289,positive,adult,220,booster1,06-Jul-21,17-Apr-21,80,vector,40,40 to 49
611,female,CD,Vedolizumab Only,50259,positive,adult,71,booster2,02-Dec-21,16-Apr-21,230,vector,41,40 to 49
612,female,CD,Vedolizumab Only,29354,positive,adult,41,booster2,24-Mar-22,17-Apr-21,341,vector,41,40 to 49
613,female,CD,Anti-TNF Only,2466,positive,elderly,,booster1,10-Aug-21,12-Apr-21,120,mRNA,67,60 to 69
614,female,CD,Anti-TNF Only,1404,positive,elderly,,booster2,25-Jan-22,13-Apr-21,287,mRNA,67,60 to 69
615,female,CD,Anti-TNF Only,5702,positive,elderly,,booster2,04-Jun-22,15-Apr-21,415,mRNA,68,60 to 69
616,female,CD,Ustekinumab Only,100,negative,adult,18,pre_dose,09-Jun-21,27-May-21,13,vector,58,50 to 59
617,female,CD,Ustekinumab Only,10418,positive,adult,59,primary,20-Jul-21,29-May-21,52,vector,58,50 to 59
618,female,CD,Ustekinumab Only,16805,positive,adult,,booster1,12-Aug-21,28-May-21,76,vector,58,50 to 59
619,female,CD,Ustekinumab Only,15863,positive,adult,294,booster2,12-Mar-22,23-May-21,293,vector,59,50 to 59
620,female,CD,Ustekinumab Only,11458,positive,adult,405,booster2,01-Jul-22,25-May-21,402,vector,59,50 to 59
621,female,CD,Combination Therapy,128,negative,adult,,primary,04-Jun-21,10-Apr-21,55,mRNA,36,30 to 39
622,female,CD,Combination Therapy,44,negative,adult,,booster1,29-Jul-21,08-Apr-21,112,mRNA,36,30 to 39
623,female,CD,Combination Therapy,299,positive,adult,,booster2,11-Mar-22,10-Apr-21,335,mRNA,37,30 to 39
624,female,CD,Anti-TNF Only,,,elderly,265,primary,16-Oct-21,17-Sep-21,29,mRNA,64,60 to 69
625,female,CD,Anti-TNF Only,27359,positive,elderly,331,booster1,21-Dec-21,19-Sep-21,93,mRNA,65,60 to 69
626,female,UC,Vedolizumab Only,10217,positive,adult,,booster1,06-Aug-21,25-Apr-21,103,mRNA,24,18 to 29
627,female,UC,Vedolizumab Only,42367,positive,adult,,booster2,26-Jan-22,21-Apr-21,280,mRNA,25,18 to 29
628,female,UC,Vedolizumab Only,9382,positive,adult,,booster2,22-May-22,24-Apr-21,393,mRNA,25,18 to 29
629,female,CD,Combination Therapy,6861,positive,adult,218,booster1,16-Sep-21,05-Apr-21,164,vector,35,30 to 39
630,female,CD,Combination Therapy,12446,positive,adult,135,booster2,08-Dec-21,07-Apr-21,245,vector,35,30 to 39
631,female,CD,Ustekinumab Only,13915,positive,adult,,booster1,15-Jul-21,22-Apr-21,84,mRNA,43,40 to 49
632,male,CD,Vedolizumab Only,8806,positive,adult,290,booster1,22-Jul-21,11-Apr-21,102,mRNA,41,40 to 49
633,male,CD,Vedolizumab Only,14800,positive,adult,177,booster2,12-Nov-21,06-Apr-21,220,mRNA,41,40 to 49
634,male,CD,Vedolizumab Only,4434,positive,adult,92,booster2,05-Feb-22,08-Apr-21,303,mRNA,42,40 to 49
635,male,CD,Anti-TNF Only,2965,positive,adult,,booster1,22-Aug-21,06-May-21,108,mRNA,32,30 to 39
636,male,CD,Anti-TNF Only,4562,positive,adult,,booster2,18-Dec-21,10-May-21,222,mRNA,33,30 to 39
637,female,CD,Anti-TNF Only,3240,positive,adult,,booster1,19-Aug-21,10-Apr-21,131,mRNA,54,50 to 59
638,female,CD,Vedolizumab Only,21605,positive,adult,,booster1,24-Jul-21,28-May-21,57,vector,53,50 to 59
639,female,CD,Vedolizumab Only,21697,positive,adult,,booster2,11-Nov-21,28-May-21,167,vector,54,50 to 59
640,female,CD,Vedolizumab Only,858,positive,adult,,booster2,18-Feb-22,30-May-21,264,vector,54,50 to 59
641,female,CD,Vedolizumab Only,,,adult,,booster2,18-Mar-22,28-May-21,294,vector,54,50 to 59
642,female,CD,Vedolizumab Only,29159,positive,adult,,booster2,09-Jul-22,28-May-21,407,vector,54,50 to 59
643,female,CD,Vedolizumab Only,22250,positive,adult,,booster1,25-Aug-21,01-May-21,116,mRNA,36,30 to 39
644,female,CD,Vedolizumab Only,13837,positive,adult,,booster2,24-Dec-21,28-Apr-21,240,mRNA,36,30 to 39
645,female,UC,No Immunosuppressives,9660,positive,adult,522,booster2,12-Feb-22,15-Apr-21,303,vector,27,18 to 29
646,female,CD,Anti-TNF Only,3524,positive,adult,225,primary,03-Jun-21,13-Apr-21,51,mRNA,50,50 to 59
647,female,CD,Anti-TNF Only,6,negative,adult,282,booster1,30-Jul-21,16-Apr-21,105,mRNA,50,50 to 59
648,female,CD,Anti-TNF Only,250,positive,adult,444,booster1,08-Jan-22,17-Apr-21,266,mRNA,50,50 to 59
649,female,CD,Anti-TNF Only,2197,positive,adult,470,booster2,03-Feb-22,13-Apr-21,296,mRNA,50,50 to 59
650,female,CD,Anti-TNF Only,3694,positive,adult,582,booster2,26-May-22,13-Apr-21,408,mRNA,51,50 to 59
651,male,UC,Tofacitinib Only,67861,positive,adult,,booster2,21-Jul-22,25-Apr-21,452,vector,38,30 to 39
652,female,CD,Vedolizumab Only,12260,positive,adult,259,booster1,08-Aug-21,03-May-21,97,mRNA,52,50 to 59
653,female,CD,Vedolizumab Only,39386,positive,adult,18,booster2,12-May-22,03-May-21,374,mRNA,53,50 to 59
654,female,CD,Anti-TNF Only,166,positive,adult,262,primary,28-Apr-21,28-Mar-21,31,mRNA,49,40 to 49
655,female,CD,Anti-TNF Only,6739,positive,adult,124,booster2,22-Oct-21,30-Mar-21,206,mRNA,49,40 to 49
656,female,CD,Combination Therapy,5803,positive,adult,224,booster1,09-Jul-21,31-Mar-21,100,mRNA,23,18 to 29
657,female,CD,Combination Therapy,,,adult,43,booster2,02-Apr-22,03-Apr-21,364,mRNA,24,18 to 29
658,female,CD,Vedolizumab Only,1898,positive,adult,294,primary,27-Feb-21,01-Jan-21,57,mRNA,37,30 to 39
659,female,CD,Vedolizumab Only,31563,positive,adult,287,booster1,06-Mar-21,06-Jan-21,59,mRNA,37,30 to 39
660,female,CD,Vedolizumab Only,1700,positive,adult,,booster1,18-Dec-21,02-Jan-21,350,mRNA,38,30 to 39
661,female,CD,Vedolizumab Only,14416,positive,adult,5,booster1,23-Dec-21,31-Dec-20,357,mRNA,38,30 to 39
662,female,CD,Anti-TNF Only,2496,positive,adult,304,primary,29-Sep-21,04-Jul-21,87,vector,42,40 to 49
663,male,CD,Anti-TNF Only,929,positive,adult,408,booster1,22-Jul-21,11-Apr-21,102,mRNA,48,40 to 49
664,male,CD,Anti-TNF Only,6705,positive,adult,590,booster2,20-Jan-22,05-Apr-21,290,mRNA,48,40 to 49
665,male,CD,Anti-TNF Only,2051,positive,adult,696,booster2,06-May-22,07-Apr-21,394,mRNA,49,40 to 49
666,male,CD,Anti-TNF Only,5891,positive,adult,738,booster2,17-Jun-22,10-Apr-21,433,mRNA,49,40 to 49
667,female,CD,Anti-TNF Only,12251,positive,adult,273,booster1,01-Sep-21,21-Apr-21,133,mRNA,29,18 to 29
668,male,UC,Combination Therapy,25046,positive,adult,199,primary,27-Jun-21,20-May-21,38,mRNA,44,40 to 49
669,male,UC,Combination Therapy,78175,positive,adult,238,booster1,05-Aug-21,22-May-21,75,mRNA,44,40 to 49
670,male,UC,Combination Therapy,12279,positive,adult,77,booster1,23-Dec-21,26-May-21,211,mRNA,45,40 to 49
671,female,UC,Anti-TNF Only,183,positive,adult,359,primary,27-May-21,07-Apr-21,50,mRNA,30,30 to 39
672,female,UC,Anti-TNF Only,1202,positive,adult,319,booster1,06-Jul-21,11-Apr-21,86,mRNA,30,30 to 39
673,female,UC,Anti-TNF Only,209,positive,adult,239,booster1,24-Sep-21,11-Apr-21,166,mRNA,30,30 to 39
674,female,UC,Anti-TNF Only,4815,positive,adult,105,booster2,05-Feb-22,13-Apr-21,298,mRNA,30,30 to 39
675,female,CD,Combination Therapy,1994,positive,adult,236,booster1,06-Aug-21,14-Apr-21,114,mRNA,48,40 to 49
676,female,CD,Combination Therapy,180,positive,adult,98,booster1,22-Dec-21,18-Apr-21,248,mRNA,49,40 to 49
677,female,CD,Combination Therapy,6625,positive,adult,32,booster2,26-Feb-22,15-Apr-21,317,mRNA,49,40 to 49
678,female,CD,Combination Therapy,9613,positive,adult,73,booster2,11-Jun-22,14-Apr-21,423,mRNA,49,40 to 49
679,female,CD,Anti-TNF Only,8,negative,adult,,pre_dose,16-Mar-21,11-Mar-21,5,vector,61,60 to 69
680,female,CD,Anti-TNF Only,176,positive,adult,23,primary,18-May-21,10-Mar-21,69,vector,61,60 to 69
681,female,CD,Anti-TNF Only,1925,positive,adult,,booster1,20-Jul-21,10-Mar-21,132,vector,61,60 to 69
682,female,CD,Anti-TNF Only,843,positive,adult,,booster1,18-Sep-21,11-Mar-21,191,vector,61,60 to 69
683,female,CD,Anti-TNF Only,54531,positive,adult,,booster2,27-Oct-21,15-Mar-21,226,vector,61,60 to 69
684,female,CD,Anti-TNF Only,2096,positive,adult,,booster2,02-Mar-22,15-Mar-21,352,vector,62,60 to 69
685,other,CD,Anti-TNF Only,31331,positive,elderly,,booster2,25-Jun-22,11-Mar-21,471,vector,62,60 to 69
686,female,CD,Anti-TNF Only,2779,positive,adult,198,booster1,19-Aug-21,19-Apr-21,122,vector,48,40 to 49
687,female,CD,Anti-TNF Only,11195,positive,adult,21,booster1,26-Mar-22,21-Apr-21,339,vector,49,40 to 49
688,female,CD,Combination Therapy,249,positive,adult,,booster1,23-Jul-21,15-Apr-21,99,mRNA,55,50 to 59
689,female,CD,Combination Therapy,1955,positive,adult,,booster2,23-Nov-21,10-Apr-21,227,mRNA,56,50 to 59
690,female,CD,Combination Therapy,166,positive,adult,,booster2,18-Feb-22,13-Apr-21,311,mRNA,56,50 to 59
691,female,CD,Combination Therapy,2183,positive,adult,401,booster2,19-Apr-22,12-Apr-21,372,mRNA,56,50 to 59
692,female,CD,Combination Therapy,401,positive,adult,350,booster2,04-Aug-22,14-Apr-21,477,mRNA,57,50 to 59
693,male,UC,Anti-TNF Only,27,negative,adult,39,primary,27-May-21,13-Apr-21,44,mRNA,59,50 to 59
694,male,UC,Anti-TNF Only,1857,positive,adult,,booster1,06-Aug-21,15-Apr-21,113,mRNA,59,50 to 59
695,male,UC,Anti-TNF Only,6913,positive,adult,,booster2,07-Nov-21,18-Apr-21,203,mRNA,59,50 to 59
696,female,CD,Anti-TNF Only,2474,positive,adult,,booster1,16-Jun-21,16-Apr-21,61,mRNA,57,50 to 59
697,female,CD,Anti-TNF Only,2106,positive,adult,401,booster1,05-Aug-21,17-Apr-21,110,mRNA,57,50 to 59
698,female,CD,Anti-TNF Only,1296,positive,adult,291,booster1,02-Oct-21,15-Apr-21,170,mRNA,57,50 to 59
699,female,CD,Anti-TNF Only,1262,positive,adult,395,booster2,14-Jan-22,21-Apr-21,268,mRNA,57,50 to 59
700,female,CD,Anti-TNF Only,3305,positive,adult,540,booster2,08-Jun-22,21-Apr-21,413,mRNA,58,50 to 59
701,female,CD,Anti-TNF Only,1653,positive,elderly,321,booster1,22-Jul-21,30-Mar-21,114,mRNA,66,60 to 69
702,female,CD,Anti-TNF Only,415,positive,elderly,197,booster2,23-Nov-21,28-Mar-21,240,mRNA,66,60 to 69
703,male,CD,Vedolizumab Only,2930,positive,adult,,booster1,27-Jul-21,06-Apr-21,112,mRNA,46,40 to 49
704,male,CD,Vedolizumab Only,4592,positive,adult,,booster2,18-Nov-21,08-Apr-21,224,mRNA,46,40 to 49
705,male,CD,Vedolizumab Only,2153,positive,adult,,booster2,02-Feb-22,09-Apr-21,299,mRNA,46,40 to 49
706,female,CD,Anti-TNF Only,176,positive,elderly,350,primary,09-May-21,22-Mar-21,48,mRNA,63,60 to 69
707,female,CD,Anti-TNF Only,3697,positive,elderly,203,booster1,25-Jul-21,26-Mar-21,121,mRNA,63,60 to 69
708,female,CD,Anti-TNF Only,559,positive,elderly,75,booster1,30-Nov-21,23-Mar-21,252,mRNA,64,60 to 69
709,female,CD,Anti-TNF Only,27505,positive,elderly,158,booster1,21-Jul-22,27-Mar-21,481,mRNA,64,60 to 69
710,male,CD,Combination Therapy,1027,positive,adult,,booster1,24-Aug-21,12-Apr-21,134,mRNA,37,30 to 39
711,male,CD,Combination Therapy,16407,positive,adult,,booster2,23-Feb-22,08-Apr-21,321,mRNA,37,30 to 39
712,male,CD,Combination Therapy,165,positive,adult,185,booster1,13-Aug-21,21-Mar-21,145,vector,59,50 to 59
713,male,CD,Combination Therapy,671,positive,adult,93,booster2,13-Nov-21,24-Mar-21,234,vector,59,50 to 59
714,male,CD,Combination Therapy,161,positive,adult,10,booster2,04-Feb-22,26-Mar-21,315,vector,59,50 to 59
715,male,CD,Anti-TNF Only,6194,positive,adult,210,booster2,11-Nov-21,26-Apr-21,199,mRNA,61,60 to 69
716,male,CD,Anti-TNF Only,786,positive,adult,,booster2,09-Mar-22,22-Apr-21,321,mRNA,62,60 to 69
717,male,CD,Anti-TNF Only,5756,positive,adult,,booster2,04-May-22,23-Apr-21,376,mRNA,62,60 to 69
718,male,CD,Anti-TNF Only,2060,positive,adult,,booster2,05-Aug-22,23-Apr-21,469,mRNA,62,60 to 69
719,female,CD,Anti-TNF Only,406,positive,adult,243,booster1,18-Aug-21,30-Mar-21,141,mRNA,40,40 to 49
720,female,CD,Anti-TNF Only,4686,positive,adult,137,booster2,02-Dec-21,28-Mar-21,249,mRNA,40,40 to 49
721,female,CD,Anti-TNF Only,5837,positive,adult,256,booster1,02-Sep-21,05-Jun-21,89,mRNA,42,40 to 49
722,female,CD,Anti-TNF Only,4935,positive,adult,414,booster2,07-Feb-22,04-Jun-21,248,mRNA,43,40 to 49
723,female,CD,Anti-TNF Only,30,negative,adult,,booster1,01-Aug-21,01-May-21,92,mRNA,48,40 to 49
724,female,CD,Anti-TNF Only,6890,positive,adult,39,booster1,07-Aug-21,22-Apr-21,107,mRNA,51,50 to 59
725,female,CD,Anti-TNF Only,2348,positive,adult,,booster2,26-Nov-21,19-Apr-21,221,mRNA,51,50 to 59
726,female,CD,Anti-TNF Only,15436,positive,adult,,booster2,24-Feb-22,22-Apr-21,308,mRNA,52,50 to 59
727,male,CD,Anti-TNF Only,3824,positive,adult,211,booster1,03-Jul-21,14-Mar-21,111,vector,58,50 to 59
728,male,CD,Anti-TNF Only,3323,positive,adult,133,booster1,19-Sep-21,17-Mar-21,186,vector,58,50 to 59
729,male,CD,Anti-TNF Only,5119,positive,adult,69,booster2,22-Nov-21,15-Mar-21,252,vector,59,50 to 59
730,male,CD,Anti-TNF Only,2547,positive,adult,9,booster2,21-Jan-22,13-Mar-21,314,vector,59,50 to 59
731,female,CD,Combination Therapy,892,positive,adult,292,primary,04-Jul-21,08-May-21,57,mRNA,47,40 to 49
732,female,CD,Combination Therapy,18779,positive,adult,251,booster1,14-Aug-21,08-May-21,98,mRNA,47,40 to 49
733,female,CD,Combination Therapy,55365,positive,adult,133,booster2,10-Dec-21,09-May-21,215,mRNA,47,40 to 49
734,female,CD,Combination Therapy,10241,positive,adult,,booster2,05-Apr-22,04-May-21,336,mRNA,47,40 to 49
735,female,UC,No Immunosuppressives,20715,positive,adult,293,booster1,31-Jul-21,30-Apr-21,92,mRNA,35,30 to 39
736,female,UC,No Immunosuppressives,47223,positive,adult,607,booster2,10-Jun-22,02-May-21,404,mRNA,35,30 to 39
737,male,CD,Combination Therapy,829,positive,adult,226,booster1,29-Jul-21,23-Apr-21,97,mRNA,33,30 to 39
738,female,UC,Anti-TNF Only,7113,positive,adult,217,primary,13-Jul-21,28-Apr-21,76,vector,48,40 to 49
739,female,UC,Anti-TNF Only,5122,positive,adult,240,booster1,05-Aug-21,27-Apr-21,100,vector,48,40 to 49
740,female,UC,Anti-TNF Only,1197,positive,adult,336,booster1,09-Nov-21,26-Apr-21,197,vector,48,40 to 49
741,female,UC,No Immunosuppressives,6782,positive,adult,257,booster1,14-Aug-21,13-Apr-21,123,mRNA,51,50 to 59
742,female,UC,No Immunosuppressives,19661,positive,adult,347,booster2,12-Nov-21,14-Apr-21,212,mRNA,51,50 to 59
743,female,UC,No Immunosuppressives,3439,positive,adult,491,booster2,05-Apr-22,16-Apr-21,354,mRNA,52,50 to 59
744,female,CD,Ustekinumab Only,244,positive,adult,,booster1,29-Oct-21,11-Jan-21,291,mRNA,56,50 to 59
745,female,CD,Combination Therapy,3688,positive,adult,,booster1,29-Jul-21,09-Apr-21,111,mRNA,53,50 to 59
746,female,CD,Combination Therapy,50002,positive,adult,,booster2,03-Feb-22,13-Apr-21,296,mRNA,53,50 to 59
747,female,CD,Combination Therapy,40023,positive,adult,,booster2,03-Jun-22,12-Apr-21,417,mRNA,53,50 to 59
748,female,CD,Anti-TNF Only,755,positive,adult,64,booster2,03-Feb-22,14-Apr-21,295,vector,29,18 to 29
749,female,UC,Anti-TNF Only,3713,positive,adult,,booster1,14-Aug-21,21-Apr-21,115,vector,39,30 to 39
750,female,UC,Anti-TNF Only,10078,positive,adult,10,booster2,16-Feb-22,16-Apr-21,306,vector,40,40 to 49
751,female,CD,Anti-TNF Only,26,negative,elderly,,primary,13-May-21,24-Mar-21,50,mRNA,66,60 to 69
752,female,CD,Anti-TNF Only,1296,positive,elderly,,booster1,12-Aug-21,24-Mar-21,141,mRNA,66,60 to 69
753,female,CD,Anti-TNF Only,7895,positive,elderly,,booster2,12-Nov-21,28-Mar-21,229,mRNA,67,60 to 69
754,female,CD,Anti-TNF Only,1205,positive,elderly,,booster2,11-Mar-22,27-Mar-21,349,mRNA,67,60 to 69
755,female,CD,Anti-TNF Only,10542,positive,elderly,,booster2,05-May-22,25-Mar-21,406,mRNA,67,60 to 69
756,male,CD,Combination Therapy,122,negative,adult,,primary,03-Jul-21,27-Apr-21,67,vector,33,30 to 39
757,male,CD,Combination Therapy,1040,positive,adult,,booster1,23-Oct-21,25-Apr-21,181,vector,33,30 to 39
758,male,CD,Anti-TNF Only,1121,positive,adult,368,booster1,29-Jul-21,16-Apr-21,104,mRNA,55,50 to 59
759,male,CD,Anti-TNF Only,3115,positive,adult,,booster2,12-Nov-21,15-Apr-21,211,mRNA,55,50 to 59
760,male,CD,Anti-TNF Only,697,positive,adult,165,booster2,17-Feb-22,14-Apr-21,309,mRNA,56,50 to 59
761,female,CD,Anti-TNF Only,166,positive,adult,259,primary,29-Jun-21,26-Apr-21,64,mRNA,47,40 to 49
762,female,CD,Anti-TNF Only,5043,positive,adult,238,booster1,20-Jul-21,28-Apr-21,83,mRNA,47,40 to 49
763,female,CD,Anti-TNF Only,656,positive,adult,101,booster1,04-Dec-21,01-May-21,217,mRNA,47,40 to 49
764,female,CD,Anti-TNF Only,4058,positive,adult,68,booster2,06-Jan-22,26-Apr-21,255,mRNA,47,40 to 49
765,female,CD,Anti-TNF Only,31123,positive,adult,63,booster2,17-May-22,27-Apr-21,385,mRNA,48,40 to 49
766,male,UC,Anti-TNF Only,3231,positive,adult,173,booster1,26-Aug-21,13-Apr-21,135,mRNA,34,30 to 39
767,male,UC,Anti-TNF Only,16629,positive,adult,89,booster2,18-Nov-21,08-Apr-21,224,mRNA,34,30 to 39
768,male,UC,Anti-TNF Only,29286,positive,adult,14,booster2,01-Mar-22,08-Apr-21,327,mRNA,35,30 to 39
769,female,CD,Anti-TNF Only,76,negative,adult,,primary,01-Jun-21,18-Apr-21,44,mRNA,51,50 to 59
770,female,UC,Anti-TNF Only,1675,positive,adult,,booster1,27-Jul-22,17-Apr-21,466,mRNA,54,50 to 59
771,male,CD,Vedolizumab Only,785,positive,elderly,,primary,11-May-21,24-Mar-21,48,mRNA,68,60 to 69
772,male,CD,Vedolizumab Only,2730,positive,elderly,,booster1,06-Jul-21,23-Mar-21,105,mRNA,68,60 to 69
773,male,CD,Vedolizumab Only,1319,positive,elderly,,booster1,28-Oct-21,26-Mar-21,216,mRNA,68,60 to 69
774,male,CD,Vedolizumab Only,33265,positive,elderly,,booster2,28-Dec-21,26-Mar-21,277,mRNA,69,60 to 69
775,male,CD,Vedolizumab Only,40043,positive,elderly,,booster2,14-Jun-22,21-Mar-21,450,mRNA,69,60 to 69
776,female,CD,Corticosteroids,242,positive,elderly,,primary,20-May-21,04-Apr-21,46,mRNA,66,60 to 69
777,female,CD,Corticosteroids,7916,positive,elderly,,booster1,24-Jul-21,07-Apr-21,108,mRNA,66,60 to 69
778,female,CD,Corticosteroids,,,elderly,,booster2,03-Mar-22,09-Apr-21,328,mRNA,67,60 to 69
779,female,CD,Corticosteroids,14509,positive,elderly,,booster2,14-Jul-22,06-Apr-21,464,mRNA,67,60 to 69
780,female,CD,Anti-TNF Only,659,positive,adult,,booster1,04-Aug-21,16-Apr-21,110,mRNA,49,40 to 49
781,female,CD,Anti-TNF Only,465,positive,adult,,booster2,13-Apr-22,15-Apr-21,363,mRNA,50,50 to 59
782,female,CD,Anti-TNF Only,10009,positive,adult,,primary,03-Mar-21,15-Jan-21,47,vector,32,30 to 39
783,female,CD,Anti-TNF Only,997,positive,adult,,booster1,27-Jul-21,16-Jan-21,192,vector,32,30 to 39
784,female,CD,Anti-TNF Only,6381,positive,adult,,booster2,13-Apr-22,17-Jan-21,451,vector,33,30 to 39
785,male,UC,Vedolizumab Only,40047,positive,adult,,booster2,19-May-22,14-May-21,370,mRNA,55,50 to 59
786,female,UC,Combination Therapy,36,negative,adult,,pre_dose,30-Apr-21,29-Apr-21,1,mRNA,41,40 to 49
787,female,UC,Combination Therapy,10015,positive,adult,,booster1,23-Jul-21,27-Apr-21,87,mRNA,41,40 to 49
788,female,UC,Combination Therapy,155,positive,adult,30,booster1,06-Jan-22,23-Apr-21,258,mRNA,41,40 to 49
789,female,UC,Combination Therapy,14129,positive,adult,7,booster1,12-Feb-22,27-Apr-21,291,mRNA,41,40 to 49
790,male,UC,Tofacitinib Only,3450,positive,adult,,booster1,29-Aug-21,09-Apr-21,142,mRNA,32,30 to 39
791,male,UC,Tofacitinib Only,40011,positive,adult,,booster2,13-Feb-22,14-Apr-21,305,mRNA,32,30 to 39
792,female,UC,Anti-TNF Only,1518,positive,adult,31,primary,31-Dec-21,27-Mar-21,279,vector,34,30 to 39
793,male,UC,Ustekinumab Only,2848,positive,adult,173,booster1,12-Aug-21,21-Apr-21,113,mRNA,22,18 to 29
794,male,UC,Ustekinumab Only,515,positive,adult,6,booster1,26-Jan-22,25-Apr-21,276,mRNA,23,18 to 29
795,male,CD,Ustekinumab Only,2880,positive,elderly,,booster1,23-Jul-21,14-Apr-21,100,mRNA,66,60 to 69
796,female,CD,Anti-TNF Only,17187,positive,adult,13,booster1,02-Feb-22,15-Apr-21,293,mRNA,47,40 to 49
797,female,CD,Anti-TNF Only,6049,positive,adult,145,booster2,14-Jun-22,12-Apr-21,428,mRNA,48,40 to 49
798,female,CD,Combination Therapy,30,negative,adult,,primary,22-Oct-21,20-Jan-21,275,vector,53,50 to 59
799,male,CD,Anti-TNF Only,8,negative,adult,,primary,20-Apr-21,29-Mar-21,22,vector,43,40 to 49
800,male,CD,Combination Therapy,2542,positive,adult,221,booster1,30-Jun-21,24-Apr-21,67,mRNA,25,18 to 29
801,male,CD,Combination Therapy,380,positive,adult,127,booster1,02-Oct-21,22-Apr-21,163,mRNA,26,18 to 29
802,male,CD,Combination Therapy,10165,positive,adult,32,booster2,10-Mar-22,25-Apr-21,319,mRNA,26,18 to 29
803,male,CD,Combination Therapy,10196,positive,adult,151,booster2,07-Jul-22,19-Apr-21,444,mRNA,26,18 to 29
804,male,CD,Ustekinumab Only,273,positive,elderly,,primary,01-Jun-21,22-Mar-21,71,mRNA,64,60 to 69
805,male,CD,Ustekinumab Only,11555,positive,elderly,,booster1,11-Aug-21,18-Mar-21,146,mRNA,64,60 to 69
806,male,CD,Ustekinumab Only,28771,positive,elderly,,booster2,10-Feb-22,18-Mar-21,329,mRNA,64,60 to 69
807,male,CD,Ustekinumab Only,7872,positive,elderly,,booster2,05-May-22,18-Mar-21,413,mRNA,65,60 to 69
808,male,CD,Ustekinumab Only,1014,positive,adult,60,pre_dose,23-Apr-21,02-Apr-21,21,mRNA,53,50 to 59
809,male,CD,Ustekinumab Only,14046,positive,adult,93,primary,26-May-21,02-Apr-21,54,mRNA,53,50 to 59
810,male,CD,Ustekinumab Only,21754,positive,adult,166,booster1,07-Aug-21,04-Apr-21,125,mRNA,53,50 to 59
811,male,CD,Ustekinumab Only,3013,positive,adult,331,booster1,19-Jan-22,01-Apr-21,293,mRNA,54,50 to 59
812,male,CD,Ustekinumab Only,38423,positive,adult,370,booster2,27-Feb-22,04-Apr-21,329,mRNA,54,50 to 59
813,male,CD,Ustekinumab Only,22146,positive,adult,484,booster2,21-Jun-22,02-Apr-21,445,mRNA,54,50 to 59
814,male,CD,Anti-TNF Only,9,negative,adult,,booster1,05-Aug-21,25-Apr-21,102,vector,35,30 to 39
815,male,CD,Anti-TNF Only,4602,positive,adult,400,booster1,28-Jan-22,23-Apr-21,280,vector,36,30 to 39
816,male,CD,Anti-TNF Only,1124,positive,adult,567,booster1,14-Jul-22,27-Apr-21,443,vector,36,30 to 39
817,male,CD,Ustekinumab Only,190,positive,elderly,,primary,29-Apr-21,09-Mar-21,51,mRNA,76,70+
818,male,CD,Ustekinumab Only,5057,positive,elderly,,booster1,10-Jun-21,09-Mar-21,93,mRNA,76,70+
819,male,CD,Ustekinumab Only,634,positive,elderly,,booster1,16-Sep-21,06-Mar-21,194,mRNA,76,70+
820,male,CD,Ustekinumab Only,8384,positive,elderly,,booster2,22-Jan-22,09-Mar-21,319,mRNA,77,70+
821,male,CD,Ustekinumab Only,609,positive,elderly,,primary,20-Apr-21,25-Feb-21,54,mRNA,73,70+
822,male,CD,Ustekinumab Only,11713,positive,elderly,,booster1,11-Jun-21,22-Feb-21,109,mRNA,73,70+
823,male,CD,Ustekinumab Only,1972,positive,elderly,,booster1,14-Sep-21,27-Feb-21,199,mRNA,74,70+
824,male,CD,Ustekinumab Only,20892,positive,elderly,,booster2,19-Jan-22,22-Feb-21,331,mRNA,74,70+
825,female,CD,Combination Therapy,460,positive,adult,335,booster1,25-Jun-21,20-Apr-21,66,mRNA,26,18 to 29
826,female,CD,Combination Therapy,101,negative,adult,251,booster1,17-Sep-21,21-Apr-21,149,mRNA,27,18 to 29
827,female,CD,Combination Therapy,2200,positive,adult,190,booster2,17-Nov-21,25-Apr-21,206,mRNA,27,18 to 29
828,female,CD,Combination Therapy,189,positive,adult,41,booster2,15-Apr-22,21-Apr-21,359,mRNA,27,18 to 29
829,male,CD,Vedolizumab Only,1343,positive,elderly,,booster1,10-Jun-21,17-Mar-21,85,mRNA,77,70+
830,male,CD,Vedolizumab Only,216,positive,elderly,,booster1,08-Sep-21,12-Mar-21,180,mRNA,78,70+
831,male,CD,Vedolizumab Only,1405,positive,elderly,,booster2,18-Feb-22,17-Mar-21,338,mRNA,78,70+
832,female,UC,No Immunosuppressives,24,negative,elderly,,primary,14-May-21,27-Mar-21,48,mRNA,72,70+
833,female,UC,No Immunosuppressives,367,positive,elderly,,booster1,30-Jul-21,28-Mar-21,124,mRNA,72,70+
834,female,UC,No Immunosuppressives,4806,positive,elderly,,booster2,18-Mar-22,23-Mar-21,360,mRNA,73,70+
835,female,UC,No Immunosuppressives,2683,positive,elderly,,booster2,27-May-22,23-Mar-21,430,mRNA,73,70+
836,male,CD,Ustekinumab Only,131,negative,adult,,primary,27-Jul-21,27-May-21,61,mRNA,56,50 to 59
837,male,CD,Ustekinumab Only,615,positive,adult,,booster1,08-Jan-22,30-May-21,223,mRNA,57,50 to 59
838,female,CD,Ustekinumab Only,8252,positive,elderly,,booster1,04-Aug-21,13-Apr-21,113,mRNA,64,60 to 69
839,female,CD,Ustekinumab Only,28054,positive,elderly,,booster2,11-Nov-21,12-Apr-21,213,mRNA,64,60 to 69
840,female,CD,Ustekinumab Only,11090,positive,elderly,,booster2,13-Feb-22,11-Apr-21,308,mRNA,64,60 to 69
841,female,CD,Ustekinumab Only,58590,positive,elderly,,booster2,21-Apr-22,11-Apr-21,375,mRNA,65,60 to 69
842,female,CD,Ustekinumab Only,9874,positive,elderly,,booster2,04-Aug-22,12-Apr-21,479,mRNA,65,60 to 69
843,female,CD,Corticosteroids,326,positive,adult,,booster1,07-Sep-21,07-Apr-21,153,mRNA,49,40 to 49
844,female,CD,Corticosteroids,5159,positive,adult,,booster2,07-Oct-21,04-Apr-21,186,mRNA,49,40 to 49
845,female,CD,Corticosteroids,204,positive,adult,,booster2,05-Feb-22,09-Apr-21,302,mRNA,49,40 to 49
846,female,CD,Corticosteroids,624,positive,adult,,booster2,11-Jul-22,04-Apr-21,463,mRNA,50,50 to 59
847,male,CD,Ustekinumab Only,1188,positive,adult,215,booster1,26-Aug-21,13-Apr-21,135,mRNA,50,50 to 59
848,female,CD,Ustekinumab Only,78069,positive,adult,,booster1,29-Jul-21,27-Apr-21,93,vector,43,40 to 49
849,female,CD,Ustekinumab Only,29652,positive,adult,,booster2,26-Jan-22,30-Apr-21,271,vector,44,40 to 49
850,female,CD,Ustekinumab Only,37994,positive,adult,,booster2,09-Apr-22,28-Apr-21,346,vector,44,40 to 49
851,female,CD,Ustekinumab Only,18138,positive,adult,,booster2,07-Jul-22,30-Apr-21,433,vector,44,40 to 49
852,female,UC,Anti-TNF Only,83,negative,adult,190,booster1,04-Aug-21,14-Dec-20,233,mRNA,41,40 to 49
853,female,UC,Anti-TNF Only,39393,positive,adult,13,booster2,23-Feb-22,19-Dec-20,431,mRNA,41,40 to 49
854,male,CD,Anti-TNF Only,135,negative,adult,371,primary,29-May-21,13-Apr-21,46,mRNA,25,18 to 29
855,male,UC,Anti-TNF Only,39,negative,adult,,primary,27-Jul-21,08-Mar-21,141,vector,34,30 to 39
856,male,CD,Corticosteroids,18,negative,elderly,,booster1,14-May-21,13-Mar-21,62,mRNA,82,70+
857,male,CD,Corticosteroids,32,negative,elderly,,booster1,11-Jun-21,09-Mar-21,94,mRNA,82,70+
858,male,CD,Corticosteroids,2,negative,elderly,,booster1,04-Sep-21,12-Mar-21,176,mRNA,82,70+
859,male,CD,Corticosteroids,24,negative,elderly,,booster2,08-Apr-22,14-Mar-21,390,mRNA,83,70+
860,male,CD,Corticosteroids,38,negative,elderly,,booster2,30-Jul-22,11-Mar-22,141,mRNA,83,70+
861,female,CD,Ustekinumab Only,443,positive,elderly,,primary,01-May-21,18-Mar-21,44,mRNA,66,60 to 69
862,female,CD,Ustekinumab Only,5961,positive,elderly,,booster1,10-Jun-21,15-Mar-21,87,mRNA,66,60 to 69
863,female,CD,Ustekinumab Only,777,positive,elderly,,booster1,30-Sep-21,17-Mar-21,197,mRNA,66,60 to 69
864,female,CD,Ustekinumab Only,36727,positive,elderly,,booster2,05-Jan-22,17-Mar-21,294,mRNA,67,60 to 69
865,female,UC,Anti-TNF Only,117,negative,adult,272,booster1,10-Sep-21,07-Jan-21,246,mRNA,46,40 to 49
866,female,UC,Anti-TNF Only,11011,positive,adult,216,booster2,05-Nov-21,10-Jan-21,299,mRNA,46,40 to 49
867,female,UC,Anti-TNF Only,3586,positive,adult,104,booster2,25-Feb-22,10-Jan-21,411,mRNA,47,40 to 49
868,female,UC,Anti-TNF Only,5824,positive,adult,48,booster2,22-Apr-22,11-Jan-21,466,mRNA,47,40 to 49
869,male,CD,Anti-TNF Only,723,positive,adult,,booster1,24-Sep-21,22-Apr-21,155,mRNA,54,50 to 59
870,male,CD,Anti-TNF Only,10285,positive,adult,,booster2,01-Mar-22,23-Apr-21,312,mRNA,54,50 to 59
871,male,CD,Anti-TNF Only,2053,positive,adult,,booster1,03-Jul-21,13-Apr-21,81,mRNA,39,30 to 39
872,male,CD,Anti-TNF Only,569,positive,adult,,booster1,28-Aug-21,11-Apr-21,139,mRNA,39,30 to 39
873,male,CD,Anti-TNF Only,6348,positive,adult,,booster2,30-Nov-21,12-Apr-21,232,mRNA,39,30 to 39
874,male,CD,Anti-TNF Only,1589,positive,adult,,booster2,12-Feb-22,11-Apr-21,307,mRNA,39,30 to 39
875,female,CD,Combination Therapy,137,negative,adult,,primary,18-May-21,05-Apr-21,43,mRNA,31,30 to 39
876,female,CD,Combination Therapy,1951,positive,adult,112,booster1,16-Jun-21,07-Apr-21,70,mRNA,31,30 to 39
877,female,CD,Combination Therapy,2654,positive,adult,26,booster2,03-Feb-22,10-Apr-21,299,mRNA,32,30 to 39
878,male,CD,Anti-TNF Only,159,positive,adult,48,booster1,08-Sep-21,12-Apr-21,149,mRNA,28,18 to 29
879,male,CD,Anti-TNF Only,5484,positive,adult,162,booster2,17-Nov-21,15-Apr-21,216,mRNA,28,18 to 29
880,male,CD,Ustekinumab Only,52,negative,adult,245,pre_dose,30-Apr-21,20-Apr-21,10,vector,56,50 to 59
881,male,CD,Ustekinumab Only,2328,positive,adult,275,primary,10-Jun-21,21-Apr-21,50,vector,56,50 to 59
882,male,CD,Ustekinumab Only,49,negative,adult,,booster1,05-Aug-21,22-Apr-21,105,vector,56,50 to 59
883,male,CD,Ustekinumab Only,69231,positive,adult,,booster2,06-Nov-21,24-Apr-21,196,vector,57,50 to 59
884,male,CD,Ustekinumab Only,11252,positive,adult,,booster2,03-Mar-22,24-Apr-21,313,vector,57,50 to 59
885,male,CD,Combination Therapy,816,positive,adult,141,booster1,13-Aug-21,12-Apr-21,123,mRNA,45,40 to 49
886,male,CD,Combination Therapy,1657,positive,adult,,booster2,01-Jan-22,10-Apr-21,266,mRNA,46,40 to 49
887,male,CD,Combination Therapy,16716,positive,adult,56,booster2,26-Feb-22,12-Apr-21,320,mRNA,46,40 to 49
888,male,CD,Combination Therapy,19301,positive,adult,194,booster2,14-Jul-22,09-Apr-21,461,mRNA,46,40 to 49
889,male,CD,Corticosteroids,4213,positive,adult,,booster1,31-Jul-21,12-Apr-21,110,vector,45,40 to 49
890,male,CD,Combination Therapy,15310,positive,adult,,booster2,04-Dec-21,14-Apr-21,234,vector,45,40 to 49
891,male,CD,Combination Therapy,1889,positive,adult,,booster2,09-Mar-22,10-Apr-21,333,vector,46,40 to 49
892,female,CD,Combination Therapy,313,positive,elderly,,booster2,26-Nov-21,29-Mar-21,242,mRNA,64,60 to 69
893,female,CD,Combination Therapy,84,negative,elderly,,booster2,08-Feb-22,30-Mar-21,315,mRNA,64,60 to 69
894,male,UC,Ustekinumab Only,4192,positive,adult,,booster1,03-Aug-21,07-Apr-21,118,mRNA,37,30 to 39
895,male,UC,Ustekinumab Only,24277,positive,adult,,booster2,03-Feb-22,04-Apr-21,305,mRNA,37,30 to 39
896,male,CD,Anti-TNF Only,750,positive,elderly,380,primary,01-Jun-21,19-Mar-21,74,vector,65,60 to 69
897,male,CD,Anti-TNF Only,3715,positive,elderly,337,booster1,14-Jul-21,24-Mar-21,112,vector,65,60 to 69
898,male,CD,Anti-TNF Only,20084,positive,elderly,135,booster2,01-Feb-22,20-Mar-21,318,vector,66,60 to 69
899,male,CD,Anti-TNF Only,2355,positive,elderly,36,booster2,11-May-22,19-Mar-21,418,vector,66,60 to 69
900,male,UC,Ustekinumab Only,40,negative,adult,,booster1,24-Nov-21,13-May-21,195,mRNA,55,50 to 59
901,male,UC,Ustekinumab Only,5523,positive,adult,,booster2,02-Feb-22,17-May-21,261,mRNA,55,50 to 59
902,female,CD,Ustekinumab Only,6,negative,adult,,primary,23-Jun-21,16-Apr-21,68,mRNA,41,40 to 49
903,female,CD,Ustekinumab Only,962,positive,adult,,booster1,15-Jul-21,15-Apr-21,91,mRNA,41,40 to 49
904,female,CD,Ustekinumab Only,5444,positive,adult,,booster2,30-Jan-22,16-Apr-21,289,mRNA,41,40 to 49
905,female,CD,Ustekinumab Only,3109,positive,adult,,booster2,17-May-22,14-Apr-21,398,mRNA,41,40 to 49
906,female,CD,Anti-TNF Only,51,negative,adult,226,booster1,18-Sep-21,09-Apr-21,162,mRNA,35,30 to 39
907,female,CD,Anti-TNF Only,2175,positive,adult,212,booster2,02-Oct-21,10-Apr-21,175,mRNA,35,30 to 39
908,female,CD,Anti-TNF Only,149,negative,adult,100,booster2,22-Jan-22,09-Apr-21,288,mRNA,35,30 to 39
909,male,CD,Anti-TNF Only,12,negative,elderly,112,pre_dose,20-Mar-21,17-Mar-21,3,vector,70,70+
910,male,CD,Anti-TNF Only,93,negative,elderly,,primary,14-May-21,18-Mar-21,57,vector,70,70+
911,male,CD,Anti-TNF Only,1589,positive,elderly,,booster1,08-Jul-21,17-Mar-21,113,vector,70,70+
912,male,CD,Anti-TNF Only,803,positive,elderly,,booster1,29-Sep-21,16-Mar-21,197,vector,70,70+
913,male,CD,Anti-TNF Only,24901,positive,elderly,,booster2,29-Oct-21,22-Mar-21,221,vector,70,70+
914,male,CD,Anti-TNF Only,3474,positive,elderly,,booster2,28-Jan-22,21-Mar-21,313,vector,70,70+
915,male,CD,Ustekinumab Only,,,elderly,,booster2,20-Apr-22,16-Mar-21,400,vector,71,70+
916,male,CD,Ustekinumab Only,,,elderly,,booster2,20-Jul-22,18-Mar-22,124,vector,71,70+
917,female,CD,Combination Therapy,2966,positive,adult,89,booster1,30-Jul-21,15-Apr-21,106,mRNA,22,18 to 29
918,female,CD,Combination Therapy,,,adult,26,booster2,27-Oct-21,13-Apr-21,197,mRNA,23,18 to 29
919,female,CD,Combination Therapy,16242,positive,adult,112,booster2,16-Feb-22,18-Apr-21,304,mRNA,23,18 to 29
920,male,UC,Combination Therapy,32,negative,adult,,primary,19-May-21,09-Apr-21,40,mRNA,49,40 to 49
921,male,UC,Combination Therapy,840,positive,adult,,booster1,15-Jun-21,11-Apr-21,65,mRNA,49,40 to 49
922,male,UC,Combination Therapy,1104,positive,adult,,booster2,12-Nov-21,05-Apr-21,221,mRNA,49,40 to 49
923,male,UC,Combination Therapy,220,positive,adult,,booster2,11-Feb-22,11-Apr-21,306,mRNA,50,50 to 59
924,male,CD,Ustekinumab Only,39,negative,adult,224,booster1,03-Jul-21,15-Apr-21,79,mRNA,55,50 to 59
925,male,CD,Ustekinumab Only,6607,positive,adult,113,booster2,22-Oct-21,12-Apr-21,193,mRNA,56,50 to 59
926,male,CD,Ustekinumab Only,25464,positive,adult,20,booster2,04-Mar-22,13-Apr-21,325,mRNA,56,50 to 59
927,male,CD,Ustekinumab Only,10317,positive,adult,216,booster1,28-Jul-21,15-Apr-21,104,mRNA,53,50 to 59
928,male,CD,Ustekinumab Only,4333,positive,adult,48,booster2,17-Nov-21,16-Apr-21,215,mRNA,53,50 to 59
929,male,CD,Ustekinumab Only,9854,positive,adult,25,booster2,26-Mar-22,15-Apr-21,345,mRNA,54,50 to 59
930,male,CD,Anti-TNF Only,39,negative,elderly,,booster1,12-Aug-21,23-Apr-21,111,vector,69,60 to 69
931,male,CD,Anti-TNF Only,45,negative,elderly,,booster1,07-Oct-21,20-Apr-21,170,vector,69,60 to 69
932,male,CD,Anti-TNF Only,542,positive,elderly,,booster2,27-Jan-22,21-Apr-21,281,vector,69,60 to 69
933,male,CD,Ustekinumab Only,1018,positive,adult,,booster1,12-Aug-21,16-Apr-21,118,mRNA,50,50 to 59
934,male,CD,Ustekinumab Only,3713,positive,adult,,primary,02-Jun-21,16-Apr-21,47,vector,30,30 to 39
935,male,CD,Ustekinumab Only,52595,positive,adult,,booster2,15-Jun-22,13-Apr-21,428,vector,31,30 to 39
936,male,CD,Ustekinumab Only,8636,positive,adult,,booster1,30-Jun-21,24-Apr-21,67,mRNA,59,50 to 59
937,male,CD,Ustekinumab Only,28054,positive,adult,162,booster2,28-Jul-21,23-Apr-21,96,mRNA,59,50 to 59
938,male,CD,Ustekinumab Only,17089,positive,adult,,booster2,21-Oct-21,23-Apr-21,181,mRNA,59,50 to 59
939,male,CD,Ustekinumab Only,2387,positive,adult,,booster2,10-Feb-22,28-Apr-21,288,mRNA,60,60 to 69
940,male,UC,Combination Therapy,103,negative,adult,,primary,05-May-21,19-Mar-21,47,vector,60,60 to 69
941,male,UC,Combination Therapy,2486,positive,adult,,booster1,30-Jul-21,17-Mar-21,135,vector,61,60 to 69
942,male,UC,Combination Therapy,10762,positive,adult,,booster2,31-May-22,14-Mar-21,443,vector,61,60 to 69
943,female,UC,Combination Therapy,3115,positive,adult,,booster1,11-Aug-21,31-Mar-21,133,mRNA,51,50 to 59
944,female,UC,Combination Therapy,14673,positive,adult,,booster2,18-Nov-21,30-Mar-21,233,mRNA,51,50 to 59
945,female,UC,Combination Therapy,3028,positive,adult,,booster2,02-Mar-22,02-Apr-21,334,mRNA,51,50 to 59
946,female,UC,Combination Therapy,27819,positive,adult,245,booster2,16-Apr-22,30-Mar-21,382,mRNA,51,50 to 59
947,female,CD,Ustekinumab Only,817,positive,elderly,,booster1,27-Jul-21,07-Mar-21,142,mRNA,64,60 to 69
948,female,CD,Ustekinumab Only,20187,positive,elderly,,booster2,14-Oct-21,09-Mar-21,219,mRNA,64,60 to 69
949,female,CD,Ustekinumab Only,6764,positive,elderly,,booster2,18-Feb-22,08-Mar-21,347,mRNA,64,60 to 69
950,female,CD,Ustekinumab Only,12856,positive,elderly,,booster2,08-May-22,11-Mar-21,423,mRNA,64,60 to 69
951,female,CD,Ustekinumab Only,8963,positive,elderly,,booster2,06-Jul-22,08-Mar-21,485,mRNA,65,60 to 69
952,female,CD,Combination Therapy,49,negative,adult,,primary,04-Jun-21,23-Apr-21,42,mRNA,33,30 to 39
953,female,CD,Combination Therapy,570,positive,adult,,booster1,03-Jul-21,19-Apr-21,75,mRNA,33,30 to 39
954,female,CD,Combination Therapy,2546,positive,adult,,booster2,16-Nov-21,19-Apr-21,211,mRNA,33,30 to 39
955,female,CD,Combination Therapy,886,positive,adult,,booster2,25-Jan-22,24-Apr-21,276,mRNA,34,30 to 39
956,female,CD,Combination Therapy,516,positive,adult,275,booster2,09-Mar-22,22-Apr-21,321,mRNA,34,30 to 39
957,male,CD,Vedolizumab Only,21458,positive,adult,490,booster1,07-Sep-21,10-Jun-21,89,mRNA,48,40 to 49
958,male,CD,Vedolizumab Only,6587,positive,adult,634,booster1,29-Jan-22,10-Jun-21,233,mRNA,49,40 to 49
959,female,CD,Ustekinumab Only,8634,positive,adult,,booster1,05-Aug-21,01-Apr-21,126,mRNA,55,50 to 59
960,female,CD,Ustekinumab Only,26097,positive,adult,,booster2,26-Feb-22,30-Mar-21,333,mRNA,56,50 to 59
961,female,CD,Ustekinumab Only,42440,positive,adult,,booster2,28-Jul-22,29-Mar-21,486,mRNA,56,50 to 59
962,female,UC,Anti-TNF Only,782,positive,adult,,booster2,23-Oct-21,19-Apr-21,187,mRNA,35,30 to 39
963,female,UC,Anti-TNF Only,73,negative,adult,,booster2,24-Feb-22,19-Apr-21,311,mRNA,35,30 to 39
964,female,CD,Ustekinumab Only,1673,positive,adult,,primary,05-Jun-21,17-Apr-21,49,vector,47,40 to 49
965,female,CD,Ustekinumab Only,19245,positive,adult,233,booster1,02-Jul-21,17-Apr-21,76,vector,47,40 to 49
966,female,CD,Ustekinumab Only,1781,positive,adult,146,booster1,31-Dec-21,11-Apr-21,264,vector,48,40 to 49
967,female,CD,Ustekinumab Only,76746,positive,adult,120,booster2,12-Feb-22,12-Apr-21,306,vector,48,40 to 49
968,female,CD,Ustekinumab Only,40024,positive,adult,27,booster2,24-May-22,11-Apr-21,408,vector,48,40 to 49
969,male,CD,Anti-TNF Only,18,negative,adult,138,pre_dose,12-Feb-22,04-Feb-22,8,vector,42,40 to 49
970,male,CD,Ustekinumab Only,3792,positive,adult,61,booster1,05-Aug-21,16-Apr-21,111,mRNA,34,30 to 39
971,male,CD,Ustekinumab Only,5890,positive,adult,30,booster2,03-Nov-21,18-Apr-21,199,mRNA,34,30 to 39
972,male,CD,Ustekinumab Only,2060,positive,adult,233,booster2,08-Feb-22,17-Apr-21,297,mRNA,34,30 to 39
973,male,CD,Ustekinumab Only,5434,positive,adult,209,booster2,01-Apr-22,18-Apr-21,348,mRNA,35,30 to 39
974,male,CD,Combination Therapy,3014,positive,adult,125,booster1,15-Aug-21,29-Mar-21,139,mRNA,59,50 to 59
975,male,CD,Combination Therapy,1004,positive,adult,13,booster2,06-Feb-22,31-Mar-21,312,mRNA,60,60 to 69
976,male,CD,Combination Therapy,865,positive,adult,,booster2,14-Jun-22,01-Apr-21,439,mRNA,60,60 to 69
977,female,CD,Ustekinumab Only,2935,positive,adult,,booster1,08-Oct-21,06-May-21,155,mRNA,53,50 to 59
978,female,CD,Ustekinumab Only,18449,positive,adult,,booster2,12-Nov-21,02-May-21,194,mRNA,53,50 to 59
979,female,CD,Ustekinumab Only,5313,positive,adult,,booster2,22-Feb-22,30-Apr-21,298,mRNA,53,50 to 59
980,male,UC,Corticosteroids,39,negative,adult,,booster1,01-Sep-21,19-May-21,105,mRNA,61,60 to 69
981,male,UC,Corticosteroids,42,negative,adult,146,booster2,01-Dec-21,19-May-21,196,mRNA,61,60 to 69
982,male,UC,Corticosteroids,35,negative,adult,,booster2,23-Mar-22,15-May-21,312,mRNA,61,60 to 69
983,female,CD,Anti-TNF Only,26092,positive,adult,,booster1,10-Jul-21,24-Apr-21,77,vector,40,40 to 49
984,female,CD,Anti-TNF Only,13882,positive,adult,,booster2,29-Jan-22,25-Apr-21,279,vector,41,40 to 49
985,female,CD,Anti-TNF Only,18894,positive,adult,,booster2,04-Jun-22,22-Apr-21,408,vector,41,40 to 49
986,female,CD,Ustekinumab Only,408,positive,adult,,pre_dose,30-Apr-21,19-Apr-21,11,mRNA,46,40 to 49
987,female,CD,Ustekinumab Only,5989,positive,adult,,primary,04-Jun-21,17-Apr-21,48,mRNA,46,40 to 49
988,female,CD,Ustekinumab Only,10408,positive,adult,,booster1,06-Jul-21,21-Apr-21,76,mRNA,46,40 to 49
989,female,CD,Ustekinumab Only,17803,positive,adult,,booster2,13-Oct-21,18-Apr-21,178,mRNA,46,40 to 49
990,female,CD,Ustekinumab Only,2548,positive,adult,,booster2,01-Feb-22,16-Apr-21,291,mRNA,47,40 to 49
991,female,CD,Ustekinumab Only,18127,positive,adult,120,booster2,23-Mar-22,17-Apr-21,340,mRNA,47,40 to 49
992,female,CD,Ustekinumab Only,7212,positive,adult,,booster2,01-Jul-22,15-Apr-21,442,mRNA,47,40 to 49
993,female,CD,Combination Therapy,5907,positive,adult,,booster1,26-May-21,07-Apr-21,49,mRNA,21,18 to 29
994,female,CD,Combination Therapy,2481,positive,adult,,booster2,06-Jan-22,10-Apr-21,271,mRNA,22,18 to 29
995,female,CD,Anti-TNF Only,36,negative,adult,,pre_dose,14-Apr-21,11-Apr-21,3,vector,56,50 to 59
996,female,CD,Anti-TNF Only,49,negative,adult,390,primary,26-May-21,09-Apr-21,47,vector,56,50 to 59
997,female,CD,Anti-TNF Only,149,negative,adult,300,booster1,12-Aug-21,05-Apr-21,129,vector,56,50 to 59
998,female,CD,Anti-TNF Only,123,negative,adult,185,booster1,02-Sep-21,09-Apr-21,146,vector,56,50 to 59
999,female,CD,Anti-TNF Only,1419,positive,adult,73,booster2,14-Oct-21,05-Apr-21,192,vector,56,50 to 59
1000,female,CD,Anti-TNF Only,70,negative,adult,27,booster2,09-Mar-22,08-Apr-21,335,vector,57,50 to 59
1001,female,CD,Anti-TNF Only,344,positive,adult,,booster2,01-Jun-22,06-Apr-21,421,vector,57,50 to 59
1002,female,CD,Ustekinumab Only,1248,positive,adult,,booster1,01-Aug-21,17-Mar-21,137,vector,59,50 to 59
1003,female,CD,Ustekinumab Only,27288,positive,adult,237,booster2,12-Nov-21,19-Mar-21,238,vector,59,50 to 59
1004,female,CD,Ustekinumab Only,2402,positive,adult,162,booster2,10-Mar-22,19-Mar-21,356,vector,60,60 to 69
1005,female,CD,Anti-TNF Only,9873,positive,adult,56,booster1,09-Jun-21,19-Apr-21,51,mRNA,48,40 to 49
1006,female,CD,Anti-TNF Only,358,positive,adult,,booster1,09-Oct-21,23-Apr-21,169,mRNA,48,40 to 49
1007,female,CD,Anti-TNF Only,10958,positive,adult,,booster2,20-Nov-21,24-Apr-21,210,mRNA,48,40 to 49
1008,female,CD,Anti-TNF Only,17972,positive,adult,,booster2,22-Mar-22,25-Apr-21,331,mRNA,49,40 to 49
1009,female,CD,Anti-TNF Only,91,negative,adult,341,primary,13-May-21,22-Mar-21,52,vector,58,50 to 59
1010,female,CD,Anti-TNF Only,2588,positive,adult,225,booster2,28-Oct-21,23-Mar-21,219,vector,59,50 to 59
1011,female,CD,Anti-TNF Only,563,positive,adult,169,booster2,26-May-22,20-Mar-21,432,vector,59,50 to 59
1012,female,CD,Combination Therapy,12682,positive,adult,187,primary,05-Jun-21,17-Apr-21,49,mRNA,54,50 to 59
1013,female,CD,Combination Therapy,61535,positive,adult,36,booster1,10-Jul-21,22-Apr-21,79,mRNA,55,50 to 59
1014,female,CD,Combination Therapy,16279,positive,adult,,booster1,28-Sep-21,21-Apr-21,160,mRNA,55,50 to 59
1015,female,CD,Combination Therapy,59825,positive,adult,,booster2,09-Nov-21,22-Apr-21,201,mRNA,55,50 to 59
1016,female,CD,Combination Therapy,14870,positive,adult,194,booster2,15-Mar-22,16-Apr-21,333,mRNA,55,50 to 59
1017,female,CD,Combination Therapy,42096,positive,adult,,booster2,17-Apr-22,19-Apr-21,363,mRNA,55,50 to 59
1018,female,UC,Combination Therapy,9339,positive,adult,,booster1,21-Aug-21,11-Apr-21,132,mRNA,43,40 to 49
1019,female,UC,Combination Therapy,14772,positive,adult,,booster2,16-Feb-22,06-Apr-21,316,mRNA,43,40 to 49
1020,female,CD,Ustekinumab Only,30,negative,adult,,primary,27-Jun-21,03-May-21,55,mRNA,37,30 to 39
1021,female,CD,Ustekinumab Only,4221,positive,adult,,booster1,20-Aug-21,04-May-21,108,mRNA,38,30 to 39
1022,female,CD,Ustekinumab Only,2235,positive,adult,23,booster2,12-Nov-21,05-May-21,191,mRNA,38,30 to 39
1023,female,CD,Ustekinumab Only,1730,positive,adult,108,booster2,03-Feb-22,07-May-21,272,mRNA,38,30 to 39
1024,female,CD,Anti-TNF Only,970,positive,adult,138,booster1,12-Aug-21,19-Apr-21,115,mRNA,29,18 to 29
1025,female,CD,Anti-TNF Only,472,positive,adult,355,booster1,23-Sep-21,18-Apr-21,158,mRNA,29,18 to 29
1026,female,CD,Anti-TNF Only,35328,positive,adult,232,booster2,30-Jan-22,20-Apr-21,285,mRNA,29,18 to 29
1027,female,CD,Combination Therapy,21,negative,adult,64,primary,27-Jun-21,21-Apr-21,67,mRNA,39,30 to 39
1028,female,CD,Combination Therapy,410,positive,adult,,booster1,24-Jul-21,19-Apr-21,96,mRNA,39,30 to 39
1029,female,CD,Combination Therapy,3993,positive,adult,117,booster2,14-Oct-21,23-Apr-21,174,mRNA,39,30 to 39
1030,female,CD,Combination Therapy,603,positive,adult,,booster2,04-Feb-22,22-Apr-21,288,mRNA,39,30 to 39
1031,female,CD,Combination Therapy,13285,positive,adult,,booster2,01-Apr-22,24-Apr-21,342,mRNA,39,30 to 39
1032,male,UC,Ustekinumab Only,17,negative,elderly,,primary,08-May-21,17-Mar-21,52,mRNA,68,60 to 69
1033,male,UC,Ustekinumab Only,2134,positive,elderly,61,booster2,22-Feb-22,20-Mar-21,339,mRNA,69,60 to 69
1034,female,CD,Anti-TNF Only,50,negative,adult,,primary,26-Feb-21,08-Jan-21,49,mRNA,48,40 to 49
1035,female,CD,Anti-TNF Only,276,positive,adult,,booster1,30-Mar-21,09-Jan-21,80,mRNA,48,40 to 49
1036,female,CD,Anti-TNF Only,8450,positive,adult,,booster2,28-Dec-21,07-Jan-21,355,mRNA,48,40 to 49
1037,female,CD,Anti-TNF Only,2911,positive,adult,,booster2,09-Apr-22,10-Jan-21,454,mRNA,49,40 to 49
1038,female,CD,Ustekinumab Only,866,positive,adult,,booster1,01-Sep-21,26-Apr-21,128,mRNA,57,50 to 59
1039,female,CD,Ustekinumab Only,31563,positive,adult,,booster2,29-Jan-22,23-Apr-21,281,mRNA,58,50 to 59
1040,female,CD,Ustekinumab Only,42121,positive,adult,,booster2,11-Jun-22,27-Apr-21,410,mRNA,58,50 to 59
1041,male,CD,Ustekinumab Only,25680,positive,adult,30,booster2,12-Oct-21,09-Apr-21,186,vector,53,50 to 59
1042,male,CD,Ustekinumab Only,9959,positive,adult,,booster2,08-Dec-21,12-Apr-21,240,vector,53,50 to 59
1043,male,CD,Ustekinumab Only,107,negative,elderly,,primary,21-May-21,22-Mar-21,60,mRNA,66,60 to 69
1044,male,CD,Ustekinumab Only,1432,positive,elderly,359,booster1,11-Aug-21,23-Mar-21,141,mRNA,67,60 to 69
1045,male,CD,Ustekinumab Only,18331,positive,elderly,304,booster2,04-May-22,24-Mar-21,406,mRNA,67,60 to 69
1046,male,UC,Anti-TNF Only,48,negative,elderly,239,pre_dose,27-Mar-21,25-Mar-21,2,mRNA,72,70+
1047,male,UC,Anti-TNF Only,564,positive,elderly,220,booster2,25-Feb-22,27-Mar-21,335,mRNA,73,70+
1048,male,UC,Anti-TNF Only,379,positive,elderly,112,booster2,04-May-22,26-Mar-21,404,mRNA,73,70+
1049,male,UC,Anti-TNF Only,11980,positive,elderly,50,booster2,19-May-22,27-Mar-21,418,mRNA,73,70+
1050,female,CD,Combination Therapy,1408,positive,adult,40,primary,29-May-21,13-Apr-21,46,vector,44,40 to 49
1051,female,CD,Combination Therapy,2898,positive,adult,233,booster1,08-Sep-21,14-Apr-21,147,vector,44,40 to 49
1052,female,CD,Combination Therapy,4715,positive,adult,209,booster2,18-Nov-21,15-Apr-21,217,vector,45,40 to 49
1053,female,CD,Combination Therapy,1279,positive,adult,125,booster2,04-Feb-22,12-Apr-21,298,vector,45,40 to 49
1054,female,CD,Combination Therapy,2849,positive,adult,13,booster2,05-Jul-22,17-Apr-21,444,vector,45,40 to 49
1055,male,CD,Anti-TNF Only,154,positive,adult,,primary,26-May-21,01-Apr-21,55,mRNA,59,50 to 59
1056,male,CD,Anti-TNF Only,1209,positive,adult,,booster1,10-Aug-21,04-Apr-21,128,mRNA,59,50 to 59
1057,male,CD,Anti-TNF Only,53464,positive,adult,,booster2,10-Nov-21,03-Apr-21,221,mRNA,60,60 to 69
1058,male,CD,Anti-TNF Only,6782,positive,adult,,booster2,01-Mar-22,31-Mar-21,335,mRNA,60,60 to 69
1059,male,UC,Combination Therapy,457,positive,adult,,booster1,07-Aug-21,14-Apr-21,115,mRNA,48,40 to 49
1060,female,UC,No Immunosuppressives,20478,positive,adult,,booster1,28-Apr-21,01-Jan-21,117,mRNA,47,40 to 49
1061,female,CD,Ustekinumab Only,480,positive,elderly,209,primary,28-Apr-21,14-Mar-21,45,mRNA,72,70+
1062,female,CD,Ustekinumab Only,2167,positive,elderly,,booster1,19-May-21,18-Mar-21,62,mRNA,72,70+
1063,female,CD,Ustekinumab Only,1122,positive,elderly,,booster1,04-Aug-21,15-Mar-21,142,mRNA,72,70+
1064,female,CD,Ustekinumab Only,24984,positive,elderly,,booster2,01-Dec-21,15-Mar-21,261,mRNA,72,70+
1065,female,CD,Ustekinumab Only,8713,positive,elderly,,booster2,17-Mar-22,19-Mar-21,363,mRNA,72,70+
1066,female,CD,Ustekinumab Only,,,elderly,,booster2,06-May-22,18-Mar-21,414,mRNA,73,70+
1067,female,CD,Anti-TNF Only,970,positive,adult,,booster1,06-Aug-21,28-Apr-21,100,mRNA,59,50 to 59
1068,female,CD,Anti-TNF Only,670,positive,adult,,booster1,02-Oct-21,27-Apr-21,158,mRNA,59,50 to 59
1069,female,CD,Anti-TNF Only,803,positive,adult,,booster2,22-Jan-22,29-Apr-21,268,mRNA,60,60 to 69
1070,female,CD,Anti-TNF Only,2556,positive,adult,,booster2,17-May-22,28-Apr-21,384,mRNA,60,60 to 69
1071,female,CD,Combination Therapy,47,negative,adult,,primary,25-Jun-21,08-May-21,48,mRNA,35,30 to 39
1072,female,CD,Combination Therapy,497,positive,adult,,booster1,05-Sep-21,06-May-21,122,mRNA,35,30 to 39
1073,female,CD,Combination Therapy,702,positive,adult,,booster2,18-Feb-22,03-May-21,291,mRNA,36,30 to 39
1074,female,CD,Combination Therapy,140,negative,adult,,booster2,25-Jun-22,08-May-21,413,mRNA,36,30 to 39
1075,male,CD,Ustekinumab Only,3180,positive,adult,,primary,19-May-21,14-Apr-21,35,vector,56,50 to 59
1076,male,CD,Ustekinumab Only,19922,positive,adult,,booster1,03-Sep-21,10-Apr-21,146,vector,56,50 to 59
1077,male,CD,Ustekinumab Only,3892,positive,adult,,booster1,04-Mar-22,11-Apr-21,327,vector,56,50 to 59
1078,female,CD,Combination Therapy,256,positive,adult,159,primary,16-Jun-21,02-May-21,45,mRNA,42,40 to 49
1079,female,CD,Vedolizumab Only,912,positive,adult,13,booster1,24-Jul-21,28-Apr-21,87,mRNA,42,40 to 49
1080,female,CD,Combination Therapy,2504,positive,adult,302,booster2,06-Nov-21,03-May-21,187,mRNA,42,40 to 49
1081,female,CD,Combination Therapy,7971,positive,adult,411,booster2,23-Feb-22,03-May-21,296,mRNA,43,40 to 49
1082,female,CD,Combination Therapy,21268,positive,adult,464,booster2,17-Apr-22,27-Apr-21,355,mRNA,43,40 to 49
1083,female,CD,Combination Therapy,6193,positive,adult,566,booster2,28-Jul-22,03-May-21,451,mRNA,43,40 to 49
1084,female,CD,Anti-TNF Only,3818,positive,adult,,booster1,11-Sep-21,12-Apr-21,152,mRNA,33,30 to 39
1085,female,CD,Anti-TNF Only,4270,positive,adult,,booster2,04-Feb-22,07-Apr-21,303,mRNA,34,30 to 39
1086,female,CD,Anti-TNF Only,9976,positive,adult,,booster2,13-May-22,10-Apr-21,398,mRNA,34,30 to 39
1087,male,UC,Anti-TNF Only,755,positive,adult,,primary,10-Jun-21,26-Apr-21,45,vector,34,30 to 39
1088,male,UC,Vedolizumab Only,2209,positive,adult,,booster1,30-Jul-21,25-Apr-21,96,vector,34,30 to 39
1089,male,UC,Vedolizumab Only,24220,positive,adult,,booster2,13-Nov-21,23-Apr-21,204,vector,34,30 to 39
1090,male,UC,Anti-TNF Only,1968,positive,adult,,booster2,12-Apr-22,28-Apr-21,349,vector,35,30 to 39
1091,female,CD,Anti-TNF Only,356,positive,adult,,primary,26-Feb-21,31-Jan-21,26,vector,32,30 to 39
1092,female,CD,Anti-TNF Only,103,negative,adult,,primary,10-Sep-21,29-Dec-20,255,vector,33,30 to 39
1093,female,CD,Combination Therapy,53,negative,adult,,pre_dose,22-Apr-21,12-Apr-21,10,mRNA,48,40 to 49
1094,female,CD,Vedolizumab Only,31,negative,adult,352,primary,07-May-21,29-Apr-21,8,vector,42,40 to 49
1095,male,CD,Vedolizumab Only,1620,positive,adult,,primary,22-May-21,30-Mar-21,53,mRNA,54,50 to 59
1096,female,UC,Anti-TNF Only,27029,positive,adult,,booster1,22-Jun-21,06-Apr-21,77,mRNA,45,40 to 49
1097,female,UC,Anti-TNF Only,24159,positive,adult,,booster2,08-Oct-21,04-Apr-21,187,mRNA,45,40 to 49
1098,female,UC,Anti-TNF Only,4242,positive,adult,,booster2,24-Mar-22,04-Apr-21,354,mRNA,46,40 to 49
1099,female,UC,Anti-TNF Only,12379,positive,adult,,booster2,24-Jun-22,04-Apr-21,446,mRNA,46,40 to 49
1100,male,CD,Ustekinumab Only,9276,positive,adult,,booster1,11-Aug-21,03-Apr-21,130,mRNA,37,30 to 39
1101,male,CD,Ustekinumab Only,14186,positive,adult,,booster2,26-Jan-22,30-Mar-21,302,mRNA,38,30 to 39
1102,male,CD,Ustekinumab Only,8117,positive,adult,,booster2,19-Apr-22,03-Apr-21,381,mRNA,38,30 to 39
1103,male,UC,Combination Therapy,1159,positive,adult,,booster1,02-Sep-21,11-May-21,114,mRNA,33,30 to 39
1104,male,UC,Combination Therapy,391,positive,adult,,booster2,18-Feb-22,10-May-21,284,mRNA,33,30 to 39
1105,male,UC,Combination Therapy,401,positive,adult,,booster2,09-Jun-22,14-May-21,391,mRNA,33,30 to 39
1106,male,CD,Anti-TNF Only,22,negative,adult,44,pre_dose,13-Apr-21,12-Apr-21,1,mRNA,51,50 to 59
1107,male,CD,Anti-TNF Only,1299,positive,adult,,primary,27-May-21,14-Apr-21,43,mRNA,51,50 to 59
1108,male,CD,Anti-TNF Only,553,positive,adult,96,booster1,31-Aug-21,12-Apr-21,141,mRNA,51,50 to 59
1109,male,CD,Anti-TNF Only,182,positive,adult,142,booster1,16-Oct-21,15-Apr-21,184,mRNA,51,50 to 59
1110,male,CD,Anti-TNF Only,1118,positive,adult,265,booster2,16-Feb-22,16-Apr-21,306,mRNA,52,50 to 59
1111,male,CD,Anti-TNF Only,24281,positive,adult,331,booster2,23-Apr-22,14-Apr-21,374,mRNA,52,50 to 59
1112,male,CD,Anti-TNF Only,3637,positive,adult,404,booster2,05-Jul-22,15-Apr-21,446,mRNA,52,50 to 59
1113,male,UC,Vedolizumab Only,34,negative,elderly,,primary,03-Jun-21,03-Apr-21,61,mRNA,67,60 to 69
1114,male,CD,Combination Therapy,9757,positive,adult,206,booster1,12-Aug-21,20-May-21,84,mRNA,21,18 to 29
1115,male,UC,Combination Therapy,2128,positive,adult,148,booster1,09-Sep-21,26-Apr-21,136,mRNA,41,40 to 49
1116,male,UC,Combination Therapy,40019,positive,adult,132,booster2,16-Jun-22,22-Apr-21,420,mRNA,41,40 to 49
1117,female,UC,Anti-TNF Only,10144,positive,adult,,booster2,02-Nov-21,09-Apr-21,207,mRNA,35,30 to 39
1118,female,UC,Anti-TNF Only,1293,positive,adult,,booster2,23-Feb-22,07-Apr-21,322,mRNA,35,30 to 39
1119,female,CD,Anti-TNF Only,173,positive,adult,232,primary,09-Mar-21,16-Jan-21,52,mRNA,53,50 to 59
1120,male,UC,Anti-TNF Only,659,positive,adult,227,primary,06-Jun-21,22-Apr-21,45,mRNA,33,30 to 39
1121,male,UC,Anti-TNF Only,8068,positive,adult,,booster1,18-Aug-21,22-Apr-21,118,mRNA,33,30 to 39
1122,male,UC,Anti-TNF Only,746,positive,adult,5,booster1,14-Jan-22,22-Apr-21,267,mRNA,33,30 to 39
1123,male,UC,Anti-TNF Only,40016,positive,adult,129,booster2,28-May-22,23-Apr-21,400,mRNA,34,30 to 39
1124,male,CD,Anti-TNF Only,11,negative,adult,102,primary,29-Sep-21,11-Mar-21,202,vector,45,40 to 49
1125,male,UC,Anti-TNF Only,17866,positive,adult,682,booster1,15-Jul-22,04-May-21,437,mRNA,30,30 to 39
1126,female,CD,Anti-TNF Only,2973,positive,adult,223,booster1,27-Aug-21,09-Apr-21,140,mRNA,52,50 to 59
1127,female,CD,Anti-TNF Only,11701,positive,adult,125,booster2,03-Dec-21,12-Apr-21,235,mRNA,53,50 to 59
1128,female,CD,Anti-TNF Only,190,positive,adult,,booster1,10-Jun-21,14-Jan-21,147,mRNA,43,40 to 49
1129,female,CD,Anti-TNF Only,91,negative,adult,,booster1,25-Sep-21,14-Jan-21,254,mRNA,43,40 to 49
1130,female,CD,Anti-TNF Only,1954,positive,adult,,booster2,02-Jul-22,16-Jan-22,167,mRNA,44,40 to 49
1131,male,CD,Vedolizumab Only,25298,positive,adult,,booster1,02-Sep-21,11-Apr-21,144,mRNA,34,30 to 39
1132,male,CD,Vedolizumab Only,18852,positive,adult,,booster2,16-Feb-22,08-Apr-21,314,mRNA,35,30 to 39
1133,male,CD,Vedolizumab Only,5230,positive,adult,,booster1,21-Jul-21,08-Apr-21,104,mRNA,35,30 to 39
1134,male,CD,Vedolizumab Only,1998,positive,adult,,booster1,08-Oct-21,06-Apr-21,185,mRNA,35,30 to 39
1135,male,CD,Vedolizumab Only,4033,positive,adult,,booster2,11-Mar-22,04-Apr-21,341,mRNA,36,30 to 39
1136,male,CD,Anti-TNF Only,50,negative,elderly,,primary,15-Apr-21,26-Feb-21,48,mRNA,81,70+
1137,male,CD,Anti-TNF Only,645,positive,elderly,146,booster1,27-May-21,02-Mar-21,86,mRNA,81,70+
1138,male,CD,Anti-TNF Only,77,negative,elderly,,booster1,11-Sep-21,01-Mar-21,194,mRNA,82,70+
1139,male,CD,Anti-TNF Only,665,positive,elderly,,booster2,30-Dec-21,26-Feb-21,307,mRNA,82,70+
1140,male,CD,Anti-TNF Only,288,positive,elderly,,booster2,04-Mar-22,02-Mar-21,367,mRNA,82,70+
1141,female,CD,Vedolizumab Only,38889,positive,elderly,,booster1,12-Mar-21,01-Jan-21,70,mRNA,65,60 to 69
1142,female,CD,Vedolizumab Only,5214,positive,elderly,,booster1,06-Oct-21,01-Jan-21,278,mRNA,66,60 to 69
1143,female,CD,Vedolizumab Only,8121,positive,elderly,,booster2,10-Feb-22,02-Jan-21,404,mRNA,66,60 to 69
1144,male,CD,Ustekinumab Only,16,negative,adult,,pre_dose,28-Apr-21,14-Apr-21,14,mRNA,46,40 to 49
1145,male,CD,Ustekinumab Only,4149,positive,adult,,booster1,03-Jul-21,17-Apr-21,77,mRNA,47,40 to 49
1146,male,CD,Ustekinumab Only,2108,positive,adult,,booster1,07-Oct-21,18-Apr-21,172,mRNA,47,40 to 49
1147,male,CD,Ustekinumab Only,,,adult,,booster2,11-Feb-22,16-Apr-21,301,mRNA,47,40 to 49
1148,male,CD,Ustekinumab Only,40044,positive,adult,,booster2,01-Jun-22,12-Apr-21,415,mRNA,47,40 to 49
1149,female,CD,Anti-TNF Only,17231,positive,adult,191,booster1,18-Aug-21,08-Apr-21,132,mRNA,22,18 to 29
1150,female,CD,Anti-TNF Only,8480,positive,adult,13,booster2,12-Feb-22,09-Apr-21,309,mRNA,22,18 to 29
1151,female,CD,Anti-TNF Only,,,adult,42,booster2,08-Apr-22,08-Apr-21,365,mRNA,22,18 to 29
1152,female,CD,Anti-TNF Only,,,adult,160,booster2,04-Aug-22,12-Apr-21,479,mRNA,23,18 to 29
1153,female,CD,Ustekinumab Only,256,positive,adult,337,primary,06-Jun-21,13-Apr-21,54,mRNA,29,18 to 29
1154,female,CD,Ustekinumab Only,1475,positive,adult,304,booster1,09-Jul-21,11-Apr-21,89,mRNA,29,18 to 29
1155,male,UC,Ustekinumab Only,10823,positive,adult,,booster1,04-Aug-21,30-Apr-21,96,mRNA,18,18 to 29
1156,female,CD,Ustekinumab Only,1338,positive,adult,,booster1,05-Oct-21,01-Jul-21,96,vector,32,30 to 39
1157,female,CD,Ustekinumab Only,34,negative,adult,,primary,28-May-21,27-Apr-21,31,vector,56,50 to 59
1158,female,CD,Anti-TNF Only,933,positive,adult,,booster1,13-Oct-21,21-Apr-21,175,vector,56,50 to 59
1159,female,CD,Anti-TNF Only,14885,positive,adult,,booster2,02-Mar-22,22-Apr-21,314,vector,57,50 to 59
1160,female,CD,Anti-TNF Only,3080,positive,adult,,booster2,20-Jul-22,23-Apr-21,453,vector,57,50 to 59
1161,female,CD,Vedolizumab Only,17,negative,adult,,pre_dose,31-Mar-21,31-Mar-21,0,mRNA,36,30 to 39
1162,female,CD,Vedolizumab Only,451,positive,adult,,primary,12-Jun-21,31-Mar-21,73,mRNA,37,30 to 39
1163,female,CD,Vedolizumab Only,11040,positive,adult,,booster1,01-Sep-21,03-Apr-21,151,mRNA,37,30 to 39
1164,female,CD,Vedolizumab Only,2209,positive,adult,,booster2,23-Feb-22,31-Mar-21,329,mRNA,37,30 to 39
1165,male,CD,Anti-TNF Only,48,negative,adult,251,pre_dose,18-May-21,04-May-21,14,mRNA,42,40 to 49
1166,male,CD,Anti-TNF Only,146,negative,adult,209,primary,29-Jun-21,30-Apr-21,60,mRNA,42,40 to 49
1167,male,CD,Anti-TNF Only,7048,positive,adult,181,booster1,27-Jul-21,02-May-21,86,mRNA,42,40 to 49
1168,female,CD,Vedolizumab Only,5498,positive,adult,39,primary,05-Jun-21,04-May-21,32,mRNA,48,40 to 49
1169,female,CD,Vedolizumab Only,6352,positive,adult,120,booster1,25-Aug-21,08-May-21,109,mRNA,48,40 to 49
1170,male,CD,Anti-TNF Only,47,negative,adult,,primary,16-May-21,10-Apr-21,36,mRNA,32,30 to 39
1171,male,CD,Anti-TNF Only,825,positive,pediatric,,booster1,08-Aug-21,09-Apr-21,121,mRNA,1,00 to 09
1172,male,CD,Anti-TNF Only,5951,positive,pediatric,,booster2,30-Oct-21,11-Apr-21,202,mRNA,4,00 to 09
1173,male,CD,Anti-TNF Only,406,positive,pediatric,,booster2,05-Feb-22,09-Apr-21,302,mRNA,7,00 to 09
1174,male,CD,Anti-TNF Only,10571,positive,pediatric,,booster2,17-Apr-22,11-Apr-21,371,mRNA,10,10 to 17
1175,male,CD,Anti-TNF Only,1250,positive,pediatric,,booster2,21-Jul-22,10-Apr-21,467,mRNA,4,00 to 09
1176,female,CD,Vedolizumab Only,46553,positive,pediatric,222,booster1,06-Apr-21,11-Jan-21,85,mRNA,3,00 to 09
1177,female,CD,Vedolizumab Only,,,pediatric,115,booster2,09-Mar-22,10-Jan-21,423,mRNA,6,00 to 09
1178,male,CD,Combination Therapy,1348,positive,pediatric,98,primary,02-Jun-21,04-Apr-21,59,mRNA,12,10 to 17
1179,male,CD,Combination Therapy,5847,positive,adult,213,booster1,25-Sep-21,09-Apr-21,169,mRNA,56,50 to 59
1180,male,CD,Combination Therapy,35415,positive,pediatric,324,booster2,14-Jan-22,04-Apr-21,285,mRNA,2,00 to 09
1181,male,CD,Combination Therapy,10191,positive,pediatric,435,booster2,05-May-22,04-Apr-21,396,mRNA,2,00 to 09
1182,male,CD,Combination Therapy,34081,positive,pediatric,462,booster2,01-Jun-22,10-Apr-21,417,mRNA,13,10 to 17
1183,female,CD,Ustekinumab Only,7109,positive,pediatric,,booster1,09-Jun-21,17-Apr-21,53,mRNA,13,10 to 17
1184,female,CD,Ustekinumab Only,30186,positive,pediatric,,booster2,05-Jan-22,15-Apr-21,265,mRNA,1,00 to 09
1185,female,CD,Ustekinumab Only,119,negative,pediatric,,primary,24-Jun-21,07-May-21,48,vector,12,10 to 17
1186,female,CD,Ustekinumab Only,8503,positive,pediatric,,booster1,06-Aug-21,07-May-21,91,vector,5,00 to 09
1187,female,CD,Ustekinumab Only,743,positive,adult,,booster1,01-Mar-22,07-May-21,298,vector,50,50 to 59
1188,female,CD,Ustekinumab Only,14762,positive,adult,,booster2,30-Mar-22,11-May-21,323,vector,50,50 to 59
1189,female,CD,Ustekinumab Only,3751,positive,adult,,booster2,08-Jul-22,07-May-21,427,vector,51,50 to 59
1190,male,CD,Ustekinumab Only,40,negative,adult,,pre_dose,01-May-21,15-Apr-21,16,vector,33,30 to 39
1191,female,CD,Ustekinumab Only,644,positive,adult,,primary,25-May-21,08-Apr-21,47,mRNA,34,30 to 39
1192,female,CD,Ustekinumab Only,16173,positive,adult,,primary,14-Aug-21,12-Apr-21,124,mRNA,34,30 to 39
1193,female,CD,Ustekinumab Only,68649,positive,adult,,booster2,26-Jan-22,12-Apr-21,289,mRNA,34,30 to 39
1194,female,UC,Anti-TNF Only,29,negative,adult,,primary,25-Sep-21,04-Mar-21,205,vector,44,40 to 49
1195,male,CD,Combination Therapy,30298,positive,adult,180,booster2,09-Nov-21,08-Apr-21,215,mRNA,22,18 to 29
1196,female,UC,Combination Therapy,2301,positive,adult,355,primary,04-Jun-21,08-Apr-21,57,mRNA,36,30 to 39
1197,female,UC,Combination Therapy,28092,positive,adult,319,booster1,10-Jul-21,09-Apr-21,92,mRNA,36,30 to 39
1198,female,UC,Combination Therapy,61734,positive,adult,194,booster2,12-Nov-21,13-Apr-21,213,mRNA,36,30 to 39
1199,female,UC,Combination Therapy,10339,positive,adult,83,booster2,03-Mar-22,13-Apr-21,324,mRNA,36,30 to 39
1200,female,UC,Combination Therapy,57885,positive,adult,27,booster2,28-Apr-22,08-Apr-21,385,mRNA,36,30 to 39
1201,female,CD,Combination Therapy,1095,positive,elderly,,booster1,15-May-21,12-Mar-21,64,mRNA,65,60 to 69
1202,female,CD,Combination Therapy,550,positive,elderly,,booster1,02-Oct-21,14-Mar-21,202,mRNA,66,60 to 69
1203,female,CD,Combination Therapy,19707,positive,elderly,,booster2,10-Nov-21,14-Mar-21,241,mRNA,66,60 to 69
1204,female,CD,Combination Therapy,17713,positive,elderly,,booster2,27-Apr-22,09-Mar-21,414,mRNA,66,60 to 69
1205,female,CD,Combination Therapy,40045,positive,elderly,,booster2,21-Jul-22,08-Mar-22,135,mRNA,66,60 to 69
1206,female,CD,Vedolizumab Only,6125,positive,elderly,340,booster1,01-May-21,10-Mar-21,52,mRNA,79,70+
1207,female,CD,Vedolizumab Only,917,positive,elderly,315,booster1,26-May-21,09-Mar-21,78,mRNA,79,70+
1208,female,CD,Vedolizumab Only,458,positive,elderly,203,booster1,15-Sep-21,13-Mar-21,186,mRNA,79,70+
1209,female,CD,Vedolizumab Only,2602,positive,elderly,143,booster2,14-Nov-21,12-Mar-21,247,mRNA,80,70+
1210,female,CD,Anti-TNF Only,391,positive,adult,,booster1,09-Sep-21,09-Apr-21,153,mRNA,36,30 to 39
1211,female,CD,Anti-TNF Only,1787,positive,adult,,booster2,04-Mar-22,12-Apr-21,326,mRNA,37,30 to 39
1212,female,CD,Anti-TNF Only,852,positive,adult,,booster2,20-Apr-22,10-Apr-21,375,mRNA,37,30 to 39
1213,male,CD,Anti-TNF Only,1007,positive,adult,,primary,15-Jun-21,13-Apr-21,63,vector,35,30 to 39
1214,female,UC,Vedolizumab Only,1198,positive,adult,,primary,18-May-21,12-Apr-21,36,mRNA,32,30 to 39
1215,female,UC,Vedolizumab Only,8796,positive,adult,,booster1,02-Sep-21,13-Apr-21,142,mRNA,33,30 to 39
1216,female,UC,No Immunosuppressives,20994,positive,adult,87,primary,25-Feb-21,13-Jan-21,43,mRNA,45,40 to 49
1217,female,UC,No Immunosuppressives,1810,positive,adult,341,booster1,06-Nov-21,16-Jan-21,294,mRNA,46,40 to 49
1218,female,CD,Ustekinumab Only,43,negative,adult,,pre_dose,21-Apr-21,04-Apr-21,17,mRNA,56,50 to 59
1219,female,CD,Ustekinumab Only,1527,positive,adult,,booster1,08-Sep-21,02-Apr-21,159,mRNA,56,50 to 59
1220,female,CD,Ustekinumab Only,9979,positive,adult,,booster2,25-Feb-22,02-Apr-21,329,mRNA,57,50 to 59
1221,female,UC,Ustekinumab Only,329,positive,adult,,primary,27-Jun-21,27-Apr-21,61,mRNA,35,30 to 39
1222,female,UC,Ustekinumab Only,32060,positive,adult,,booster1,26-Jul-21,28-Apr-21,89,mRNA,35,30 to 39
1223,female,UC,Ustekinumab Only,25495,positive,adult,,booster2,22-Dec-21,26-Apr-21,240,mRNA,36,30 to 39
1224,female,UC,Ustekinumab Only,6204,positive,adult,,booster2,11-Apr-22,26-Apr-21,350,mRNA,36,30 to 39
1225,male,CD,Ustekinumab Only,247,positive,adult,,primary,01-Jun-21,11-Apr-21,51,vector,55,50 to 59
1226,male,CD,Ustekinumab Only,540,positive,adult,120,booster1,31-Dec-21,10-Apr-21,265,vector,56,50 to 59
1227,male,CD,Ustekinumab Only,8287,positive,adult,,booster2,09-Feb-22,11-Apr-21,304,vector,56,50 to 59
1228,male,CD,Ustekinumab Only,1708,positive,adult,,booster2,10-Jun-22,10-Apr-21,426,vector,56,50 to 59
1229,male,CD,Combination Therapy,45,negative,adult,,primary,02-Jul-21,09-May-21,54,mRNA,36,30 to 39
1230,male,CD,Combination Therapy,48,negative,adult,390,booster1,06-Aug-21,11-May-21,87,mRNA,36,30 to 39
1231,male,CD,Combination Therapy,364,positive,adult,300,booster2,19-Jan-22,10-May-21,254,mRNA,37,30 to 39
1232,male,CD,Combination Therapy,2111,positive,adult,185,booster2,20-May-22,13-May-21,372,mRNA,37,30 to 39
1233,female,UC,Ustekinumab Only,464,positive,adult,73,booster1,24-Jul-21,10-Apr-21,105,mRNA,24,18 to 29
1234,female,UC,Ustekinumab Only,480,positive,pediatric,,booster2,22-Jan-22,07-Apr-21,290,mRNA,5,00 to 09
1235,female,UC,Ustekinumab Only,857,positive,pediatric,,booster2,05-Jun-22,08-Apr-21,423,mRNA,5,00 to 09
1236,female,CD,Ustekinumab Only,540,positive,adult,,primary,22-May-21,11-Apr-21,41,mRNA,37,30 to 39
1237,female,CD,Ustekinumab Only,3693,positive,adult,,booster1,31-Aug-21,08-Apr-21,145,mRNA,38,30 to 39
1238,female,CD,Ustekinumab Only,9282,positive,adult,,booster2,18-Feb-22,11-Apr-21,313,mRNA,38,30 to 39
1239,male,CD,Anti-TNF Only,57,negative,adult,,primary,12-Jun-21,18-Apr-21,55,vector,47,40 to 49
1240,male,CD,Anti-TNF Only,10173,positive,adult,,booster1,03-Aug-21,17-Apr-21,108,vector,47,40 to 49
1241,male,CD,Anti-TNF Only,569,positive,adult,,booster1,31-Dec-21,18-Apr-21,257,vector,48,40 to 49
1242,male,CD,Anti-TNF Only,10631,positive,adult,,booster2,01-Feb-22,18-Apr-21,289,vector,48,40 to 49
1243,male,CD,Anti-TNF Only,1340,positive,adult,,booster2,07-May-22,21-Apr-21,381,vector,48,40 to 49
1244,female,CD,Anti-TNF Only,202,positive,adult,,primary,14-Apr-21,17-Feb-21,56,mRNA,60,60 to 69
1245,female,CD,Anti-TNF Only,470,positive,adult,,booster1,17-Jun-21,22-Feb-21,115,mRNA,60,60 to 69
1246,female,CD,Anti-TNF Only,194,positive,adult,,booster1,17-Sep-21,18-Feb-21,211,mRNA,60,60 to 69
1247,female,CD,Anti-TNF Only,449,positive,adult,,booster2,04-Feb-22,21-Feb-21,348,mRNA,61,60 to 69
1248,female,CD,Anti-TNF Only,2242,positive,adult,,booster2,08-Apr-22,20-Feb-21,412,mRNA,61,60 to 69
1249,male,CD,Anti-TNF Only,38668,positive,adult,147,primary,01-Jun-21,11-Apr-21,51,mRNA,47,40 to 49
1250,male,CD,Anti-TNF Only,10108,positive,adult,,booster1,27-Aug-21,08-Apr-21,141,mRNA,47,40 to 49
1251,male,CD,Anti-TNF Only,19509,positive,adult,399,booster2,08-Feb-22,08-Apr-21,306,mRNA,47,40 to 49
1252,male,CD,Anti-TNF Only,11474,positive,adult,491,booster2,11-May-22,08-Apr-21,398,mRNA,48,40 to 49
1253,male,UC,Tofacitinib Only,24726,positive,adult,175,primary,10-Jun-21,21-Apr-21,50,mRNA,37,30 to 39
1254,male,UC,Tofacitinib Only,14585,positive,adult,271,booster1,14-Sep-21,23-Apr-21,144,mRNA,37,30 to 39
1255,female,CD,Ustekinumab Only,27,negative,adult,,primary,05-May-21,08-Apr-21,27,mRNA,60,60 to 69
1256,female,CD,Ustekinumab Only,2211,positive,adult,,booster1,19-Aug-21,09-Apr-21,132,mRNA,60,60 to 69
1257,female,CD,Ustekinumab Only,5227,positive,adult,,booster2,09-Feb-22,10-Apr-21,305,mRNA,61,60 to 69
1258,female,CD,Ustekinumab Only,7110,positive,adult,,booster2,17-Jun-22,09-Apr-21,434,mRNA,61,60 to 69
1259,male,CD,Ustekinumab Only,3,negative,elderly,,pre_dose,08-Apr-21,04-Apr-21,4,mRNA,63,60 to 69
1260,male,CD,Ustekinumab Only,14221,positive,elderly,,booster1,03-Sep-21,07-Apr-21,149,mRNA,64,60 to 69
1261,male,CD,Ustekinumab Only,28561,positive,elderly,,booster2,22-Feb-22,03-Apr-21,325,mRNA,64,60 to 69
1262,male,CD,Ustekinumab Only,6598,positive,elderly,,booster2,04-Jun-22,08-Apr-21,422,mRNA,64,60 to 69
1263,female,CD,Anti-TNF Only,223,positive,adult,412,primary,26-Feb-21,09-Jan-21,48,mRNA,30,30 to 39
1264,female,CD,Anti-TNF Only,0,negative,adult,376,booster1,03-Apr-21,11-Jan-21,82,mRNA,30,30 to 39
1265,female,CD,Anti-TNF Only,1196,positive,adult,216,booster1,10-Sep-21,12-Jan-21,241,mRNA,30,30 to 39
1266,female,CD,Anti-TNF Only,4423,positive,adult,78,booster2,26-Jan-22,12-Jan-21,379,mRNA,31,30 to 39
1267,male,CD,Combination Therapy,247,positive,adult,223,primary,05-Jun-21,31-Mar-21,66,mRNA,17,10 to 17
1268,male,CD,Combination Therapy,1197,positive,adult,,booster1,23-Jul-21,01-Apr-21,113,mRNA,17,10 to 17
1269,female,CD,Combination Therapy,2541,positive,adult,,booster1,25-Aug-21,08-May-21,109,mRNA,20,18 to 29
1270,female,CD,Anti-TNF Only,145,negative,adult,205,primary,17-Jun-21,30-Apr-21,48,mRNA,53,50 to 59
1271,female,CD,Anti-TNF Only,3821,positive,adult,151,booster1,10-Aug-21,30-Apr-21,102,mRNA,53,50 to 59
1272,female,CD,Anti-TNF Only,16456,positive,adult,35,booster1,12-Feb-22,29-Apr-21,289,mRNA,53,50 to 59
1273,female,CD,Anti-TNF Only,19816,positive,adult,62,booster2,11-Mar-22,01-May-21,314,mRNA,53,50 to 59
1274,female,CD,Anti-TNF Only,6986,positive,adult,152,booster2,09-Jun-22,27-Apr-21,408,mRNA,54,50 to 59
1275,male,CD,Anti-TNF Only,524,positive,adult,213,primary,30-Jun-21,18-Apr-21,73,mRNA,36,30 to 39
1276,male,CD,Anti-TNF Only,113,negative,adult,390,booster1,01-Jan-22,18-Apr-21,258,mRNA,37,30 to 39
1277,female,CD,Anti-TNF Only,30,negative,adult,,pre_dose,30-Apr-21,16-Apr-21,14,mRNA,50,50 to 59
1278,female,CD,Anti-TNF Only,1869,positive,adult,,booster1,15-Jul-21,16-Apr-21,90,mRNA,50,50 to 59
1279,female,CD,Anti-TNF Only,1894,positive,adult,,booster1,17-Jul-21,17-Apr-21,91,mRNA,50,50 to 59
1280,female,CD,Anti-TNF Only,12722,positive,adult,,booster2,20-Oct-21,19-Apr-21,184,mRNA,50,50 to 59
1281,female,CD,Anti-TNF Only,1167,positive,adult,,booster2,01-Mar-22,17-Apr-21,318,mRNA,50,50 to 59
1282,female,CD,Ustekinumab Only,424,positive,adult,531,primary,25-Feb-21,30-Dec-20,57,mRNA,49,40 to 49
1283,female,CD,Ustekinumab Only,5797,positive,adult,470,booster1,27-Apr-21,30-Dec-20,118,mRNA,49,40 to 49
1284,female,CD,Ustekinumab Only,9723,positive,adult,274,booster2,09-Nov-21,03-Jan-21,310,mRNA,50,50 to 59
1285,female,CD,Ustekinumab Only,4236,positive,adult,193,booster2,29-Jan-22,02-Jan-21,392,mRNA,50,50 to 59
1286,female,CD,Ustekinumab Only,13980,positive,adult,300,booster2,14-May-22,29-Dec-21,136,mRNA,50,50 to 59
1287,male,CD,Ustekinumab Only,13185,positive,adult,132,booster1,09-Sep-21,05-May-21,127,mRNA,33,30 to 39
1288,female,CD,Anti-TNF Only,5684,positive,adult,320,booster1,10-Mar-21,20-Dec-20,80,mRNA,22,18 to 29
1289,female,CD,Anti-TNF Only,1417,positive,adult,238,booster1,31-May-21,14-Dec-20,168,mRNA,22,18 to 29
1290,female,CD,Anti-TNF Only,15536,positive,adult,87,booster2,29-Oct-21,16-Dec-20,317,mRNA,22,18 to 29
1291,female,CD,Anti-TNF Only,16668,positive,adult,11,booster2,04-Feb-22,18-Dec-20,413,mRNA,22,18 to 29
1292,female,UC,Immunomodulator Only,4,negative,adult,,pre_dose,16-Mar-21,05-Mar-21,11,mRNA,53,50 to 59
1293,female,UC,Immunomodulator Only,48,negative,adult,,primary,04-May-21,04-Mar-21,61,mRNA,53,50 to 59
1294,female,UC,Immunomodulator Only,508,positive,adult,185,booster1,02-Jul-21,04-Mar-21,120,mRNA,53,50 to 59
1295,female,UC,Immunomodulator Only,552,positive,adult,,booster1,04-Sep-21,02-Mar-21,186,mRNA,54,50 to 59
1296,female,UC,Immunomodulator Only,9443,positive,adult,,booster2,18-Nov-21,28-Feb-21,263,mRNA,54,50 to 59
1297,female,UC,Immunomodulator Only,1246,positive,adult,,booster2,09-Feb-22,04-Mar-21,342,mRNA,54,50 to 59
1298,female,UC,Immunomodulator Only,1511,positive,adult,,booster2,29-Mar-22,04-Mar-21,390,mRNA,54,50 to 59
1299,female,UC,Immunomodulator Only,1020,positive,adult,,booster2,19-Jul-22,05-Mar-22,136,mRNA,54,50 to 59
1300,female,CD,Combination Therapy,77,negative,adult,,primary,10-Mar-21,17-Jan-21,52,vector,38,30 to 39
1301,female,CD,Combination Therapy,2680,positive,adult,,booster1,08-Apr-21,20-Jan-21,78,vector,38,30 to 39
1302,female,CD,Combination Therapy,84,negative,adult,,booster1,01-Oct-21,20-Jan-21,254,vector,39,30 to 39
1303,female,CD,Combination Therapy,4887,positive,adult,,booster2,13-Jul-22,12-Apr-21,457,vector,39,30 to 39
1304,male,UC,No Immunosuppressives,357,positive,adult,73,primary,25-Feb-21,19-Feb-21,6,mRNA,27,18 to 29
1305,male,UC,No Immunosuppressives,6021,positive,adult,282,booster1,09-May-21,21-Feb-21,77,mRNA,27,18 to 29
1306,male,UC,No Immunosuppressives,4863,positive,adult,393,booster1,28-Aug-21,19-Feb-21,190,mRNA,28,18 to 29
1307,male,UC,No Immunosuppressives,9707,positive,adult,525,booster1,07-Jan-22,16-Feb-21,325,mRNA,28,18 to 29
1308,male,UC,No Immunosuppressives,4385,positive,adult,634,booster2,26-Apr-22,17-Feb-21,433,mRNA,28,18 to 29
1309,female,CD,Ustekinumab Only,1031,positive,adult,309,primary,08-Apr-21,17-Feb-21,50,mRNA,40,40 to 49
1310,female,CD,Ustekinumab Only,9582,positive,adult,253,booster1,03-Jun-21,21-Feb-21,102,mRNA,40,40 to 49
1311,female,CD,Ustekinumab Only,2667,positive,adult,155,booster1,09-Sep-21,17-Feb-21,204,mRNA,41,40 to 49
1312,female,CD,Ustekinumab Only,6702,positive,adult,70,booster2,03-Dec-21,20-Feb-21,286,mRNA,41,40 to 49
1313,male,UC,Anti-TNF Only,13221,positive,adult,,booster1,10-Aug-21,25-Apr-21,107,vector,32,30 to 39
1314,female,CD,Vedolizumab Only,14854,positive,elderly,,primary,05-Mar-21,08-Feb-21,25,vector,71,70+
1315,female,CD,Vedolizumab Only,1023,positive,elderly,,primary,20-Aug-21,05-Mar-21,168,vector,71,70+
1316,female,CD,Anti-TNF Only,1605,positive,adult,237,booster1,28-May-21,30-Mar-21,59,mRNA,47,40 to 49
1317,female,CD,Anti-TNF Only,69,negative,adult,162,booster1,10-Sep-21,29-Mar-21,165,mRNA,48,40 to 49
1318,female,CD,Anti-TNF Only,417,positive,adult,50,booster2,15-Dec-21,01-Apr-21,258,mRNA,48,40 to 49
1319,female,CD,Anti-TNF Only,3665,positive,adult,56,booster2,15-Mar-22,27-Mar-21,353,mRNA,48,40 to 49
1320,female,UC,No Immunosuppressives,31588,positive,adult,,booster1,18-Nov-21,30-Aug-21,80,mRNA,46,40 to 49
1321,female,CD,Anti-TNF Only,5577,positive,adult,,booster1,27-Mar-21,04-Jan-21,82,mRNA,34,30 to 39
1322,female,CD,Anti-TNF Only,184,positive,adult,,booster1,28-Sep-21,07-Jan-21,264,mRNA,34,30 to 39
1323,female,CD,Anti-TNF Only,29603,positive,adult,,booster2,18-Nov-21,04-Jan-21,318,mRNA,35,30 to 39
1324,female,CD,Anti-TNF Only,10932,positive,adult,,booster2,18-Feb-22,03-Jan-21,411,mRNA,35,30 to 39
1325,female,CD,Anti-TNF Only,23608,positive,adult,,booster2,19-Apr-22,06-Jan-21,468,mRNA,35,30 to 39
1326,female,CD,Ustekinumab Only,19,negative,elderly,,pre_dose,29-Mar-21,28-Mar-21,1,mRNA,65,60 to 69
1327,female,CD,Ustekinumab Only,247,positive,elderly,,primary,12-May-21,24-Mar-21,49,mRNA,65,60 to 69
1328,female,CD,Ustekinumab Only,4703,positive,elderly,,booster1,15-Jul-21,22-Mar-21,115,mRNA,65,60 to 69
1329,female,CD,Ustekinumab Only,18769,positive,elderly,,booster2,12-Oct-21,25-Mar-21,201,mRNA,65,60 to 69
1330,female,CD,Ustekinumab Only,4324,positive,elderly,,booster2,27-Jan-22,27-Mar-21,306,mRNA,66,60 to 69
1331,female,CD,Ustekinumab Only,21788,positive,elderly,,booster2,01-Apr-22,24-Mar-21,373,mRNA,66,60 to 69
1332,female,CD,Ustekinumab Only,,,elderly,,booster2,02-Jul-22,25-Mar-21,464,mRNA,66,60 to 69
1333,male,UC,Anti-TNF Only,13,negative,adult,,pre_dose,27-Apr-21,19-Apr-21,8,mRNA,60,60 to 69
1334,male,UC,Anti-TNF Only,6376,positive,adult,,booster1,15-Jun-21,22-Apr-21,54,mRNA,60,60 to 69
1335,male,UC,Anti-TNF Only,11593,positive,adult,,booster2,30-Nov-21,21-Apr-21,223,mRNA,61,60 to 69
1336,female,CD,Vedolizumab Only,18,negative,adult,,pre_dose,09-Apr-21,03-Apr-21,6,mRNA,32,30 to 39
1337,female,CD,Vedolizumab Only,148,negative,adult,,primary,03-Jun-21,04-Apr-21,60,mRNA,32,30 to 39
1338,male,CD,Ustekinumab Only,14659,positive,elderly,83,primary,05-May-21,24-Mar-21,42,mRNA,72,70+
1339,male,CD,Ustekinumab Only,20430,positive,elderly,174,booster1,04-Aug-21,25-Mar-21,132,mRNA,72,70+
1340,male,CD,Ustekinumab Only,32239,positive,elderly,237,booster2,20-Nov-21,23-Mar-21,242,mRNA,72,70+
1341,male,CD,Ustekinumab Only,10469,positive,elderly,407,booster2,25-Mar-22,21-Mar-21,369,mRNA,73,70+
1342,male,CD,Ustekinumab Only,37325,positive,elderly,465,booster2,22-May-22,24-Mar-21,424,mRNA,73,70+
1343,female,CD,Anti-TNF Only,257,positive,adult,208,primary,16-Jun-21,12-Apr-21,65,mRNA,31,30 to 39
1344,female,CD,Anti-TNF Only,5268,positive,adult,180,booster1,14-Jul-21,13-Apr-21,92,mRNA,31,30 to 39
1345,female,CD,Anti-TNF Only,36876,positive,adult,24,booster1,03-Feb-22,14-Apr-21,295,mRNA,32,30 to 39
1346,female,CD,Anti-TNF Only,28337,positive,adult,99,booster2,19-Apr-22,08-Apr-21,376,mRNA,32,30 to 39
1347,female,CD,Ustekinumab Only,120,negative,adult,162,primary,15-Jun-21,24-Apr-21,52,mRNA,60,60 to 69
1348,female,CD,Ustekinumab Only,2272,positive,adult,,booster1,01-Oct-21,27-Apr-21,157,mRNA,60,60 to 69
1349,female,CD,Ustekinumab Only,10667,positive,adult,,booster2,02-Nov-21,24-Apr-21,192,mRNA,60,60 to 69
1350,female,CD,Ustekinumab Only,1280,positive,adult,,booster2,01-Mar-22,26-Apr-21,309,mRNA,60,60 to 69
1351,female,CD,Ustekinumab Only,10800,positive,adult,,booster2,05-May-22,24-Apr-21,376,mRNA,61,60 to 69
1352,male,CD,Vedolizumab Only,6451,positive,adult,,booster1,20-Mar-21,11-Jan-21,68,mRNA,50,50 to 59
1353,male,CD,Vedolizumab Only,674,positive,adult,,booster1,24-Sep-21,16-Jan-21,251,mRNA,51,50 to 59
1354,male,CD,Vedolizumab Only,2918,positive,adult,,booster2,15-Feb-22,16-Jan-21,395,mRNA,51,50 to 59
1355,female,CD,Anti-TNF Only,489,positive,adult,401,primary,20-Apr-21,05-Mar-21,46,mRNA,28,18 to 29
1356,female,CD,Anti-TNF Only,942,positive,adult,338,booster1,22-Jun-21,03-Mar-21,111,mRNA,29,18 to 29
1357,female,CD,Anti-TNF Only,433,positive,adult,,booster1,01-Sep-21,28-Feb-21,185,mRNA,29,18 to 29
1358,female,CD,Anti-TNF Only,16851,positive,adult,112,booster2,03-Feb-22,27-Feb-21,341,mRNA,29,18 to 29
1359,female,CD,Anti-TNF Only,6523,positive,adult,9,booster2,04-Jun-22,02-Mar-21,459,mRNA,30,30 to 39
1360,female,CD,Ustekinumab Only,1319,positive,adult,,booster1,02-Apr-21,01-Jan-21,91,mRNA,33,30 to 39
1361,female,CD,Ustekinumab Only,209,positive,adult,,booster1,17-Sep-21,02-Jan-21,258,mRNA,33,30 to 39
1362,female,CD,Ustekinumab Only,2494,positive,adult,,booster2,24-Feb-22,31-Dec-20,420,mRNA,34,30 to 39
1363,female,CD,Anti-TNF Only,137,negative,adult,127,primary,28-May-21,09-Apr-21,49,mRNA,33,30 to 39
1364,female,CD,Anti-TNF Only,15382,positive,adult,112,booster2,22-Jan-22,09-Apr-21,288,mRNA,33,30 to 39
1365,female,CD,Anti-TNF Only,4150,positive,adult,153,booster2,04-Mar-22,05-Apr-21,333,mRNA,33,30 to 39
1366,male,UC,Anti-TNF Only,6790,positive,adult,177,booster2,21-Oct-21,07-Apr-21,197,mRNA,34,30 to 39
1367,male,CD,Anti-TNF Only,60,negative,adult,,primary,21-May-21,16-Apr-21,35,mRNA,39,30 to 39
1368,male,CD,Anti-TNF Only,9614,positive,adult,,booster1,14-Aug-21,17-Apr-21,119,mRNA,39,30 to 39
1369,male,CD,Anti-TNF Only,9877,positive,adult,,booster2,13-Jan-22,12-Apr-21,276,mRNA,39,30 to 39
1370,male,CD,Anti-TNF Only,3997,positive,adult,,booster2,07-Apr-22,12-Apr-21,360,mRNA,40,40 to 49
1371,male,CD,Anti-TNF Only,11185,positive,adult,,booster2,04-Jun-22,17-Apr-21,413,mRNA,40,40 to 49
1372,female,CD,Ustekinumab Only,6091,positive,elderly,,primary,02-Jun-21,20-Apr-21,43,mRNA,63,60 to 69
1373,female,CD,Ustekinumab Only,27459,positive,elderly,,booster1,30-Sep-21,19-Apr-21,164,mRNA,63,60 to 69
1374,female,CD,Ustekinumab Only,67269,positive,elderly,,booster2,01-Dec-21,16-Apr-21,229,mRNA,64,60 to 69
1375,female,CD,Combination Therapy,236,positive,adult,,primary,21-May-21,03-Apr-21,48,mRNA,58,50 to 59
1376,female,CD,Combination Therapy,1037,positive,adult,,booster1,11-Aug-21,03-Apr-21,130,mRNA,58,50 to 59
1377,female,CD,Combination Therapy,13560,positive,adult,,booster2,29-Oct-21,31-Mar-21,212,mRNA,58,50 to 59
1378,female,CD,Combination Therapy,740,positive,adult,,booster2,06-Mar-22,31-Mar-21,340,mRNA,59,50 to 59
1379,female,CD,Combination Therapy,4018,positive,adult,,booster2,02-Apr-22,04-Apr-21,363,mRNA,59,50 to 59
1380,female,UC,Ustekinumab Only,8499,positive,adult,126,booster1,01-Sep-21,13-Apr-21,141,vector,45,40 to 49
1381,female,UC,Ustekinumab Only,,,adult,99,booster2,14-Apr-22,13-Apr-21,366,vector,45,40 to 49
1382,female,UC,Ustekinumab Only,,,adult,155,booster2,09-Jun-22,14-Apr-21,421,vector,45,40 to 49
1383,male,CD,Anti-TNF Only,15,negative,elderly,,pre_dose,31-Mar-21,21-Mar-21,10,mRNA,72,70+
1384,male,CD,Anti-TNF Only,576,positive,elderly,,booster2,08-Feb-22,23-Mar-21,322,mRNA,72,70+
1385,male,UC,Ustekinumab Only,1115,positive,adult,,booster1,16-Aug-21,07-Apr-21,131,mRNA,39,30 to 39
1386,male,CD,Ustekinumab Only,162,positive,adult,224,primary,04-Jun-21,25-Apr-21,40,mRNA,43,40 to 49
1387,male,CD,Ustekinumab Only,2270,positive,adult,174,booster1,24-Jul-21,25-Apr-21,90,mRNA,43,40 to 49
1388,male,CD,Ustekinumab Only,8884,positive,adult,20,booster2,25-Dec-21,24-Apr-21,245,mRNA,43,40 to 49
1389,male,CD,Ustekinumab Only,23024,positive,adult,76,booster2,31-Mar-22,25-Apr-21,340,mRNA,44,40 to 49
1390,male,CD,Ustekinumab Only,40003,positive,adult,132,booster2,26-May-22,20-Apr-21,401,mRNA,44,40 to 49
1391,female,CD,Ustekinumab Only,12,negative,elderly,,primary,09-Apr-21,26-Mar-21,14,mRNA,64,60 to 69
1392,female,CD,Ustekinumab Only,180,positive,elderly,,primary,23-May-21,27-Mar-21,57,mRNA,64,60 to 69
1393,female,CD,Ustekinumab Only,15520,positive,elderly,,booster1,21-Jul-21,25-Mar-21,118,mRNA,64,60 to 69
1394,female,CD,Ustekinumab Only,1108,positive,elderly,,booster1,18-Dec-21,27-Mar-21,266,mRNA,64,60 to 69
1395,female,CD,Ustekinumab Only,50964,positive,elderly,,booster2,18-Jan-22,27-Mar-21,297,mRNA,65,60 to 69
1396,female,CD,Ustekinumab Only,8732,positive,elderly,,booster2,10-May-22,26-Mar-21,410,mRNA,65,60 to 69
1397,male,UC,Anti-TNF Only,6640,positive,adult,,booster1,21-Jul-21,12-Apr-21,100,mRNA,22,18 to 29
1398,male,UC,Anti-TNF Only,5509,positive,adult,,booster2,07-Jan-22,09-Apr-21,273,mRNA,23,18 to 29
1399,male,UC,Anti-TNF Only,4388,positive,adult,,booster2,01-Apr-22,09-Apr-21,357,mRNA,23,18 to 29
1400,female,UC,Ustekinumab Only,4647,positive,adult,377,booster1,04-May-21,29-Dec-20,126,mRNA,38,30 to 39
1401,male,CD,Ustekinumab Only,938,positive,adult,341,primary,29-May-21,22-Apr-21,37,vector,51,50 to 59
1402,male,CD,Ustekinumab Only,38327,positive,adult,225,booster2,16-Feb-22,24-Apr-21,298,vector,52,50 to 59
1403,male,CD,Ustekinumab Only,70608,positive,adult,169,booster2,30-Jun-22,22-Apr-21,434,vector,52,50 to 59
1404,male,CD,Anti-TNF Only,1498,positive,adult,,booster1,04-Sep-21,03-May-21,124,mRNA,56,50 to 59
1405,male,CD,Combination Therapy,51,negative,adult,345,pre_dose,09-Apr-21,08-Apr-21,1,mRNA,28,18 to 29
1406,male,CD,Combination Therapy,121,negative,adult,302,primary,02-Jun-21,07-Apr-21,56,mRNA,29,18 to 29
1407,male,CD,Combination Therapy,6663,positive,adult,187,booster1,27-Aug-21,03-Apr-21,146,mRNA,29,18 to 29
1408,male,CD,Combination Therapy,10135,positive,adult,,booster2,10-Feb-22,07-Apr-21,309,mRNA,29,18 to 29
1409,female,CD,Ustekinumab Only,20112,positive,elderly,,booster1,02-Sep-21,27-May-21,98,vector,64,60 to 69
1410,male,UC,Anti-TNF Only,973,positive,adult,225,booster1,18-Aug-21,11-May-21,99,mRNA,38,30 to 39
1411,male,CD,Combination Therapy,2873,positive,adult,,booster1,24-Aug-21,12-Apr-21,134,mRNA,57,50 to 59
1412,male,CD,Combination Therapy,12431,positive,adult,,booster2,04-Nov-21,12-Apr-21,206,mRNA,57,50 to 59
1413,male,CD,Combination Therapy,2017,positive,adult,,booster2,04-Mar-22,11-Apr-21,327,mRNA,58,50 to 59
1414,male,CD,Combination Therapy,17112,positive,adult,,booster2,04-Jun-22,11-Apr-21,419,mRNA,58,50 to 59
1415,male,CD,Ustekinumab Only,13,negative,adult,,pre_dose,04-May-21,20-Apr-21,14,mRNA,42,40 to 49
1416,male,CD,Ustekinumab Only,5028,positive,adult,,booster1,24-Aug-21,22-Apr-21,124,mRNA,43,40 to 49
1417,male,CD,Ustekinumab Only,9936,positive,adult,,booster2,25-May-22,24-Apr-21,396,mRNA,43,40 to 49
1418,male,CD,Immunomodulator Only,114,negative,elderly,,primary,27-Apr-21,05-Mar-21,53,mRNA,73,70+
1419,male,CD,Immunomodulator Only,38,negative,elderly,169,booster1,19-May-21,06-Mar-21,74,mRNA,73,70+
1420,male,CD,Immunomodulator Only,429,positive,elderly,,booster1,28-Aug-21,02-Mar-21,179,mRNA,73,70+
1421,male,CD,Immunomodulator Only,18009,positive,elderly,,booster2,16-Nov-21,03-Mar-21,258,mRNA,74,70+
1422,male,CD,Immunomodulator Only,5395,positive,elderly,,booster2,04-Mar-22,03-Mar-21,366,mRNA,74,70+
1423,male,CD,Immunomodulator Only,20570,positive,elderly,,booster2,22-Apr-22,08-Mar-21,410,mRNA,74,70+
1424,male,CD,Anti-TNF Only,519,positive,elderly,,primary,04-May-21,20-Mar-21,45,mRNA,73,70+
1425,male,CD,Anti-TNF Only,1749,positive,elderly,,booster1,04-Jun-21,24-Mar-21,72,mRNA,73,70+
1426,male,CD,Anti-TNF Only,132,negative,elderly,,booster1,01-Jan-22,18-Mar-21,289,mRNA,73,70+
1427,male,UC,No Immunosuppressives,99,negative,elderly,,primary,20-Apr-21,24-Feb-21,55,mRNA,72,70+
1428,male,UC,No Immunosuppressives,994,positive,elderly,,booster1,09-Jun-21,24-Feb-21,105,mRNA,73,70+
1429,male,UC,No Immunosuppressives,209,positive,elderly,,booster1,14-Sep-21,02-Mar-21,196,mRNA,73,70+
1430,male,UC,No Immunosuppressives,7946,positive,elderly,,booster2,18-Nov-21,26-Feb-21,265,mRNA,73,70+
1431,male,UC,No Immunosuppressives,7032,positive,elderly,,booster2,08-Feb-22,25-Feb-21,348,mRNA,73,70+
1432,male,UC,No Immunosuppressives,11582,positive,elderly,,booster2,05-Apr-22,25-Feb-21,404,mRNA,73,70+
1433,male,UC,No Immunosuppressives,2590,positive,elderly,,booster2,19-Jul-22,02-Mar-22,139,mRNA,74,70+
1434,male,UC,No Immunosuppressives,132,negative,adult,,primary,03-Jul-21,24-Apr-21,70,mRNA,53,50 to 59
1435,male,UC,No Immunosuppressives,7957,positive,adult,,booster1,20-Aug-21,22-Apr-21,120,mRNA,53,50 to 59
1436,male,UC,No Immunosuppressives,38390,positive,adult,,booster1,04-Mar-22,23-Apr-21,315,mRNA,53,50 to 59
1437,male,UC,No Immunosuppressives,29205,positive,adult,,booster1,29-Jul-22,22-Apr-21,463,mRNA,54,50 to 59
1438,female,CD,Vedolizumab Only,95,negative,elderly,,primary,28-Apr-21,27-Feb-21,60,mRNA,76,70+
1439,female,CD,Vedolizumab Only,3048,positive,elderly,345,booster1,23-Jun-21,03-Mar-21,112,mRNA,76,70+
1440,female,CD,Vedolizumab Only,5025,positive,elderly,,booster2,26-May-22,26-Feb-21,454,mRNA,77,70+
1441,female,UC,Anti-TNF Only,2951,positive,adult,306,booster1,24-Apr-21,13-Jan-21,101,mRNA,26,18 to 29
1442,female,UC,Anti-TNF Only,8679,positive,adult,106,booster2,10-Nov-21,14-Jan-21,300,mRNA,27,18 to 29
1443,male,UC,Ustekinumab Only,2028,positive,adult,,booster1,07-Aug-21,24-Mar-21,136,mRNA,54,50 to 59
1444,female,CD,Ustekinumab Only,400,positive,adult,429,primary,14-Apr-21,24-Feb-21,49,mRNA,23,18 to 29
1445,female,CD,Ustekinumab Only,1699,positive,adult,34,booster2,14-May-22,23-Feb-21,445,mRNA,24,18 to 29
1446,male,CD,Vedolizumab Only,654,positive,elderly,,primary,24-Apr-21,12-Mar-21,43,mRNA,73,70+
1447,male,CD,Vedolizumab Only,1797,positive,elderly,,booster1,27-May-21,14-Mar-21,74,mRNA,73,70+
1448,male,CD,Vedolizumab Only,710,positive,elderly,,booster1,18-Sep-21,12-Mar-21,190,mRNA,73,70+
1449,male,CD,Vedolizumab Only,3622,positive,elderly,302,booster2,13-Nov-21,13-Mar-21,245,mRNA,73,70+
1450,male,CD,Vedolizumab Only,5842,positive,elderly,,booster2,04-May-22,11-Mar-21,419,mRNA,74,70+
1451,male,CD,Ustekinumab Only,78,negative,adult,209,primary,21-Aug-21,09-Jul-21,43,mRNA,48,40 to 49
1452,male,CD,Ustekinumab Only,11552,positive,adult,113,booster2,25-Nov-21,10-Jul-21,138,mRNA,48,40 to 49
1453,male,CD,Ustekinumab Only,69107,positive,adult,4,booster2,22-Mar-22,09-Jul-21,256,mRNA,48,40 to 49
1454,male,CD,Combination Therapy,47,negative,adult,,pre_dose,22-Apr-21,15-Apr-21,7,mRNA,49,40 to 49
1455,male,CD,Combination Therapy,66,negative,adult,,primary,21-May-21,10-Apr-21,41,mRNA,49,40 to 49
1456,male,CD,Combination Therapy,1651,positive,adult,,booster1,08-Jul-21,13-Apr-21,86,mRNA,49,40 to 49
1457,male,CD,Combination Therapy,1864,positive,adult,,booster1,24-Sep-21,15-Apr-21,162,mRNA,49,40 to 49
1458,male,CD,Combination Therapy,12400,positive,adult,187,booster2,30-Oct-21,11-Apr-21,202,mRNA,49,40 to 49
1459,male,CD,Combination Therapy,2126,positive,adult,,booster2,25-Feb-22,12-Apr-21,319,mRNA,50,50 to 59
1460,female,UC,Anti-TNF Only,1009,positive,elderly,,booster1,06-Jul-21,21-Mar-21,107,mRNA,65,60 to 69
1461,female,UC,Anti-TNF Only,1539,positive,elderly,,booster1,08-Sep-21,26-Mar-21,166,mRNA,65,60 to 69
1462,female,UC,Anti-TNF Only,8071,positive,elderly,,booster2,07-Oct-21,21-Mar-21,200,mRNA,65,60 to 69
1463,female,UC,Anti-TNF Only,975,positive,elderly,,booster2,24-Feb-22,27-Mar-21,334,mRNA,66,60 to 69
1464,female,UC,Anti-TNF Only,10281,positive,elderly,,booster2,19-Apr-22,24-Mar-21,391,mRNA,66,60 to 69
1465,female,CD,Ustekinumab Only,9389,positive,elderly,,primary,15-May-21,02-Apr-21,43,mRNA,74,70+
1466,female,CD,Ustekinumab Only,768,positive,elderly,,booster1,07-Nov-21,29-Mar-21,223,mRNA,75,70+
1467,female,CD,Ustekinumab Only,5395,positive,elderly,,booster2,18-Feb-22,01-Apr-21,323,mRNA,75,70+
1468,female,CD,Ustekinumab Only,7163,positive,elderly,,booster2,24-May-22,30-Mar-21,420,mRNA,75,70+
1469,male,CD,Anti-TNF Only,252,positive,adult,268,primary,23-Apr-21,02-Mar-21,52,mRNA,41,40 to 49
1470,male,CD,Anti-TNF Only,454,positive,adult,164,booster1,05-Aug-21,28-Feb-21,158,mRNA,41,40 to 49
1471,male,CD,Anti-TNF Only,181,positive,adult,72,booster1,05-Nov-21,02-Mar-21,248,mRNA,41,40 to 49
1472,male,CD,Anti-TNF Only,13499,positive,adult,31,booster1,16-Feb-22,27-Feb-21,354,mRNA,42,40 to 49
1473,male,CD,Anti-TNF Only,134,negative,adult,53,booster1,10-Mar-22,24-Feb-21,379,mRNA,42,40 to 49
1474,female,CD,Vedolizumab Only,1221,positive,adult,,primary,28-May-21,23-Apr-21,35,vector,38,30 to 39
1475,female,CD,Vedolizumab Only,36706,positive,adult,,booster1,21-Aug-21,22-Apr-21,121,vector,38,30 to 39
1476,female,CD,Vedolizumab Only,41854,positive,adult,,booster1,03-Aug-22,23-Apr-21,467,vector,39,30 to 39
1477,female,CD,Ustekinumab Only,577,positive,adult,,primary,25-Jun-21,26-Apr-21,60,mRNA,56,50 to 59
1478,female,CD,Ustekinumab Only,3077,positive,adult,,booster1,21-Aug-21,22-Apr-21,121,mRNA,56,50 to 59
1479,female,CD,Ustekinumab Only,515,positive,adult,,booster1,15-Dec-21,27-Apr-21,232,mRNA,57,50 to 59
1480,female,CD,Ustekinumab Only,20287,positive,adult,,booster2,25-May-22,27-Apr-21,393,mRNA,57,50 to 59
1481,male,CD,No Immunosuppressives,154,positive,elderly,,primary,27-Apr-21,07-Mar-21,51,mRNA,74,70+
1482,male,CD,No Immunosuppressives,5765,positive,elderly,,booster1,21-May-21,06-Mar-21,76,mRNA,74,70+
1483,male,CD,No Immunosuppressives,1009,positive,elderly,,booster1,18-Sep-21,09-Mar-21,193,mRNA,74,70+
1484,male,CD,No Immunosuppressives,5488,positive,elderly,,booster2,14-Jan-22,04-Mar-21,316,mRNA,75,70+
1485,male,CD,No Immunosuppressives,2356,positive,elderly,,booster2,12-Apr-22,07-Mar-21,401,mRNA,75,70+
1486,male,CD,No Immunosuppressives,24197,positive,elderly,,booster2,31-May-22,05-Mar-21,452,mRNA,75,70+
1487,female,CD,Anti-TNF Only,321,positive,adult,,booster1,29-Aug-21,13-Apr-21,138,mRNA,60,60 to 69
1488,female,CD,Anti-TNF Only,8828,positive,adult,,booster2,10-Nov-21,14-Apr-21,210,mRNA,60,60 to 69
1489,female,CD,Anti-TNF Only,4144,positive,adult,,booster2,26-Jan-22,15-Apr-21,286,mRNA,60,60 to 69
1490,female,CD,Anti-TNF Only,15202,positive,adult,,booster2,24-May-22,15-Apr-21,404,mRNA,60,60 to 69
1491,male,CD,Anti-TNF Only,29,negative,adult,277,pre_dose,15-Apr-21,14-Apr-21,1,mRNA,52,50 to 59
1492,male,CD,Anti-TNF Only,142,negative,adult,221,primary,10-Jun-21,16-Apr-21,55,mRNA,53,50 to 59
1493,male,CD,Anti-TNF Only,1882,positive,adult,165,booster1,05-Aug-21,11-Apr-21,116,mRNA,53,50 to 59
1494,male,CD,Anti-TNF Only,172,positive,adult,53,booster1,25-Nov-21,13-Apr-21,226,mRNA,53,50 to 59
1495,male,CD,Anti-TNF Only,38575,positive,adult,29,booster2,15-Feb-22,15-Apr-21,306,mRNA,53,50 to 59
1496,male,CD,Anti-TNF Only,9516,positive,adult,,booster2,25-May-22,11-Apr-21,409,mRNA,54,50 to 59
1497,male,CD,No Immunosuppressives,604,positive,adult,,primary,19-Jun-21,30-Apr-21,50,mRNA,35,30 to 39
1498,male,CD,No Immunosuppressives,10315,positive,adult,,booster1,21-Jul-21,28-Apr-21,84,mRNA,35,30 to 39
1499,male,CD,No Immunosuppressives,2651,positive,adult,,booster1,25-Dec-21,27-Apr-21,242,mRNA,35,30 to 39
1500,male,CD,No Immunosuppressives,30847,positive,adult,,booster2,21-Jan-22,26-Apr-21,270,mRNA,35,30 to 39
1501,male,CD,No Immunosuppressives,24911,positive,adult,,booster2,11-Jun-22,29-Apr-21,408,mRNA,36,30 to 39
1502,male,UC,No Immunosuppressives,29,negative,elderly,,primary,09-May-21,27-Mar-21,43,mRNA,68,60 to 69
1503,male,UC,No Immunosuppressives,3252,positive,elderly,,booster1,06-Jul-21,25-Mar-21,103,mRNA,68,60 to 69
1504,male,UC,No Immunosuppressives,833,positive,elderly,,booster1,16-Oct-21,24-Mar-21,206,mRNA,68,60 to 69
1505,male,UC,No Immunosuppressives,12958,positive,elderly,,booster2,06-Jan-22,24-Mar-21,288,mRNA,69,60 to 69
1506,male,UC,No Immunosuppressives,7659,positive,elderly,,booster2,20-Apr-22,24-Mar-21,392,mRNA,69,60 to 69
1507,male,UC,No Immunosuppressives,15777,positive,elderly,,booster2,14-Jun-22,23-Mar-21,448,mRNA,69,60 to 69
1508,female,CD,Ustekinumab Only,1661,positive,adult,,primary,09-Jun-21,10-Apr-21,60,mRNA,49,40 to 49
1509,female,CD,Ustekinumab Only,26159,positive,adult,,booster1,06-Aug-21,11-Apr-21,117,mRNA,49,40 to 49
1510,female,CD,Ustekinumab Only,5801,positive,adult,,booster2,24-Nov-21,14-Apr-21,224,mRNA,50,50 to 59
1511,female,CD,Ustekinumab Only,10473,positive,adult,,booster2,11-Feb-22,14-Apr-21,303,mRNA,50,50 to 59
1512,female,CD,Ustekinumab Only,20971,positive,adult,,booster2,21-Jun-22,14-Apr-21,433,mRNA,50,50 to 59
1513,female,UC,Vedolizumab Only,8237,positive,adult,,booster1,30-Mar-21,04-Jan-21,85,mRNA,35,30 to 39
1514,female,UC,Vedolizumab Only,2018,positive,adult,,booster1,24-Nov-21,05-Jan-21,323,mRNA,35,30 to 39
1515,female,UC,Vedolizumab Only,30953,positive,adult,,booster2,01-Mar-22,04-Jan-21,421,mRNA,36,30 to 39
1516,male,CD,Ustekinumab Only,291,positive,adult,327,primary,19-Jun-21,12-May-21,38,mRNA,47,40 to 49
1517,male,CD,Ustekinumab Only,12709,positive,adult,271,booster1,14-Aug-21,10-May-21,96,mRNA,47,40 to 49
1518,male,CD,Ustekinumab Only,16356,positive,adult,166,booster2,27-Nov-21,11-May-21,200,mRNA,48,40 to 49
1519,male,CD,Ustekinumab Only,2013,positive,adult,48,booster2,25-Mar-22,10-May-21,319,mRNA,48,40 to 49
1520,male,CD,Ustekinumab Only,139,negative,adult,242,primary,21-May-21,05-Apr-21,46,mRNA,48,40 to 49
1521,male,CD,Ustekinumab Only,667,positive,adult,139,booster1,01-Sep-21,04-Apr-21,150,mRNA,48,40 to 49
1522,male,CD,Ustekinumab Only,6862,positive,adult,59,booster2,20-Nov-21,04-Apr-21,230,mRNA,48,40 to 49
1523,male,CD,Ustekinumab Only,30906,positive,adult,,booster2,11-Mar-22,04-Apr-21,341,mRNA,49,40 to 49
1524,male,CD,Ustekinumab Only,37339,positive,adult,130,booster2,28-May-22,09-Apr-21,414,mRNA,49,40 to 49
1525,male,CD,Combination Therapy,89,negative,adult,,primary,19-May-21,05-Apr-21,44,mRNA,56,50 to 59
1526,male,CD,Combination Therapy,70,negative,adult,,booster1,14-Aug-21,05-Apr-21,131,mRNA,57,50 to 59
1527,male,CD,Combination Therapy,4895,positive,pediatric,,booster2,01-Feb-22,10-Apr-21,297,mRNA,8,00 to 09
1528,male,CD,Combination Therapy,21923,positive,pediatric,,booster2,18-May-22,07-Apr-21,406,mRNA,15,10 to 17
1529,male,UC,Vedolizumab Only,996,positive,pediatric,,primary,22-Jul-21,23-May-21,60,vector,12,10 to 17
1530,male,UC,Vedolizumab Only,32367,positive,pediatric,,booster1,08-Aug-21,23-May-21,77,vector,2,00 to 09
1531,male,UC,Vedolizumab Only,11183,positive,adult,,booster1,06-Jan-22,19-May-21,232,vector,33,30 to 39
1532,male,UC,Vedolizumab Only,27804,positive,adult,,booster2,23-Jun-22,22-May-21,397,vector,33,30 to 39
1533,male,UC,Vedolizumab Only,110,negative,adult,,primary,28-May-21,21-Apr-21,37,mRNA,39,30 to 39
1534,male,UC,Vedolizumab Only,162,positive,adult,328,booster1,25-Jun-21,24-Apr-21,62,mRNA,39,30 to 39
1535,male,UC,Vedolizumab Only,8218,positive,adult,211,booster2,20-Oct-21,21-Apr-21,182,mRNA,40,40 to 49
1536,male,UC,Vedolizumab Only,1701,positive,adult,83,booster2,25-Feb-22,20-Apr-21,311,mRNA,40,40 to 49
1537,male,UC,Vedolizumab Only,969,positive,adult,55,booster2,25-Mar-22,21-Apr-21,338,mRNA,40,40 to 49
1538,male,UC,Vedolizumab Only,79188,positive,adult,22,booster2,10-Jun-22,23-Apr-21,413,mRNA,40,40 to 49
1539,male,CD,Ustekinumab Only,129,negative,adult,220,primary,09-Jun-21,07-May-21,33,mRNA,36,30 to 39
1540,male,CD,Ustekinumab Only,2728,positive,adult,106,booster1,01-Oct-21,02-May-21,152,mRNA,36,30 to 39
1541,male,CD,Anti-TNF Only,96,negative,elderly,232,primary,01-Jun-21,06-Apr-21,56,mRNA,65,60 to 69
1542,male,CD,Anti-TNF Only,4197,positive,elderly,151,booster1,21-Aug-21,02-Apr-21,141,mRNA,65,60 to 69
1543,male,CD,Anti-TNF Only,3669,positive,elderly,,booster2,18-Nov-21,03-Apr-21,229,mRNA,65,60 to 69
1544,male,CD,Anti-TNF Only,20597,positive,elderly,16,booster2,04-Feb-22,05-Apr-21,305,mRNA,65,60 to 69
1545,male,UC,Combination Therapy,3511,positive,adult,,booster1,31-Aug-21,30-May-21,93,mRNA,60,60 to 69
1546,male,UC,Combination Therapy,16273,positive,adult,,booster2,28-Jun-22,30-May-21,394,mRNA,61,60 to 69
1547,male,UC,Vedolizumab Only,2844,positive,adult,,booster1,24-Jul-21,19-Mar-21,127,vector,60,60 to 69
1548,male,UC,Anti-TNF Only,978,positive,elderly,,booster1,19-Aug-21,06-Apr-21,135,mRNA,68,60 to 69
1549,male,UC,Anti-TNF Only,763,positive,elderly,,booster2,09-Mar-22,04-Apr-21,339,mRNA,69,60 to 69
1550,male,UC,Vedolizumab Only,5198,positive,adult,279,booster1,31-Jul-21,10-Apr-21,112,mRNA,62,60 to 69
1551,male,UC,Vedolizumab Only,9680,positive,elderly,97,booster2,29-Jan-22,10-Apr-21,294,mRNA,62,60 to 69
1552,male,UC,Vedolizumab Only,33211,positive,elderly,,booster2,21-May-22,05-Apr-21,411,mRNA,63,60 to 69
1553,male,UC,Anti-TNF Only,78,negative,elderly,,primary,21-May-21,24-Mar-21,58,mRNA,65,60 to 69
1554,male,UC,Anti-TNF Only,10011,positive,elderly,,booster2,01-Feb-22,25-Mar-21,313,mRNA,66,60 to 69
1555,male,UC,Anti-TNF Only,2110,positive,elderly,,booster2,26-Apr-22,23-Mar-21,399,mRNA,66,60 to 69
1556,male,UC,Anti-TNF Only,23299,positive,elderly,,booster2,10-Jun-22,23-Mar-21,444,mRNA,66,60 to 69
1557,male,CD,Ustekinumab Only,38,negative,adult,,primary,20-Apr-21,13-Mar-21,38,vector,61,60 to 69
1558,male,CD,Ustekinumab Only,156,positive,adult,,booster1,13-Jul-21,10-Mar-21,125,vector,62,60 to 69
1559,male,CD,Ustekinumab Only,403,positive,elderly,,booster1,24-Dec-21,15-Mar-21,284,vector,62,60 to 69
1560,male,CD,Ustekinumab Only,65457,positive,elderly,,booster2,02-Feb-22,14-Mar-21,325,vector,62,60 to 69
1561,male,CD,Ustekinumab Only,10137,positive,elderly,,booster2,26-May-22,09-Mar-21,443,vector,62,60 to 69
1562,female,CD,Ustekinumab Only,613,positive,adult,,primary,10-Jun-21,14-Apr-21,57,vector,53,50 to 59
1563,female,CD,Ustekinumab Only,3251,positive,adult,,booster1,07-Aug-21,16-Apr-21,113,vector,54,50 to 59
1564,female,CD,Ustekinumab Only,1037,positive,adult,,booster1,21-Nov-21,11-Apr-21,224,vector,54,50 to 59
1565,female,CD,Ustekinumab Only,27082,positive,adult,,booster2,15-Dec-21,12-Apr-21,247,vector,54,50 to 59
1566,female,CD,Ustekinumab Only,38299,positive,adult,,booster2,12-Apr-22,16-Apr-21,361,vector,54,50 to 59
1567,female,CD,Ustekinumab Only,,,adult,,booster2,18-May-22,16-Apr-21,397,vector,54,50 to 59
1568,male,UC,Corticosteroids,30,negative,elderly,400,booster1,30-Mar-21,15-Jan-21,74,mRNA,62,60 to 69
1569,male,UC,Corticosteroids,51,negative,elderly,281,booster1,27-Jul-21,20-Jan-21,188,mRNA,63,60 to 69
1570,male,UC,Corticosteroids,704,positive,elderly,155,booster2,30-Nov-21,21-Jan-21,313,mRNA,63,60 to 69
1571,male,UC,Corticosteroids,401,positive,elderly,,booster2,04-Feb-22,21-Jan-21,379,mRNA,63,60 to 69
1572,male,UC,Corticosteroids,1259,positive,elderly,8,booster2,26-Apr-22,21-Jan-21,460,mRNA,63,60 to 69
1573,female,CD,Anti-TNF Only,4428,positive,elderly,,booster1,15-Jun-21,19-Apr-21,57,mRNA,64,60 to 69
1574,female,CD,Anti-TNF Only,452,positive,elderly,,booster1,24-Sep-21,14-Apr-21,163,mRNA,64,60 to 69
1575,female,CD,Anti-TNF Only,14328,positive,elderly,,booster2,04-Jan-22,15-Apr-21,264,mRNA,64,60 to 69
1576,female,CD,Anti-TNF Only,5357,positive,elderly,,booster2,16-Apr-22,18-Apr-21,363,mRNA,65,60 to 69
1577,female,CD,Anti-TNF Only,14004,positive,elderly,,booster2,25-Jun-22,19-Apr-21,432,mRNA,65,60 to 69
1578,female,CD,Combination Therapy,36,negative,elderly,,primary,25-May-21,18-Mar-21,68,vector,65,60 to 69
1579,female,CD,Combination Therapy,292,positive,elderly,,booster1,20-Jul-21,14-Mar-21,128,vector,65,60 to 69
1580,female,CD,Combination Therapy,847,positive,elderly,,booster2,09-Dec-21,17-Mar-21,267,vector,65,60 to 69
1581,male,CD,Vedolizumab Only,60,negative,elderly,,primary,22-May-21,25-Mar-21,58,mRNA,69,60 to 69
1582,male,CD,Vedolizumab Only,2927,positive,elderly,,booster1,23-Jun-21,20-Mar-21,95,mRNA,69,60 to 69
1583,male,CD,Vedolizumab Only,3056,positive,elderly,,booster2,09-Nov-21,25-Mar-21,229,mRNA,70,70+
1584,male,CD,Vedolizumab Only,517,positive,elderly,,booster2,23-Feb-22,21-Mar-21,339,mRNA,70,70+
1585,male,CD,Vedolizumab Only,6075,positive,elderly,,booster2,06-May-22,23-Mar-21,409,mRNA,70,70+
1586,female,CD,Anti-TNF Only,719,positive,adult,,primary,25-May-21,13-Apr-21,42,vector,50,50 to 59
1587,female,CD,Anti-TNF Only,4158,positive,adult,,booster1,06-Jul-21,11-Apr-21,86,vector,50,50 to 59
1588,female,CD,Anti-TNF Only,459,positive,adult,,booster1,16-Oct-21,10-Apr-21,189,vector,51,50 to 59
1589,female,CD,Anti-TNF Only,17445,positive,adult,,booster2,22-Jan-22,09-Apr-21,288,vector,51,50 to 59
1590,female,UC,Ustekinumab Only,386,positive,adult,,primary,12-Jun-21,07-Apr-21,66,mRNA,62,60 to 69
1591,female,UC,Ustekinumab Only,12139,positive,adult,,booster1,20-Jul-21,06-Apr-21,105,mRNA,62,60 to 69
1592,female,UC,Ustekinumab Only,14099,positive,elderly,355,booster2,09-Dec-21,05-Apr-21,248,mRNA,62,60 to 69
1593,female,UC,Ustekinumab Only,3221,positive,elderly,232,booster2,30-Mar-22,05-Apr-21,359,mRNA,63,60 to 69
1594,female,UC,Ustekinumab Only,45983,positive,elderly,,booster2,24-May-22,01-Apr-21,418,mRNA,63,60 to 69
1595,female,CD,Corticosteroids,682,positive,elderly,,primary,04-May-21,21-Mar-21,44,mRNA,76,70+
1596,female,CD,Corticosteroids,1542,positive,elderly,,booster1,06-Aug-21,19-Mar-21,140,mRNA,76,70+
1597,female,CD,Corticosteroids,19304,positive,elderly,,booster2,17-Nov-21,17-Mar-21,245,mRNA,76,70+
1598,female,CD,Corticosteroids,4824,positive,elderly,,booster2,22-Apr-22,20-Mar-21,398,mRNA,77,70+
1599,male,CD,Anti-TNF Only,2115,positive,adult,,booster1,01-Sep-21,14-Apr-21,140,mRNA,54,50 to 59
1600,female,CD,Vedolizumab Only,117,negative,elderly,,primary,24-Jun-21,30-Mar-21,86,mRNA,67,60 to 69
1601,female,CD,Vedolizumab Only,25855,positive,elderly,355,booster1,15-Jul-21,29-Mar-21,108,mRNA,67,60 to 69
1602,female,CD,Vedolizumab Only,1665,positive,elderly,,booster1,27-Nov-21,27-Mar-21,245,mRNA,67,60 to 69
1603,female,CD,Vedolizumab Only,3619,positive,elderly,,booster2,27-May-22,27-Mar-21,426,mRNA,68,60 to 69
1604,female,CD,Combination Therapy,37,negative,elderly,,primary,27-May-21,25-Mar-21,63,mRNA,70,70+
1605,female,CD,Combination Therapy,465,positive,elderly,,booster1,28-Aug-21,21-Mar-21,160,mRNA,70,70+
1606,female,CD,Combination Therapy,4837,positive,elderly,,booster2,19-Nov-21,26-Mar-21,238,mRNA,71,70+
1607,female,CD,Combination Therapy,525,positive,elderly,,booster2,10-Mar-22,22-Mar-21,353,mRNA,71,70+
1608,male,UC,Vedolizumab Only,526,positive,adult,,primary,28-May-21,09-Apr-21,49,mRNA,62,60 to 69
1609,male,UC,Vedolizumab Only,11289,positive,adult,,booster1,06-Aug-21,06-Apr-21,122,mRNA,62,60 to 69
1610,male,UC,Vedolizumab Only,2005,positive,elderly,,booster1,24-Nov-21,08-Apr-21,230,mRNA,62,60 to 69
1611,male,UC,Vedolizumab Only,50292,positive,elderly,232,booster2,26-Feb-22,08-Apr-21,324,mRNA,62,60 to 69
1612,male,UC,Vedolizumab Only,80000,positive,elderly,,booster2,29-Apr-22,07-Apr-21,387,mRNA,63,60 to 69
1613,male,CD,Vedolizumab Only,2434,positive,adult,,primary,15-May-21,03-Apr-21,42,mRNA,56,50 to 59
1614,male,CD,Vedolizumab Only,35299,positive,adult,,booster1,10-Jul-21,03-Apr-21,98,mRNA,56,50 to 59
1615,male,CD,Vedolizumab Only,,,adult,,booster2,30-Oct-21,04-Apr-21,209,mRNA,56,50 to 59
1616,male,CD,Vedolizumab Only,,,adult,,booster2,16-Apr-22,31-Mar-21,381,mRNA,56,50 to 59
1617,female,CD,Anti-TNF Only,394,positive,adult,,primary,26-Jun-21,22-Apr-21,65,mRNA,23,18 to 29
1618,female,CD,Anti-TNF Only,7117,positive,adult,,booster1,24-Jul-21,28-Apr-21,87,mRNA,23,18 to 29
1619,female,CD,Anti-TNF Only,1972,positive,adult,,booster2,05-Mar-22,22-Apr-21,317,mRNA,24,18 to 29
1620,female,CD,Anti-TNF Only,14187,positive,adult,,booster2,07-Apr-22,22-Apr-21,350,mRNA,24,18 to 29
1621,female,CD,No Immunosuppressives,251,positive,elderly,,primary,06-May-21,21-Mar-21,46,mRNA,64,60 to 69
1622,female,CD,No Immunosuppressives,3541,positive,elderly,,booster1,22-Jul-21,22-Mar-21,122,mRNA,64,60 to 69
1623,female,CD,No Immunosuppressives,772,positive,elderly,,booster1,01-Jan-22,24-Mar-21,283,mRNA,64,60 to 69
1624,female,CD,No Immunosuppressives,22535,positive,elderly,,booster2,05-Feb-22,23-Mar-21,319,mRNA,64,60 to 69
1625,female,CD,No Immunosuppressives,6041,positive,elderly,,booster2,24-May-22,23-Mar-21,427,mRNA,65,60 to 69
1626,male,UC,Immunomodulator Only,702,positive,adult,,primary,05-Jun-21,07-Apr-21,59,vector,57,50 to 59
1627,male,UC,Immunomodulator Only,11629,positive,adult,,booster1,19-Aug-21,11-Apr-21,130,vector,57,50 to 59
1628,male,UC,Immunomodulator Only,24839,positive,adult,,booster2,11-Feb-22,10-Apr-21,307,vector,58,50 to 59
1629,male,UC,Immunomodulator Only,10258,positive,adult,,booster2,23-Apr-22,08-Apr-21,380,vector,58,50 to 59
1630,male,CD,Corticosteroids,79,negative,adult,,primary,20-May-21,12-Apr-21,38,mRNA,55,50 to 59
1631,male,CD,Corticosteroids,396,positive,adult,,booster1,08-Jul-21,09-Apr-21,90,mRNA,55,50 to 59
1632,male,CD,Corticosteroids,18066,positive,adult,,booster2,15-Oct-21,12-Apr-21,186,mRNA,56,50 to 59
1633,male,CD,Corticosteroids,7565,positive,adult,,booster2,16-Mar-22,06-Apr-21,344,mRNA,56,50 to 59
1634,male,CD,Corticosteroids,3728,positive,adult,,booster2,18-Jun-22,09-Apr-21,435,mRNA,56,50 to 59
1635,male,CD,Combination Therapy,4704,positive,adult,,primary,04-Jul-21,29-May-21,36,mRNA,36,30 to 39
1636,female,UC,Tofacitinib Only,459,positive,adult,,primary,10-Jun-21,20-Apr-21,51,mRNA,25,18 to 29
1637,female,UC,Tofacitinib Only,7376,positive,adult,,booster1,05-Aug-21,21-Apr-21,106,mRNA,25,18 to 29
1638,female,UC,Tofacitinib Only,1757,positive,adult,,booster1,05-Jan-22,26-Apr-21,254,mRNA,26,18 to 29
1639,female,UC,Tofacitinib Only,10183,positive,adult,,booster2,15-Feb-22,20-Apr-21,301,mRNA,26,18 to 29
1640,male,UC,Anti-TNF Only,18240,positive,elderly,,booster1,10-Jun-21,18-Mar-21,84,mRNA,68,60 to 69
1641,male,UC,Anti-TNF Only,2040,positive,elderly,,booster1,30-Sep-21,17-Mar-21,197,mRNA,69,60 to 69
1642,male,UC,Anti-TNF Only,3706,positive,elderly,,booster2,19-Mar-22,16-Mar-21,368,mRNA,69,60 to 69
1643,female,CD,Vedolizumab Only,923,positive,adult,396,primary,30-Jun-21,03-May-21,58,mRNA,38,30 to 39
1644,female,CD,Vedolizumab Only,20218,positive,adult,229,booster2,14-Dec-21,30-Apr-21,228,mRNA,39,30 to 39
1645,female,CD,Vedolizumab Only,691,positive,adult,117,booster2,05-Apr-22,01-May-21,339,mRNA,39,30 to 39
1646,female,UC,Anti-TNF Only,2,negative,elderly,,primary,11-May-21,12-Mar-21,60,mRNA,65,60 to 69
1647,female,UC,Anti-TNF Only,15348,positive,elderly,,booster1,13-Jul-21,09-Mar-21,126,mRNA,65,60 to 69
1648,female,UC,Anti-TNF Only,41035,positive,elderly,,booster2,13-Jan-22,11-Mar-21,308,mRNA,66,60 to 69
1649,female,UC,Anti-TNF Only,7610,positive,elderly,,booster2,12-May-22,09-Mar-21,429,mRNA,66,60 to 69
1650,male,CD,Ustekinumab Only,823,positive,elderly,,primary,05-Aug-21,07-May-21,90,vector,62,60 to 69
1651,female,UC,Immunomodulator Only,464,positive,adult,,primary,15-Jun-21,08-May-21,38,mRNA,24,18 to 29
1652,female,UC,Immunomodulator Only,13990,positive,adult,,booster1,03-Aug-21,08-May-21,87,mRNA,24,18 to 29
1653,female,UC,Immunomodulator Only,3208,positive,adult,,booster1,27-Nov-21,07-May-21,204,mRNA,25,18 to 29
1654,female,CD,Combination Therapy,30,negative,adult,,primary,18-May-21,01-Apr-21,47,mRNA,59,50 to 59
1655,female,CD,Combination Therapy,105,negative,adult,,booster1,10-Aug-21,02-Apr-21,130,mRNA,59,50 to 59
1656,female,CD,Combination Therapy,1006,positive,adult,,booster2,21-Jan-22,28-Mar-21,299,mRNA,59,50 to 59
1657,female,CD,Ustekinumab Only,22364,positive,adult,300,booster1,21-May-21,02-Apr-21,49,mRNA,24,18 to 29
1658,female,CD,Ustekinumab Only,4368,positive,adult,182,booster1,16-Sep-21,06-Apr-21,163,mRNA,25,18 to 29
1659,male,CD,Combination Therapy,72,negative,adult,,primary,11-Jun-21,28-Apr-21,44,mRNA,55,50 to 59
1660,male,CD,Combination Therapy,2307,positive,adult,79,booster1,21-Jul-21,02-May-21,80,mRNA,55,50 to 59
1661,male,CD,Combination Therapy,36237,positive,adult,133,booster2,18-Feb-22,02-May-21,292,mRNA,55,50 to 59
1662,male,CD,Combination Therapy,5560,positive,adult,259,booster2,24-Jun-22,29-Apr-21,421,mRNA,56,50 to 59
1663,male,CD,Combination Therapy,692,positive,adult,,booster1,11-Jul-21,18-Apr-21,84,mRNA,33,30 to 39
1664,male,CD,Combination Therapy,474,positive,adult,,booster1,03-Oct-21,17-Apr-21,169,mRNA,33,30 to 39
1665,female,CD,Combination Therapy,14,negative,adult,,primary,25-Jun-21,16-May-21,40,vector,23,18 to 29
1666,female,CD,Combination Therapy,392,positive,adult,,booster1,20-Aug-21,14-May-21,98,vector,23,18 to 29
1667,female,CD,Anti-TNF Only,141,negative,elderly,341,booster1,11-May-21,13-Jan-21,118,mRNA,81,70+
1668,male,CD,Vedolizumab Only,3343,positive,elderly,,booster1,06-May-21,03-Mar-21,64,mRNA,78,70+
1669,male,CD,Vedolizumab Only,123,negative,elderly,,booster1,22-Oct-21,28-Feb-21,236,mRNA,78,70+
1670,female,UC,No Immunosuppressives,91,negative,adult,,primary,26-May-21,08-Apr-21,48,mRNA,50,50 to 59
1671,female,UC,No Immunosuppressives,2484,positive,adult,,booster1,31-Jul-21,06-Apr-21,116,mRNA,50,50 to 59
1672,female,CD,Anti-TNF Only,3370,positive,adult,,booster1,14-Jul-21,18-Apr-21,87,mRNA,53,50 to 59
1673,female,CD,Anti-TNF Only,9094,positive,adult,,booster2,19-Oct-21,16-Apr-21,186,mRNA,54,50 to 59
1674,female,CD,Anti-TNF Only,1262,positive,adult,,booster2,04-Feb-22,16-Apr-21,294,mRNA,54,50 to 59
1675,female,CD,Anti-TNF Only,6954,positive,adult,,booster2,11-May-22,17-Apr-21,389,mRNA,54,50 to 59
1676,male,CD,Ustekinumab Only,199,positive,adult,,primary,05-Jun-21,14-Mar-21,83,vector,60,60 to 69
1677,male,CD,Ustekinumab Only,2202,positive,adult,,booster1,11-Aug-21,18-Mar-21,146,vector,60,60 to 69
1678,male,CD,Ustekinumab Only,1371,positive,adult,,booster1,01-Dec-21,17-Mar-21,259,vector,61,60 to 69
1679,male,CD,Ustekinumab Only,7871,positive,adult,,booster2,02-Apr-22,16-Mar-21,382,vector,61,60 to 69
1680,male,CD,Ustekinumab Only,2521,positive,adult,,booster2,01-Jun-22,14-Mar-21,444,vector,61,60 to 69
1681,male,CD,No Immunosuppressives,66962,positive,adult,,booster1,05-May-22,03-May-21,367,mRNA,38,30 to 39
1682,male,CD,Corticosteroids,38,negative,adult,,primary,25-May-21,12-Apr-21,43,vector,31,30 to 39
1683,male,CD,Corticosteroids,3331,positive,adult,,booster1,15-Jun-21,15-Apr-21,61,vector,31,30 to 39
1684,male,CD,Corticosteroids,3401,positive,adult,,booster2,14-Oct-21,15-Apr-21,182,vector,32,30 to 39
1685,male,CD,Corticosteroids,521,positive,adult,,booster2,20-Jan-22,14-Apr-21,281,vector,32,30 to 39
1686,male,CD,Corticosteroids,918,positive,adult,,booster2,08-Jun-22,14-Apr-21,420,vector,32,30 to 39
1687,female,CD,Ustekinumab Only,478,positive,adult,292,primary,03-Jun-21,16-Apr-21,48,mRNA,56,50 to 59
1688,female,CD,Ustekinumab Only,45,negative,adult,229,booster1,05-Aug-21,13-Apr-21,114,mRNA,56,50 to 59
1689,female,CD,Ustekinumab Only,1966,positive,adult,,booster1,04-Nov-21,10-Apr-21,208,mRNA,56,50 to 59
1690,female,CD,Ustekinumab Only,16070,positive,adult,,booster2,24-Feb-22,11-Apr-21,319,mRNA,57,50 to 59
1691,female,CD,Anti-TNF Only,239,positive,adult,,primary,09-Jun-21,24-Apr-21,46,mRNA,34,30 to 39
1692,female,CD,Anti-TNF Only,3170,positive,adult,,booster1,29-Jul-21,22-Apr-21,98,mRNA,34,30 to 39
1693,female,CD,Anti-TNF Only,89,negative,adult,,primary,01-Jun-21,27-Apr-21,35,mRNA,39,30 to 39
1694,female,CD,Anti-TNF Only,3937,positive,adult,,booster1,25-Aug-21,28-Apr-21,119,mRNA,40,40 to 49
1695,female,CD,Anti-TNF Only,,,adult,,booster2,08-Feb-22,27-Apr-21,287,mRNA,40,40 to 49
1696,female,CD,Anti-TNF Only,12851,positive,adult,,booster2,25-Jun-22,27-Apr-21,424,mRNA,40,40 to 49
1697,male,CD,Ustekinumab Only,30883,positive,adult,,booster1,06-Jul-21,22-Apr-21,75,mRNA,20,18 to 29
1698,male,CD,Ustekinumab Only,,,adult,,booster2,23-Feb-22,16-Apr-21,313,mRNA,20,18 to 29
1699,female,UC,Vedolizumab Only,4224,positive,adult,,booster1,02-Jun-21,20-Apr-21,43,mRNA,58,50 to 59
1700,female,UC,Vedolizumab Only,2128,positive,adult,,booster1,30-Sep-21,19-Apr-21,164,mRNA,58,50 to 59
1701,female,UC,Vedolizumab Only,3229,positive,adult,,booster2,30-Jun-22,15-Apr-21,441,mRNA,59,50 to 59
1702,male,UC,Vedolizumab Only,19214,positive,adult,,booster1,04-Jun-21,04-Apr-21,61,mRNA,33,30 to 39
1703,male,UC,Vedolizumab Only,3667,positive,adult,,booster1,19-Oct-21,09-Apr-21,193,mRNA,34,30 to 39
1704,female,CD,Combination Therapy,1017,positive,adult,,primary,27-May-21,05-Apr-21,52,mRNA,28,18 to 29
1705,female,CD,Combination Therapy,6149,positive,adult,85,booster1,20-Aug-21,04-Apr-21,138,mRNA,28,18 to 29
1706,male,CD,Ustekinumab Only,687,positive,adult,,primary,26-Jun-21,25-Apr-21,62,mRNA,44,40 to 49
1707,male,CD,Ustekinumab Only,3006,positive,adult,,booster1,29-Sep-21,19-Apr-21,163,mRNA,44,40 to 49
1708,male,CD,Ustekinumab Only,7728,positive,adult,,booster2,06-Apr-22,20-Apr-21,351,mRNA,45,40 to 49
1709,female,CD,Anti-TNF Only,53768,positive,adult,,booster1,02-Jun-21,20-Mar-21,74,mRNA,32,30 to 39
1710,female,CD,Anti-TNF Only,2231,positive,adult,,booster1,06-Oct-21,23-Mar-21,197,mRNA,33,30 to 39
1711,female,CD,Anti-TNF Only,2394,positive,adult,,booster1,07-Aug-21,14-Apr-21,115,mRNA,51,50 to 59
1712,female,CD,Anti-TNF Only,92,negative,adult,,booster1,13-Nov-21,15-Apr-21,212,mRNA,51,50 to 59
1713,female,CD,Anti-TNF Only,5346,positive,adult,,booster2,11-Mar-22,15-Apr-21,330,mRNA,52,50 to 59
1714,female,CD,Anti-TNF Only,1767,positive,adult,,booster2,14-Jul-22,09-Apr-21,461,mRNA,52,50 to 59
1715,female,CD,Anti-TNF Only,17333,positive,adult,,booster1,12-Jun-21,04-Apr-21,69,vector,54,50 to 59
1716,female,CD,Anti-TNF Only,27912,positive,adult,,booster2,23-Oct-21,08-Apr-21,198,vector,55,50 to 59
1717,female,CD,Anti-TNF Only,121,negative,adult,269,primary,22-May-21,02-Apr-21,50,mRNA,22,18 to 29
1718,female,CD,Anti-TNF Only,1052,positive,adult,223,booster1,07-Jul-21,03-Apr-21,95,mRNA,22,18 to 29
1719,male,CD,Anti-TNF Only,35,negative,adult,,primary,03-Jun-21,18-Mar-21,77,vector,34,30 to 39
1720,male,CD,Anti-TNF Only,51,negative,adult,,primary,28-Sep-21,02-Mar-21,210,vector,35,30 to 39
1721,male,CD,Ustekinumab Only,782,positive,adult,,primary,04-Jun-21,13-Apr-21,52,mRNA,58,50 to 59
1722,male,CD,Ustekinumab Only,3326,positive,adult,,booster1,13-Aug-21,12-Apr-21,123,mRNA,58,50 to 59
1723,male,CD,Ustekinumab Only,,,adult,,booster2,21-Jan-22,09-Apr-21,287,mRNA,59,50 to 59
1724,male,CD,Ustekinumab Only,25250,positive,adult,,booster2,28-Apr-22,10-Apr-21,383,mRNA,59,50 to 59
1725,female,CD,Anti-TNF Only,182,positive,adult,31,primary,04-May-21,27-Apr-21,7,mRNA,30,30 to 39
1726,female,CD,Anti-TNF Only,7168,positive,adult,60,primary,02-Jun-21,27-Apr-21,36,mRNA,30,30 to 39
1727,female,CD,Anti-TNF Only,1953,positive,adult,157,booster1,07-Sep-21,30-Apr-21,130,mRNA,30,30 to 39
1728,female,CD,Anti-TNF Only,538,positive,adult,236,booster1,25-Nov-21,28-Apr-21,211,mRNA,30,30 to 39
1729,female,CD,Anti-TNF Only,3379,positive,adult,,booster2,25-Feb-22,01-May-21,300,mRNA,31,30 to 39
1730,male,CD,Anti-TNF Only,47,negative,adult,,primary,25-Jun-21,17-Apr-21,69,mRNA,57,50 to 59
1731,male,CD,Anti-TNF Only,4679,positive,adult,,booster1,04-Aug-21,15-Apr-21,111,mRNA,57,50 to 59
1732,male,CD,Anti-TNF Only,14974,positive,adult,,booster2,11-Dec-21,13-Apr-21,242,mRNA,57,50 to 59
1733,male,CD,Anti-TNF Only,1657,positive,adult,,booster2,02-Mar-22,19-Apr-21,317,mRNA,57,50 to 59
1734,female,CD,Combination Therapy,104,negative,adult,55,primary,14-Apr-21,07-Apr-21,7,mRNA,27,18 to 29
1735,male,CD,Combination Therapy,219,positive,elderly,,primary,06-May-21,16-Mar-21,51,vector,64,60 to 69
1736,male,CD,Combination Therapy,180,positive,elderly,,primary,10-Jun-21,15-Mar-21,87,vector,64,60 to 69
1737,male,CD,Combination Therapy,1776,positive,elderly,,booster1,07-Aug-21,15-Mar-21,145,vector,64,60 to 69
1738,male,CD,Combination Therapy,11067,positive,elderly,,booster2,08-Oct-21,19-Mar-21,203,vector,64,60 to 69
1739,male,CD,Combination Therapy,2413,positive,elderly,,booster2,22-Jan-22,18-Mar-21,310,vector,65,60 to 69
1740,male,CD,Combination Therapy,23729,positive,elderly,,booster2,11-Mar-22,14-Mar-21,362,vector,65,60 to 69
1741,male,CD,Combination Therapy,2936,positive,elderly,,booster2,01-Jul-22,18-Mar-21,470,vector,65,60 to 69
1742,female,CD,Ustekinumab Only,82,negative,adult,219,primary,22-Jun-21,29-Apr-21,54,mRNA,32,30 to 39
1743,female,CD,Ustekinumab Only,6631,positive,pediatric,184,booster1,27-Jul-21,29-Apr-21,89,mRNA,1,00 to 09
1744,female,CD,Ustekinumab Only,48801,positive,pediatric,75,booster1,12-Apr-22,27-Apr-21,350,mRNA,2,00 to 09
1745,female,CD,Anti-TNF Only,4400,positive,elderly,237,booster1,11-Sep-21,07-Jun-21,96,mRNA,65,60 to 69
1746,female,CD,Anti-TNF Only,61963,positive,elderly,40,booster2,15-Jun-22,11-Jun-21,369,mRNA,66,60 to 69
1747,male,UC,Vedolizumab Only,5460,positive,elderly,,booster1,05-Jun-21,01-Apr-21,65,mRNA,68,60 to 69
1748,male,UC,Vedolizumab Only,247,positive,elderly,,booster1,24-Sep-21,06-Apr-21,171,mRNA,68,60 to 69
1749,male,UC,Vedolizumab Only,1256,positive,elderly,,booster2,19-Nov-21,31-Mar-21,233,mRNA,68,60 to 69
1750,male,UC,Vedolizumab Only,127,negative,elderly,,booster2,12-Feb-22,04-Apr-21,314,mRNA,68,60 to 69
1751,male,UC,Vedolizumab Only,6945,positive,elderly,,booster2,13-May-22,06-Apr-21,402,mRNA,69,60 to 69
1752,male,CD,Combination Therapy,2200,positive,pediatric,101,primary,10-Jul-21,06-May-21,65,mRNA,3,00 to 09
1753,male,CD,Combination Therapy,5559,positive,pediatric,155,booster1,02-Sep-21,03-May-21,122,mRNA,12,10 to 17
1754,male,CD,Combination Therapy,2908,positive,pediatric,211,booster1,28-Oct-21,03-May-21,178,mRNA,15,10 to 17
1755,male,CD,Combination Therapy,2224,positive,pediatric,272,booster1,28-Dec-21,01-May-21,241,mRNA,12,10 to 17
1756,female,CD,Anti-TNF Only,22486,positive,pediatric,110,primary,01-Jun-21,12-Apr-21,50,mRNA,1,00 to 09
1757,female,CD,Anti-TNF Only,10581,positive,pediatric,161,booster1,22-Jul-21,15-Apr-21,98,mRNA,2,00 to 09
1758,female,CD,Anti-TNF Only,13538,positive,pediatric,273,booster2,11-Nov-21,15-Apr-21,210,mRNA,3,00 to 09
1759,female,CD,Anti-TNF Only,7597,positive,pediatric,,booster2,03-Mar-22,09-Apr-21,328,mRNA,4,00 to 09
1760,female,CD,Anti-TNF Only,870,positive,pediatric,,primary,02-Jun-21,11-Apr-21,52,mRNA,5,00 to 09
1761,female,CD,Anti-TNF Only,2865,positive,pediatric,,booster1,11-Aug-21,12-Apr-21,121,mRNA,6,00 to 09
1762,female,CD,Anti-TNF Only,1320,positive,pediatric,,booster1,21-Oct-21,10-Apr-21,194,mRNA,7,00 to 09
1763,female,UC,Vedolizumab Only,4625,positive,pediatric,316,booster1,20-Apr-21,31-Dec-20,110,mRNA,8,00 to 09
1764,female,UC,Vedolizumab Only,,,pediatric,29,booster2,31-Mar-22,27-Dec-20,459,mRNA,9,00 to 09
1765,male,UC,Corticosteroids,42,negative,elderly,257,primary,24-May-21,30-Mar-21,55,mRNA,63,60 to 69
1766,male,UC,Corticosteroids,1435,positive,elderly,155,booster1,03-Sep-21,29-Mar-21,158,mRNA,63,60 to 69
1767,male,UC,Corticosteroids,3834,positive,elderly,76,booster2,21-Nov-21,29-Mar-21,237,mRNA,63,60 to 69
1768,male,UC,Corticosteroids,8819,positive,elderly,36,booster2,13-Mar-22,03-Apr-21,344,mRNA,64,60 to 69
1769,female,UC,Vedolizumab Only,1211,positive,elderly,,booster1,04-Sep-21,02-Mar-21,186,mRNA,79,70+
1770,female,UC,Vedolizumab Only,636,positive,elderly,,booster2,19-Feb-22,07-Mar-21,349,mRNA,80,70+